ribostamycin profile

Ribostamycin: A broad-spectrum antimicrobial isolated from Streptomyces ribosifidicus. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ribostamycin : An amino cyclitol glycoside that is 4,6-diaminocyclohexane-1,2,3-triol having a 2,6-diamino-2,6-dideoxy-alpha-D-glucosyl residue attached at position 1 and a beta-D-ribosyl residue attached at position 2. It is an antibiotic produced by Streptomyces ribosidificus (formerly S. thermoflavus). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

ID Source	ID
PubMed CID	33042
CHEMBL ID	221572
CHEBI ID	45257
SCHEMBL ID	1649929
MeSH ID	M0019082

Synonym
chebi:45257 ,
CHEMBL221572
o-2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->4)-o-[.beta.-d-ribofuranosyl-(1->5)]-2-deoxy-d-streptamine
xylostatin
(2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(1r,2r,3s,4r,6s)-4,6-diamino-2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
hetangmycin
NSC138925 ,
RIO ,
ribostamycin
C01759
vistamycin
25546-65-0
DB03615
ribostamycin a
bu 1709
ribastamin
sf 733
antibiotic sf 733
nsc-138925
ribostamycinum [inn-latin]
dekamycin iv
ribostamicina [inn-spanish]
sf-733
d-streptamine, o-2,6-diamino-2,6-dideoxy-alpha-d-glucopyranosyl-(1-4)-o-(beta-d-ribofuranosyl-(1-5))-2-deoxy-
brn 1357280
d-streptamine, o-2,6-diamino-2,6-dideoxy-alpha-d-glucopyranosyl-(1-4)- o-(beta-d-ribofuranosyl-(1-5))-2-deoxy-
nsc 138925
o-2,6-diamino-2,6-dideoxy-alpha-d-glucopyranosyl-(1-4)-o-(beta-d-ribofuranosyl-(1-5))-2-deoxystreptamine
ribostamycine [inn-french]
ribostamycin [inn:ban]
einecs 247-091-5
o-2,6-diamino-2,6-dideoxy-alpha-d-glucopyranosyl-(1->4)-o-(beta-d-ribofuranosyl-(1->5))-2-deoxystreptamine
(2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(1r,2r,3s,4r,6s)-4,6-diamino-2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
D08478
ribostamycin (inn)
(1r,2r,3r,4r,6s)-4,6-diamino-3-hydroxy-2-(beta-d-ribofuranosyloxy)cyclohexyl 2,6-diamino-2,6-dideoxy-alpha-d-glucopyranoside
ribostamycine
ribostamycinum
ribostamicina
2q5jou7t53 ,
unii-2q5jou7t53
ribostamycin [inn]
d-streptamine, o-2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(.beta.-d-ribofuranosyl-(1->5))-2-deoxy-
ribostamycin [who-dd]
ribostamycin [mi]
o-2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(.beta.-d-ribofuranosyl-(1->5))-2-deoxystreptamine
NSKGQURZWSPSBC-VVPCINPTSA-N
SCHEMBL1649929
DTXSID6048541
(1r,2r,3s,4r,6s)-4,6-diamino-3-hydroxy-2-(beta-d-ribofuranosyloxy)cyclohexyl 2,6-diamino-2,6-dideoxy-alpha-d-glucopyranoside
HY-142127
CS-0378913
EN300-19766281
(2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-{[(1r,2r,3s,4r,6s)-4,6-diamino-2-{[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol
gtpl12161
(2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-(((1r,2r,3s,4r,6s)-4,6-diamino-2-(((2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-3-hydroxycyclohexyl)oxy)tetrahydro-2h-pyran-3,4-diol

Excerpt	Reference
"Ribostamycin is a broad-spectrum aminoglycoside antibiotic with a molecular weight of 454.5 g/mol. "	( Huo, Q; Leong, MB; Li Sip, YY; Zheng, T, 2018)
"Ribostamycin is a 4,5-disubstituted 2-deoxystreptamine (DOS)-containing aminoglycoside antibiotics and naturally produced by Streptomyces ribosidificus ATCC 21294. "	( Kurumbang, NP; Liou, K; Sohng, JK, 2011)
"Ribostamycin is an aminoglycoside antibiotic produced by Streptomyces ribosidificus, and extracted and isolated by NIIDA et. "	( Suzuki, Y; Umemura, K; Yamasaku, F, 1980)

Role	Description
metabolite	Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antimicrobial agent	A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
antibacterial drug	A drug used to treat or prevent bacterial infections.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Class	Description
amino cyclitol glycoside
aminoglycoside antibiotic
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Aminoglycoside 3'-phosphotransferase	Pseudomonas aeruginosa PAO1	Km	10.0000	10.0000	10.0000	10.0000	AID278807
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Assay ID	Title	Year	Journal	Article
AID428870	Antibacterial activity against Escherichia coli CSH-2 carrying Escherichia coli ARS3 pARS3 by agar dilution method	2007	Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12	Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID301914	Antibacterial activity against aminoglycoside-resistant Escherichia coli TG1 pSF815 after 12 to 18 hrs	2007	Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24	Synthesis and antibacterial activity of pyranmycin derivatives with N-1 and O-6 modifications.
AID1629128	Antimicrobial activity against Escherichia coli ATCC 25922 measured after 24 hrs by double-dilution method	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID523405	Antimicrobial activity against amikacin-susceptible Nocardia farcinica IFM 10152 after 3 days by broth microdilution method	2010	Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6	Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.
AID199517	Compound was tested for the inhibition of Rev-RBE RNA complex formation	1998	Journal of medicinal chemistry, Jan-15, Volume: 41, Issue:2	Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex.
AID1629132	Antimicrobial activity against aminoglycoside-resistant Klebsiella pneumoniae ATCC BAA-2470 measured after 24 hrs by double-dilution method	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID1629126	Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 measured after 24 hrs by double-dilution method	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID278811	Ratio of km to kcat for PH(3')-2b activity	2007	Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2	Overexpression and initial characterization of the chromosomal aminoglycoside 3'-O-phosphotransferase APH(3')-IIb from Pseudomonas aeruginosa.
AID540209	Volume of distribution at steady state in human after iv administration	2008	Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7	Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID664696	Antimicrobial activity against Staphylococcus aureus ATCC 29213	2011	ACS medicinal chemistry letters, Dec-08, Volume: 2, Issue:12	Toward Overcoming Staphylococcus aureus Aminoglycoside Resistance Mechanisms with a Functionally Designed Neomycin Analogue.
AID1629127	Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 measured after 24 hrs by double-dilution method	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID278810	Antibacterial activity against Escherichia coli BL21(DE3) expressing Pseudomonas aeruginosa APH(3')-2b	2007	Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2	Overexpression and initial characterization of the chromosomal aminoglycoside 3'-O-phosphotransferase APH(3')-IIb from Pseudomonas aeruginosa.
AID428879	Binding affinity to 16S rRNA G1494(N7) position in A1408-methylated Escherichia coli JM109 30S sunit at 1000 uM by footprint assay	2007	Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12	Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID540212	Mean residence time in human after iv administration	2008	Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7	Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID523397	Antimicrobial activity against amikacin-susceptible Nocardia farcinica IFM 10152 harboring 16s rRNA A1408G mutant after 3 days by broth microdilution method	2010	Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6	Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.
AID375076	Binding affinity to A-site RNA	2009	Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12	Design and implementation of an ribonucleic acid (RNA) directed fragment library.
AID428878	Binding affinity to 16S rRNA G1494(N7) position in A1408-methylated Escherichia coli JM109 30S sunit at 100 uM by footprint assay	2007	Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12	Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID301912	Antibacterial activity against Escherichia coli ATCC 25922 after 12 to 18 hrs	2007	Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24	Synthesis and antibacterial activity of pyranmycin derivatives with N-1 and O-6 modifications.
AID428876	Binding affinity to 16S rRNA G1494(N7) position in wild type Escherichia coli JM109 30S sunit at 100 uM by footprint assay	2007	Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12	Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID1629130	Antimicrobial activity against aminoglycoside-resistant Burkholderia cepacia ATCC 25416 measured after 24 hrs by double-dilution method	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID428872	Antibacterial activity against Escherichia coli JM109 carrying pMCL-BE by agar dilution method	2007	Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12	Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID523398	Antimicrobial activity against amikacin-susceptible Nocardia farcinica IFM 10152 harboring 16s rRNA A1408G mutant after 5 days by broth microdilution method	2010	Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6	Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.
AID1629131	Antimicrobial activity against aminoglycoside-resistant Escherichia coli ATCC BAA-2452 measured after 24 hrs by double-dilution method	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID428871	Antibacterial activity against Escherichia coli CSH-2 by agar dilution method	2007	Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12	Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID65062	Lethal dose required to kill 90% of the Escherichia coli K12 (ATCC 25868) cell population	1987	Journal of medicinal chemistry, Feb, Volume: 30, Issue:2	Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID301915	Antibacterial activity against aminoglycoside-resistant Escherichia coli TG1 pTZ19U-3 after 12 to 18 hrs	2007	Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24	Synthesis and antibacterial activity of pyranmycin derivatives with N-1 and O-6 modifications.
AID1629134	Inhibition of cytosolic eukaryotic translation in rabbit reticulocyte S30 extract measured after 60 mins by coupled transcription/translation-based luciferase reporter gene assay	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID271282	Binding affinity to bacterial ribosomal A site RNA oligonucleotide	2006	Journal of medicinal chemistry, Sep-07, Volume: 49, Issue:18	Binding of aminoglycosidic antibiotics to the oligonucleotide A-site model and 30S ribosomal subunit: Poisson-Boltzmann model, thermal denaturation, and fluorescence studies.
AID664699	Antimicrobial activity against Staphylococcus aureus harboring APH(2'''') and AAC(6') enzymes	2011	ACS medicinal chemistry letters, Dec-08, Volume: 2, Issue:12	Toward Overcoming Staphylococcus aureus Aminoglycoside Resistance Mechanisms with a Functionally Designed Neomycin Analogue.
AID428877	Binding affinity to 16S rRNA G1494(N7) position in wild type Escherichia coli JM109 30S sunit at 1000 uM by footprint assay	2007	Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12	Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID1629125	Antimicrobial activity against Haemophilus influenzae ATCC 10211 measured after 24 hrs by double-dilution method	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID278809	Antibacterial activity against Escherichia coli BL21(DE3)	2007	Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2	Overexpression and initial characterization of the chromosomal aminoglycoside 3'-O-phosphotransferase APH(3')-IIb from Pseudomonas aeruginosa.
AID1629123	Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 measured after 24 hrs by double-dilution method	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID428873	Antibacterial activity against Escherichia coli JM109 carrying pMCL210 by agar dilution method	2007	Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12	Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID523396	Antimicrobial activity against amikacin-resistant Nocardia farcinica IFM 10580 after 3 days by broth microdilution method	2010	Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6	Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.
AID1629135	Selectivity ratio, ratio of IC50 for cytosolic eukaryotic translation in rabbit reticulocyte S30 extract to IC50 for 16S rRNA A-site in Escherichia coli S30 extract	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID278807	Activity against Pseudomonas aeruginosa APH(3')-2b expressed in Escherichia coli BL21(DE3) assessed as phosphorylation	2007	Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2	Overexpression and initial characterization of the chromosomal aminoglycoside 3'-O-phosphotransferase APH(3')-IIb from Pseudomonas aeruginosa.
AID301913	Antibacterial activity against aminoglycoside-susceptible Escherichia coli TG1 after 12 to 18 hrs	2007	Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24	Synthesis and antibacterial activity of pyranmycin derivatives with N-1 and O-6 modifications.
AID65071	Estimated rate of [3H]DHS uptake in Escherichia coli K12 (ATCC 25868)	1987	Journal of medicinal chemistry, Feb, Volume: 30, Issue:2	Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID1629133	Binding affinity to 16S rRNA A-site in Escherichia coli S30 extract assessed as inhibition of translation measured after 30 mins by coupled transcription/translation-based luciferase reporter gene assay	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID1629122	Antimicrobial activity against Pseudomonas aeruginosa ATCC 47085 measured after 24 hrs by double-dilution method	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID2940	Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli	2001	Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2	Which aminoglycoside ring is most important for binding? A hydropathic analysis of gentamicin, paromomycin, and analogues.
AID664698	Antimicrobial activity against Staphylococcus aureus harboring ANT(4')-1 enzyme	2011	ACS medicinal chemistry letters, Dec-08, Volume: 2, Issue:12	Toward Overcoming Staphylococcus aureus Aminoglycoside Resistance Mechanisms with a Functionally Designed Neomycin Analogue.
AID540210	Clearance in human after iv administration	2008	Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7	Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID1629129	Antimicrobial activity against Acinetobacter baumannii ATCC 19606 measured after 24 hrs by double-dilution method	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID65065	Percent killing of the total Escherichia coli K12 (ATCC 25868) cells at the C50 concentration was determined.	1987	Journal of medicinal chemistry, Feb, Volume: 30, Issue:2	Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID278808	Antibacterial activity against Pseudomonas aeruginosa ATCC 27853	2007	Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2	Overexpression and initial characterization of the chromosomal aminoglycoside 3'-O-phosphotransferase APH(3')-IIb from Pseudomonas aeruginosa.
AID65059	Concentration required for half maximum rate of enhanced [3H]DHS uptake in Escherichia coli K12	1987	Journal of medicinal chemistry, Feb, Volume: 30, Issue:2	Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID1629124	Antimicrobial activity against Haemophilus influenzae ATCC 49247 measured after 24 hrs by double-dilution method	2016	Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17	Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID428869	Antibacterial activity against Escherichia coli isolate ARS3 carrying pARS3 by agar dilution method	2007	Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12	Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID664697	Antimicrobial activity against Staphylococcus aureus harboring APH(3'/5'''')-3 enzyme	2011	ACS medicinal chemistry letters, Dec-08, Volume: 2, Issue:12	Toward Overcoming Staphylococcus aureus Aminoglycoside Resistance Mechanisms with a Functionally Designed Neomycin Analogue.
AID540213	Half life in human after iv administration	2008	Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7	Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID1159550	Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening	2015	Nature cell biology, Nov, Volume: 17, Issue:11	6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	50 (45.45)	18.7374
1990's	7 (6.36)	18.2507
2000's	27 (24.55)	29.6817
2010's	25 (22.73)	24.3611
2020's	1 (0.91)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	3 (2.61%)	5.53%
Reviews	3 (2.61%)	6.00%
Case Studies	4 (3.48%)	4.05%
Observational	0 (0.00%)	0.25%
Other	105 (91.30%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Description	Relationhip Strength	Studies	Classes	Roles
spermidine	[no description available]	medium	2	polyazaalkane; triamine	autophagy inducer; fundamental metabolite; geroprotector
chloramphenicol	[no description available]	medium	2	C-nitro compound; carboxamide; diol; organochlorine compound	antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor
framycetin	[no description available]	high	34	aminoglycoside	allergen; antibacterial drug; Escherichia coli metabolite
spectinomycin	[no description available]	high	5	cyclic acetal; cyclic hemiketal; cyclic ketone; pyranobenzodioxin; secondary alcohol; secondary amino compound	antibacterial drug; antimicrobial agent; bacterial metabolite
streptomycin	[no description available]	high	9	antibiotic antifungal drug; antibiotic fungicide; streptomycins	antibacterial drug; antifungal agrochemical; antimicrobial agent; antimicrobial drug; bacterial metabolite; protein synthesis inhibitor
sisomicin	[no description available]	high	9	amino cyclitol glycoside; aminoglycoside antibiotic; beta-L-arabinoside; monosaccharide derivative
tobramycin	[no description available]	high	24	amino cyclitol glycoside	antibacterial agent; antimicrobial agent; toxin
amikacin	[no description available]	high	19	alpha-D-glucoside; amino cyclitol glycoside; aminoglycoside; carboxamide	antibacterial drug; antimicrobial agent; nephrotoxin
lividomycin	[no description available]	medium	6	lividomycins	metabolite
gentamicin c1	[no description available]	medium	2
paromomycin	[no description available]	high	31	amino cyclitol glycoside; aminoglycoside antibiotic	anthelminthic drug; antibacterial drug; antiparasitic agent; antiprotozoal drug
2-deoxystreptamine	[no description available]	medium	2
bekanamycin	[no description available]	medium	8	kanamycins
netilmicin	[no description available]	medium	4
gentamicin sulfate	[no description available]	medium	5
tetracycline	[no description available]	medium	2
win 52035	[no description available]	medium	1	aromatic ether
win 53338	[no description available]	medium	1	isoxazoles; monochlorobenzenes	antiviral agent
disoxaril	[no description available]	medium	1	aromatic ether
neamine	[no description available]	medium	8	2,6-dideoxy-alpha-D-glucoside; aminoglycoside	antibacterial agent
paromamine	[no description available]	medium	1	aminoglycoside; primary amino compound; triamine
antibiotic g 418	[no description available]	medium	2
kanamycin a	[no description available]	medium	27	kanamycins	bacterial metabolite
arbekacin	[no description available]	medium	2	aminoglycoside; kanamycins	antibacterial agent; antibacterial drug; antimicrobial agent; protein synthesis inhibitor
dibekacin	[no description available]	medium	8	kanamycins	antibacterial agent; protein synthesis inhibitor
isepamicin	[no description available]	medium	3
quinacrine	[no description available]	medium	1	acridines; aromatic ether; organochlorine compound; tertiary amino compound	antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
aminocaproic acid	[no description available]	medium	1	amino acid zwitterion; epsilon-amino acid; omega-amino fatty acid	antifibrinolytic drug; hematologic agent; metabolite
1-(3-chlorophenyl)piperazine	[no description available]	medium	1	monochlorobenzenes; N-arylpiperazine	drug metabolite; environmental contaminant; serotonergic agonist; xenobiotic
enprofylline	[no description available]	medium	1	oxopurine	anti-arrhythmia drug; anti-asthmatic drug; bronchodilator agent; non-steroidal anti-inflammatory drug
tacrine	[no description available]	medium	1	acridines; aromatic amine	EC 3.1.1.7 (acetylcholinesterase) inhibitor
acebutolol	[no description available]	medium	1	aromatic amide; ethanolamines; ether; monocarboxylic acid amide; propanolamine; secondary amino compound	anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympathomimetic agent
acetaminophen	[no description available]	medium	1	acetamides; phenols	antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; cyclooxygenase 3 inhibitor; environmental contaminant; ferroptosis inducer; geroprotector; hepatotoxic agent; human blood serum metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
acetazolamide	[no description available]	medium	1	monocarboxylic acid amide; sulfonamide; thiadiazoles	anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor
albuterol	[no description available]	medium	1	phenols; phenylethanolamines; secondary amino compound	beta-adrenergic agonist; bronchodilator agent; environmental contaminant; xenobiotic
alfuzosin	[no description available]	medium	1	monocarboxylic acid amide; quinazolines; tetrahydrofuranol	alpha-adrenergic antagonist; antihypertensive agent; antineoplastic agent
alosetron	[no description available]	medium	1	imidazoles; pyridoindole	antiemetic; gastrointestinal drug; serotonergic antagonist
alprazolam	[no description available]	medium	1	organochlorine compound; triazolobenzodiazepine	anticonvulsant; anxiolytic drug; GABA agonist; muscle relaxant; sedative; xenobiotic
alprenolol	[no description available]	medium	1	secondary alcohol; secondary amino compound	anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent
amantadine	[no description available]	medium	1	adamantanes; primary aliphatic amine	analgesic; antiparkinson drug; antiviral drug; dopaminergic agent; NMDA receptor antagonist; non-narcotic analgesic
diatrizoic acid	[no description available]	medium	1	acetamides; benzoic acids; organoiodine compound	environmental contaminant; radioopaque medium; xenobiotic
theophylline	[no description available]	medium	1	dimethylxanthine	adenosine receptor antagonist; anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; drug metabolite; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; fungal metabolite; human blood serum metabolite; immunomodulator; muscle relaxant; vasodilator agent
amiodarone	[no description available]	medium	1	1-benzofurans; aromatic ketone; organoiodine compound; tertiary amino compound	cardiovascular drug
amitriptyline	[no description available]	medium	1	carbotricyclic compound; tertiary amine	adrenergic uptake inhibitor; antidepressant; environmental contaminant; tropomyosin-related kinase B receptor agonist; xenobiotic
amlodipine	[no description available]	medium	1	dihydropyridine; ethyl ester; methyl ester; monochlorobenzenes; primary amino compound	antihypertensive agent; calcium channel blocker; vasodilator agent
amsacrine	[no description available]	medium	1	acridines; aromatic ether; sulfonamide	antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
antipyrine	[no description available]	medium	1	pyrazolone	antipyretic; cyclooxygenase 3 inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
aspirin	[no description available]	medium	1	benzoic acids; phenyl acetates; salicylates	anticoagulant; antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; EC 1.1.1.188 (prostaglandin-F synthase) inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; plant activator; platelet aggregation inhibitor; prostaglandin antagonist; teratogenic agent
atenolol	[no description available]	medium	1	ethanolamines; monocarboxylic acid amide; propanolamine	anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; sympatholytic agent; xenobiotic
azelastine	[no description available]	medium	1	monochlorobenzenes; phthalazines; tertiary amino compound	anti-allergic agent; anti-asthmatic drug; bronchodilator agent; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; H1-receptor antagonist; platelet aggregation inhibitor
betaxolol	[no description available]	medium	1	propanolamine	antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent
bevantolol	[no description available]	medium	1	propanolamine	anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; calcium channel blocker
biperiden	[no description available]	medium	1	piperidines; tertiary alcohol; tertiary amino compound	antidote to sarin poisoning; antidyskinesia agent; antiparkinson drug; muscarinic antagonist; parasympatholytic
bisoprolol	[no description available]	medium	1	secondary alcohol; secondary amine	anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent
bromazepam	[no description available]	medium	1	organic molecular entity
bromopride	[no description available]	medium	1	benzamides
brotizolam	[no description available]	medium	1	organic molecular entity
buflomedil	[no description available]	medium	1	aromatic ketone
bumetanide	[no description available]	medium	1	amino acid; benzoic acids; sulfonamide	diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
bunazosin	[no description available]	medium	1	quinazolines
bupivacaine	[no description available]	medium	1	aromatic amide; piperidinecarboxamide; tertiary amino compound
busulfan	[no description available]	medium	1	methanesulfonate ester	alkylating agent; antineoplastic agent; carcinogenic agent; insect sterilant; teratogenic agent
caffeine	[no description available]	medium	1	purine alkaloid; trimethylxanthine	adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic
verapamil	[no description available]	medium	1	aromatic ether; nitrile; polyether; tertiary amino compound
metrizoate	[no description available]	medium	1	monocarboxylic acid	radioopaque medium
carmustine	[no description available]	medium	1	N-nitrosoureas; organochlorine compound	alkylating agent; antineoplastic agent
carvedilol	[no description available]	medium	1	carbazoles; secondary alcohol; secondary amino compound	alpha-adrenergic antagonist; antihypertensive agent; beta-adrenergic antagonist; cardiovascular drug; vasodilator agent
chlorambucil	[no description available]	medium	1	aromatic amine; monocarboxylic acid; nitrogen mustard; organochlorine compound; tertiary amino compound	alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent
chlordiazepoxide	[no description available]	medium	1	benzodiazepine
chloroquine	[no description available]	medium	1	aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug
chlorpheniramine	[no description available]	medium	1	monochlorobenzenes; pyridines; tertiary amino compound	anti-allergic agent; antidepressant; antipruritic drug; H1-receptor antagonist; histamine antagonist; serotonin uptake inhibitor
chlorpromazine	[no description available]	medium	1	organochlorine compound; phenothiazines; tertiary amine	anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug
chlorpropamide	[no description available]	medium	1	monochlorobenzenes; N-sulfonylurea	hypoglycemic agent; insulin secretagogue
chlorthalidone	[no description available]	medium	1	isoindoles; monochlorobenzenes; sulfonamide
cifenline	[no description available]	medium	1	diarylmethane
cimetidine	[no description available]	medium	1	aliphatic sulfide; guanidines; imidazoles; nitrile	adjuvant; analgesic; anti-ulcer drug; H2-receptor antagonist; P450 inhibitor
ciprofloxacin	[no description available]	medium	1	aminoquinoline; cyclopropanes; fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone; zwitterion	antibacterial drug; antiinfective agent; antimicrobial agent; DNA synthesis inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; environmental contaminant; topoisomerase IV inhibitor; xenobiotic
citalopram	[no description available]	medium	1	2-benzofurans; cyclic ether; nitrile; organofluorine compound; tertiary amino compound
clomipramine	[no description available]	medium	1	dibenzoazepine	anticoronaviral agent; antidepressant; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; serotonergic antagonist; serotonergic drug; serotonin uptake inhibitor
clonazepam	[no description available]	medium	1	1,4-benzodiazepinone; monochlorobenzenes	anticonvulsant; anxiolytic drug; GABA modulator
clonidine	[no description available]	medium	1	clonidine; imidazoline
chlorazepate	[no description available]	medium	1	1,4-benzodiazepinone	anticonvulsant; anxiolytic drug; GABA modulator; prodrug
dapsone	[no description available]	medium	1	substituted aniline; sulfone	anti-inflammatory drug; antiinfective agent; antimalarial; leprostatic drug
desipramine	[no description available]	medium	1	dibenzoazepine; secondary amino compound	adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; cholinergic antagonist; drug allergen; EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; serotonin uptake inhibitor
nordazepam	[no description available]	medium	1	1,4-benzodiazepinone; organochlorine compound	anticonvulsant; anxiolytic drug; GABA modulator; human metabolite; sedative
amphetamine	[no description available]	medium	1	primary amine
diazepam	[no description available]	medium	1	1,4-benzodiazepinone; organochlorine compound	anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic
diazoxide	[no description available]	medium	1	benzothiadiazine; organochlorine compound; sulfone	antihypertensive agent; beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; diuretic; K-ATP channel agonist; sodium channel blocker; sympathomimetic agent; vasodilator agent
diclofenac	[no description available]	medium	1	amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound	antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
diflunisal	[no description available]	medium	1	monohydroxybenzoic acid; organofluorine compound	non-narcotic analgesic; non-steroidal anti-inflammatory drug
diphenhydramine	[no description available]	medium	1	ether; tertiary amino compound	anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative
disopyramide	[no description available]	medium	1	monocarboxylic acid amide; pyridines; tertiary amino compound	anti-arrhythmia drug
valproic acid	[no description available]	medium	1	branched-chain fatty acid; branched-chain saturated fatty acid	anticonvulsant; antimanic drug; EC 3.5.1.98 (histone deacetylase) inhibitor; GABA agent; neuroprotective agent; psychotropic drug; teratogenic agent
domperidone	[no description available]	medium	1	benzimidazoles; heteroarylpiperidine	antiemetic; dopaminergic antagonist
doxapram	[no description available]	medium	1	morpholines; pyrrolidin-2-ones	central nervous system stimulant
doxazosin	[no description available]	medium	1	aromatic amine; benzodioxine; monocarboxylic acid amide; N-acylpiperazine; N-arylpiperazine; quinazolines	alpha-adrenergic antagonist; antihyperplasia drug; antihypertensive agent; antineoplastic agent; vasodilator agent
doxepin	[no description available]	medium	1	dibenzooxepine; tertiary amino compound	antidepressant
dyphylline	[no description available]	medium	1	oxopurine; propane-1,2-diols	bronchodilator agent; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; muscle relaxant; vasodilator agent
enoxacin	[no description available]	medium	1	1,8-naphthyridine derivative; amino acid; fluoroquinolone antibiotic; monocarboxylic acid; N-arylpiperazine; quinolone antibiotic	antibacterial drug; DNA synthesis inhibitor
ethacrynic acid	[no description available]	medium	1	aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid	EC 2.5.1.18 (glutathione transferase) inhibitor; ion transport inhibitor; loop diuretic
etilefrine	[no description available]	medium	1	phenols
felodipine	[no description available]	medium	1	dichlorobenzene; dihydropyridine; ethyl ester; methyl ester	anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent
berotek	[no description available]	medium	1	resorcinols; secondary alcohol; secondary amino compound	beta-adrenergic agonist; bronchodilator agent; sympathomimetic agent; tocolytic agent
fenspiride	[no description available]	medium	1	azaspiro compound
fentanyl	[no description available]	medium	1	anilide; monocarboxylic acid amide; piperidines	adjuvant; anaesthesia adjuvant; anaesthetic; intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic
flecainide	[no description available]	medium	1	aromatic ether; monocarboxylic acid amide; organofluorine compound; piperidines	anti-arrhythmia drug
fleroxacin	[no description available]	medium	1	difluorobenzene; fluoroquinolone antibiotic; monocarboxylic acid; N-alkylpiperazine; quinolines	antibacterial drug; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor
fluconazole	[no description available]	medium	1	conazole antifungal drug; difluorobenzene; tertiary alcohol; triazole antifungal drug	environmental contaminant; P450 inhibitor; xenobiotic
flucytosine	[no description available]	medium	1	aminopyrimidine; nucleoside analogue; organofluorine compound; pyrimidine antifungal drug; pyrimidone	prodrug
flumazenil	[no description available]	medium	1	ethyl ester; imidazobenzodiazepine; organofluorine compound	antidote to benzodiazepine poisoning; GABA antagonist
flunitrazepam	[no description available]	medium	1	1,4-benzodiazepinone; C-nitro compound; monofluorobenzenes	anxiolytic drug; GABAA receptor agonist; sedative
fluorescite	[no description available]	medium	1	benzoic acids; cyclic ketone; hydroxy monocarboxylic acid; organic heterotricyclic compound; phenols; xanthene dye	fluorescent dye; radioopaque medium
fluorouracil	[no description available]	medium	1	nucleobase analogue; organofluorine compound	antimetabolite; antineoplastic agent; environmental contaminant; immunosuppressive agent; radiosensitizing agent; xenobiotic
foscarnet	[no description available]	medium	1	carboxylic acid; one-carbon compound; phosphonic acids	antiviral drug; geroprotector; HIV-1 reverse transcriptase inhibitor; sodium-dependent Pi-transporter inhibitor
furosemide	[no description available]	medium	1	chlorobenzoic acid; furans; sulfonamide	environmental contaminant; loop diuretic; xenobiotic
gabapentin	[no description available]	medium	1	gamma-amino acid	anticonvulsant; calcium channel blocker; environmental contaminant; xenobiotic
glimepiride	[no description available]	medium	1	sulfonamide
glipizide	[no description available]	medium	1	aromatic amide; monocarboxylic acid amide; N-sulfonylurea; pyrazines	EC 2.7.1.33 (pantothenate kinase) inhibitor; hypoglycemic agent; insulin secretagogue
glyburide	[no description available]	medium	1	monochlorobenzenes; N-sulfonylurea	anti-arrhythmia drug; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor; hypoglycemic agent
granisetron	[no description available]	medium	1	aromatic amide; indazoles
guanfacine	[no description available]	medium	1	acetamides
haloperidol	[no description available]	medium	1	aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol	antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist
hexobarbital	[no description available]	medium	1	barbiturates
hydralazine	[no description available]	medium	1	azaarene; hydrazines; ortho-fused heteroarene; phthalazines	antihypertensive agent; vasodilator agent
hydroflumethiazide	[no description available]	medium	1	benzothiadiazine; thiazide	antihypertensive agent; diuretic
hydroxychloroquine	[no description available]	medium	1	aminoquinoline; organochlorine compound; primary alcohol; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; antirheumatic drug; dermatologic drug
hydroxyurea	[no description available]	medium	1	one-carbon compound; ureas	antimetabolite; antimitotic; antineoplastic agent; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; genotoxin; immunomodulator; radical scavenger; teratogenic agent
hypericin	[no description available]	medium	1
ibuprofen	[no description available]	medium	1	monocarboxylic acid	antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; radical scavenger; xenobiotic
lidocaine	[no description available]	medium	1	benzenes; monocarboxylic acid amide; tertiary amino compound	anti-arrhythmia drug; drug allergen; environmental contaminant; local anaesthetic; xenobiotic
ifosfamide	[no description available]	medium	1	ifosfamides	alkylating agent; antineoplastic agent; environmental contaminant; immunosuppressive agent; xenobiotic
imipramine	[no description available]	medium	1	dibenzoazepine	adrenergic uptake inhibitor; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
amrinone	[no description available]	medium	1	bipyridines	EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
indomethacin	[no description available]	medium	1	aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole	analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic
iohexol	[no description available]	medium	1	benzenedicarboxamide; organoiodine compound	environmental contaminant; radioopaque medium; xenobiotic
iopromide	[no description available]	medium	1	dicarboxylic acid diamide; organoiodine compound	environmental contaminant; nephrotoxic agent; radioopaque medium; xenobiotic
iothalamic acid	[no description available]	medium	1	organic molecular entity
avapro	[no description available]	medium	1	azaspiro compound; biphenylyltetrazole	angiotensin receptor antagonist; antihypertensive agent; environmental contaminant; xenobiotic
isoniazid	[no description available]	medium	1	carbohydrazide	antitubercular agent; drug allergen
isoproterenol	[no description available]	medium	1	catechols; secondary alcohol; secondary amino compound	beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; sympathomimetic agent
isradipine	[no description available]	medium	1	benzoxadiazole; dihydropyridine; isopropyl ester; methyl ester
itraconazole	[no description available]	medium	1	piperazines
ketamine	[no description available]	medium	1	cyclohexanones; monochlorobenzenes; secondary amino compound	analgesic; environmental contaminant; intravenous anaesthetic; neurotoxin; NMDA receptor antagonist; xenobiotic
ketanserin	[no description available]	medium	1	aromatic ketone; organofluorine compound; piperidines; quinazolines	alpha-adrenergic antagonist; antihypertensive agent; cardiovascular drug; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; serotonergic antagonist
ketoprofen	[no description available]	medium	1	benzophenones; oxo monocarboxylic acid	antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-steroidal anti-inflammatory drug; xenobiotic
ketorolac	[no description available]	medium	1	amino acid; aromatic ketone; monocarboxylic acid; pyrrolizines; racemate	analgesic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug
labetalol	[no description available]	medium	1	benzamides; benzenes; phenols; primary carboxamide; salicylamides; secondary alcohol; secondary amino compound
lansoprazole	[no description available]	medium	1	benzimidazoles; pyridines; sulfoxide	anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
letrozole	[no description available]	medium	1	nitrile; triazoles	antineoplastic agent; EC 1.14.14.14 (aromatase) inhibitor
lorazepam	[no description available]	medium	1	benzodiazepine
losartan	[no description available]	medium	1	biphenylyltetrazole; imidazoles	angiotensin receptor antagonist; anti-arrhythmia drug; antihypertensive agent; endothelin receptor antagonist
maprotiline	[no description available]	medium	1	anthracenes
mebendazole	[no description available]	medium	1	aromatic ketone; benzimidazoles; carbamate ester	antinematodal drug; microtubule-destabilising agent; tubulin modulator
meperidine	[no description available]	medium	1	ethyl ester; piperidinecarboxylate ester; tertiary amino compound	antispasmodic drug; kappa-opioid receptor agonist; mu-opioid receptor agonist; opioid analgesic
mepivacaine	[no description available]	medium	1	piperidinecarboxamide	drug allergen; local anaesthetic
meprobamate	[no description available]	medium	1	organic molecular entity
mesalamine	[no description available]	medium	1	amino acid; aromatic amine; monocarboxylic acid; monohydroxybenzoic acid; phenols	non-steroidal anti-inflammatory drug
metformin	[no description available]	medium	1	guanidines	environmental contaminant; geroprotector; hypoglycemic agent; xenobiotic
methadone	[no description available]	medium	1	benzenes; diarylmethane; ketone; tertiary amino compound
methapyrilene	[no description available]	medium	1	ethylenediamine derivative	anti-allergic agent; carcinogenic agent; H1-receptor antagonist; sedative
methylphenidate	[no description available]	medium	1	beta-amino acid ester; methyl ester; piperidines
metoclopramide	[no description available]	medium	1	benzamides; monochlorobenzenes; substituted aniline; tertiary amino compound	antiemetic; dopaminergic antagonist; environmental contaminant; gastrointestinal drug; xenobiotic
metolazone	[no description available]	medium	1	organochlorine compound; quinazolines; sulfonamide	antihypertensive agent; diuretic; ion transport inhibitor
metoprolol	[no description available]	medium	1	aromatic ether; propanolamine; secondary alcohol; secondary amino compound	antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; geroprotector; xenobiotic
metronidazole	[no description available]	medium	1	C-nitro compound; imidazoles; primary alcohol	antiamoebic agent; antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; environmental contaminant; prodrug; radiosensitizing agent; xenobiotic
mexiletine	[no description available]	medium	1	aromatic ether; primary amino compound	anti-arrhythmia drug
midazolam	[no description available]	medium	1	imidazobenzodiazepine; monofluorobenzenes; organochlorine compound	anticonvulsant; antineoplastic agent; anxiolytic drug; apoptosis inducer; central nervous system depressant; GABAA receptor agonist; general anaesthetic; muscle relaxant; sedative
milrinone	[no description available]	medium	1	bipyridines; nitrile; pyridone	cardiotonic drug; EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor; platelet aggregation inhibitor; vasodilator agent
mirtazapine	[no description available]	medium	1	benzazepine; tetracyclic antidepressant	alpha-adrenergic antagonist; anxiolytic drug; H1-receptor antagonist; histamine antagonist; oneirogen; serotonergic antagonist
mitoxantrone	[no description available]	medium	1	dihydroxyanthraquinone	analgesic; antineoplastic agent
moclobemide	[no description available]	medium	1	benzamides; monochlorobenzenes; morpholines	antidepressant; environmental contaminant; xenobiotic
acecainide	[no description available]	medium	1	acetamides; benzamides	anti-arrhythmia drug
naratriptan	[no description available]	medium	1	heteroarylpiperidine; sulfonamide; tryptamines	serotonergic agonist; vasoconstrictor agent
nefazodone	[no description available]	medium	1	aromatic ether; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; triazoles	alpha-adrenergic antagonist; analgesic; antidepressant; serotonergic antagonist; serotonin uptake inhibitor
nefopam	[no description available]	medium	1	benzoxazocine; tertiary amino compound
nevirapine	[no description available]	medium	1	cyclopropanes; dipyridodiazepine	antiviral drug; HIV-1 reverse transcriptase inhibitor
nicardipine	[no description available]	medium	1	benzenes; C-nitro compound; diester; dihydropyridine; methyl ester; tertiary amino compound
nifedipine	[no description available]	medium	1	C-nitro compound; dihydropyridine; methyl ester	calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent
nimodipine	[no description available]	medium	1	2-methoxyethyl ester; C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; isopropyl ester	antihypertensive agent; calcium channel blocker; cardiovascular drug; vasodilator agent
nisoldipine	[no description available]	medium	1	C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; methyl ester
nitrazepam	[no description available]	medium	1	1,4-benzodiazepinone; C-nitro compound	anticonvulsant; antispasmodic drug; drug metabolite; GABA modulator; sedative
nitrendipine	[no description available]	medium	1	C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; ethyl ester; methyl ester	antihypertensive agent; calcium channel blocker; geroprotector; vasodilator agent
nizatidine	[no description available]	medium	1	1,3-thiazoles; C-nitro compound; carboxamidine; organic sulfide; tertiary amino compound	anti-ulcer drug; cholinergic drug; H2-receptor antagonist
nomifensine	[no description available]	medium	1	isoquinolines	dopamine uptake inhibitor
nortriptyline	[no description available]	medium	1	organic tricyclic compound; secondary amine	adrenergic uptake inhibitor; analgesic; antidepressant; antineoplastic agent; apoptosis inducer; drug metabolite
ofloxacin	[no description available]	medium	1	3-oxo monocarboxylic acid; N-arylpiperazine; N-methylpiperazine; organofluorine compound; oxazinoquinoline
omeprazole	[no description available]	medium	1	aromatic ether; benzimidazoles; pyridines; sulfoxide
ondansetron	[no description available]	medium	1	carbazoles
oxazepam	[no description available]	medium	1	1,4-benzodiazepinone; organochlorine compound	anxiolytic drug; environmental contaminant; xenobiotic
oxiracetam	[no description available]	medium	1	organonitrogen compound; organooxygen compound
oxybutynin	[no description available]	medium	1	acetylenic compound; carboxylic ester; racemate; tertiary alcohol; tertiary amino compound	antispasmodic drug; calcium channel blocker; local anaesthetic; muscarinic antagonist; muscle relaxant; parasympatholytic
pamidronate	[no description available]	medium	1	phosphonoacetic acid
pantoprazole	[no description available]	medium	1	aromatic ether; benzimidazoles; organofluorine compound; pyridines; sulfoxide	anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; environmental contaminant; xenobiotic
papaverine	[no description available]	medium	1	benzylisoquinoline alkaloid; dimethoxybenzene; isoquinolines	antispasmodic drug; vasodilator agent
pentamidine	[no description available]	medium	1	aromatic ether; carboxamidine; diether	anti-inflammatory agent; antifungal agent; calmodulin antagonist; chemokine receptor 5 antagonist; EC 2.3.1.48 (histone acetyltransferase) inhibitor; NMDA receptor antagonist; S100 calcium-binding protein B inhibitor; trypanocidal drug; xenobiotic
pentobarbital	[no description available]	medium	1	barbiturates	GABAA receptor agonist
pentoxifylline	[no description available]	medium	1	oxopurine
perphenazine	[no description available]	medium	1	N-(2-hydroxyethyl)piperazine; N-alkylpiperazine; organochlorine compound; phenothiazines	antiemetic; dopaminergic antagonist; phenothiazine antipsychotic drug
phenacetin	[no description available]	medium	1	acetamides; aromatic ether	cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug
phenobarbital	[no description available]	medium	1	barbiturates	anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative
moxonidine	[no description available]	medium	1	organohalogen compound; pyrimidines
pimobendan	[no description available]	medium	1	benzimidazoles; pyridazinone	cardiotonic drug; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent
pindolol	[no description available]	medium	1	indoles; secondary amine	antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist; serotonergic antagonist; vasodilator agent
piretanide	[no description available]	medium	1	aromatic ether
prazosin	[no description available]	medium	1	aromatic ether; furans; monocarboxylic acid amide; piperazines; quinazolines	alpha-adrenergic antagonist; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
prilocaine	[no description available]	medium	1	amino acid amide; monocarboxylic acid amide	anticonvulsant; local anaesthetic
primaquine	[no description available]	medium	1	aminoquinoline; aromatic ether; N-substituted diamine	antimalarial
probenecid	[no description available]	medium	1	benzoic acids; sulfonamide	uricosuric drug
procainamide	[no description available]	medium	1	benzamides	anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker
prochlorperazine	[no description available]	medium	1	N-alkylpiperazine; N-methylpiperazine; organochlorine compound; phenothiazines	alpha-adrenergic antagonist; antiemetic; cholinergic antagonist; dopamine receptor D2 antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; first generation antipsychotic
procyclidine	[no description available]	medium	1	pyrrolidines; tertiary alcohol	antidyskinesia agent; antiparkinson drug; muscarinic antagonist
promazine	[no description available]	medium	1	phenothiazines; tertiary amine	antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; muscarinic antagonist; phenothiazine antipsychotic drug; serotonergic antagonist
promethazine	[no description available]	medium	1	phenothiazines; tertiary amine	anti-allergic agent; anticoronaviral agent; antiemetic; antipruritic drug; H1-receptor antagonist; local anaesthetic; sedative
propafenone	[no description available]	medium	1	aromatic ketone; secondary alcohol; secondary amino compound	anti-arrhythmia drug
propofol	[no description available]	medium	1	phenols	anticonvulsant; antiemetic; intravenous anaesthetic; radical scavenger; sedative
propranolol	[no description available]	medium	1	naphthalenes; propanolamine; secondary amine	anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic
pyridostigmine	[no description available]	medium	1	pyridinium ion
pyrimethamine	[no description available]	medium	1	aminopyrimidine; monochlorobenzenes	antimalarial; antiprotozoal drug; EC 1.5.1.3 (dihydrofolate reductase) inhibitor
rabeprazole	[no description available]	medium	1	benzimidazoles; pyridines; sulfoxide	anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
ranitidine	[no description available]	medium	1	aralkylamine
risperidone	[no description available]	medium	1	1,2-benzoxazoles; heteroarylpiperidine; organofluorine compound; pyridopyrimidine	alpha-adrenergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; psychotropic drug; second generation antipsychotic; serotonergic antagonist
rizatriptan	[no description available]	medium	1	tryptamines	anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent
sulfadiazine	[no description available]	medium	1	pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide	antiinfective agent; antimicrobial agent; antiprotozoal drug; coccidiostat; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic
risedronic acid	[no description available]	medium	1	pyridines
sotalol	[no description available]	medium	1	ethanolamines; secondary alcohol; secondary amino compound; sulfonamide	anti-arrhythmia drug; beta-adrenergic antagonist; environmental contaminant; xenobiotic
imatinib	[no description available]	medium	1	aromatic amine; benzamides; N-methylpiperazine; pyridines; pyrimidines	antineoplastic agent; apoptosis inducer; tyrosine kinase inhibitor
vorinostat	[no description available]	medium	1	dicarboxylic acid diamide; hydroxamic acid	antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor
sulfamethoxazole	[no description available]	medium	1	isoxazoles; substituted aniline; sulfonamide antibiotic; sulfonamide	antibacterial agent; antiinfective agent; antimicrobial agent; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; epitope; P450 inhibitor; xenobiotic
sulfinpyrazone	[no description available]	medium	1	pyrazolidines; sulfoxide	uricosuric drug
sulfisoxazole	[no description available]	medium	1	isoxazoles; sulfonamide antibiotic; sulfonamide	antibacterial drug; drug allergen
sumatriptan	[no description available]	medium	1	sulfonamide; tryptamines	serotonergic agonist; vasoconstrictor agent
suprofen	[no description available]	medium	1	aromatic ketone; monocarboxylic acid; thiophenes	antirheumatic drug; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug
suramin	[no description available]	medium	1	naphthalenesulfonic acid; phenylureas; secondary carboxamide	angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug
gatifloxacin	[no description available]	medium	1	N-arylpiperazine; organofluorine compound; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone	antiinfective agent; antimicrobial agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
temozolomide	[no description available]	medium	1	imidazotetrazine; monocarboxylic acid amide; triazene derivative	alkylating agent; antineoplastic agent; prodrug
terazosin	[no description available]	medium	1	furans; piperazines; primary amino compound; quinazolines	alpha-adrenergic antagonist; antihypertensive agent; antineoplastic agent
terbutaline	[no description available]	medium	1	phenylethanolamines; resorcinols	anti-asthmatic drug; beta-adrenergic agonist; bronchodilator agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; hypoglycemic agent; sympathomimetic agent; tocolytic agent
thalidomide	[no description available]	medium	1	phthalimides; piperidones
thiotepa	[no description available]	medium	1	aziridines
tinidazole	[no description available]	medium	1	imidazoles	antiamoebic agent; antibacterial drug; antiparasitic agent; antiprotozoal drug
tizanidine	[no description available]	medium	1	benzothiadiazole; imidazoles	alpha-adrenergic agonist; muscle relaxant
tolbutamide	[no description available]	medium	1	N-sulfonylurea	human metabolite; hypoglycemic agent; insulin secretagogue; potassium channel blocker
ultram	[no description available]	medium	1	aromatic ether; tertiary alcohol; tertiary amino compound
tranexamic acid	[no description available]	medium	1	amino acid
trazodone	[no description available]	medium	1	monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; triazolopyridine	adrenergic antagonist; antidepressant; anxiolytic drug; H1-receptor antagonist; sedative; serotonin uptake inhibitor
triamterene	[no description available]	medium	1	pteridines	diuretic; sodium channel blocker
triazolam	[no description available]	medium	1	triazolobenzodiazepine	sedative
trimethoprim	[no description available]	medium	1	aminopyrimidine; methoxybenzenes	antibacterial drug; diuretic; drug allergen; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; environmental contaminant; xenobiotic
trimetrexate	[no description available]	medium	1
trimipramine	[no description available]	medium	1	dibenzoazepine; tertiary amino compound	antidepressant; environmental contaminant; xenobiotic
urapidil	[no description available]	medium	1	piperazines
venlafaxine	[no description available]	medium	1	cyclohexanols; monomethoxybenzene; tertiary alcohol; tertiary amino compound	adrenergic uptake inhibitor; analgesic; antidepressant; dopamine uptake inhibitor; environmental contaminant; serotonin uptake inhibitor; xenobiotic
viloxazine	[no description available]	medium	1	aromatic ether
zaleplon	[no description available]	medium	1	nitrile; pyrazolopyrimidine	anticonvulsant; anxiolytic drug; central nervous system depressant; sedative
zolpidem	[no description available]	medium	1	imidazopyridine	central nervous system depressant; GABA agonist; sedative
zopiclone	[no description available]	medium	1	monochloropyridine; pyrrolopyrazine	central nervous system depressant; sedative
prednisolone	[no description available]	medium	1	11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	adrenergic agent; anti-inflammatory drug; antineoplastic agent; drug metabolite; environmental contaminant; immunosuppressive agent; xenobiotic
cephaloridine	[no description available]	high	2	beta-lactam antibiotic allergen; cephalosporin; semisynthetic derivative	antibacterial drug
prednisone	[no description available]	medium	1	11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	adrenergic agent; anti-inflammatory drug; antineoplastic agent; immunosuppressive agent; prodrug
penicillin g	[no description available]	medium	1	penicillin allergen; penicillin	antibacterial drug; drug allergen; epitope
vincristine	[no description available]	medium	1	acetate ester; formamides; methyl ester; organic heteropentacyclic compound; organic heterotetracyclic compound; tertiary alcohol; tertiary amino compound; vinca alkaloid	antineoplastic agent; drug; microtubule-destabilising agent; plant metabolite; tubulin modulator
ethinyl estradiol	[no description available]	medium	1	17-hydroxy steroid; 3-hydroxy steroid; terminal acetylenic compound	xenoestrogen
apomorphine	[no description available]	medium	1	aporphine alkaloid	alpha-adrenergic drug; antidyskinesia agent; antiparkinson drug; dopamine agonist; emetic; serotonergic drug
cephalothin	[no description available]	high	2	azabicycloalkene; beta-lactam antibiotic allergen; carboxylic acid; cephalosporin; semisynthetic derivative; thiophenes	antibacterial drug; antimicrobial agent
levodopa	[no description available]	medium	1	amino acid zwitterion; dopa; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid	allelochemical; antidyskinesia agent; antiparkinson drug; dopaminergic agent; hapten; human metabolite; mouse metabolite; neurotoxin; plant growth retardant; plant metabolite; prodrug
methicillin	[no description available]	medium	1	penicillin allergen; penicillin	antibacterial drug
colchicine	[no description available]	medium	1	alkaloid; colchicine	anti-inflammatory agent; gout suppressant; mutagen
oxacillin	[no description available]	medium	1	penicillin	antibacterial agent; antibacterial drug
ampicillin	[no description available]	high	2	beta-lactam antibiotic; penicillin allergen; penicillin	antibacterial drug
triamcinolone acetonide	[no description available]	medium	1	11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; cyclic ketal; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone	anti-allergic agent; anti-inflammatory drug
phencyclidine	[no description available]	medium	1	benzenes; piperidines	anaesthetic; neurotoxin; NMDA receptor antagonist; psychotropic drug
dichloroacetic acid	[no description available]	medium	1	monocarboxylic acid; organochlorine compound	astringent; marine metabolite
methylprednisolone	[no description available]	medium	1	6-methylprednisolone; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	adrenergic agent; anti-inflammatory drug; antiemetic; environmental contaminant; neuroprotective agent; xenobiotic
penicillin v	[no description available]	medium	1	penicillin allergen; penicillin
isosorbide dinitrate	[no description available]	medium	1	glucitol derivative; nitrate ester	nitric oxide donor; vasodilator agent
ergotamine	[no description available]	medium	1	peptide ergot alkaloid	alpha-adrenergic agonist; mycotoxin; non-narcotic analgesic; oxytocic; serotonergic agonist; vasoconstrictor agent
neostigmine bromide	[no description available]	medium	1	bromide salt
nafcillin	[no description available]	medium	1	penicillin allergen; penicillin	antibacterial drug
methohexital	[no description available]	medium	1	acetylenic compound; barbiturates	drug allergen; intravenous anaesthetic
pirinitramide	[no description available]	medium	1	nitrile
edrophonium bromide	[no description available]	medium	1
azacitidine	[no description available]	medium	1	N-glycosyl-1,3,5-triazine; nucleoside analogue	antineoplastic agent
galantamine	[no description available]	medium	1	benzazepine alkaloid fundamental parent; benzazepine alkaloid; organic heterotetracyclic compound; tertiary amino compound	antidote to curare poisoning; cholinergic drug; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; plant metabolite
betamethasone	[no description available]	medium	1	11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	anti-asthmatic agent; anti-inflammatory drug; immunosuppressive agent
dextropropoxyphene	[no description available]	medium	1	1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoate	mu-opioid receptor agonist; opioid analgesic
ketobemidone	[no description available]	medium	1	piperidines
chlormethiazole	[no description available]	medium	1	thiazoles
methamphetamine	[no description available]	medium	1	amphetamines; secondary amine	central nervous system stimulant; environmental contaminant; neurotoxin; psychotropic drug; xenobiotic
lithium carbonate	[no description available]	medium	1	carbonate salt; lithium salt	antimanic drug
acetylcysteine	[no description available]	medium	1	acetylcysteine; L-cysteine derivative; N-acetyl-L-amino acid	antidote to paracetamol poisoning; antiinfective agent; antioxidant; antiviral drug; ferroptosis inhibitor; geroprotector; human metabolite; mucolytic; radical scavenger; vulnerary
erythromycin	[no description available]	medium	1	cyclic ketone; erythromycin
levonorgestrel	[no description available]	medium	1	17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; terminal acetylenic compound	contraceptive drug; female contraceptive drug; progestin; synthetic oral contraceptive
lormetazepam	[no description available]	medium	1	1,4-benzodiazepinone; organochlorine compound	sedative
vinblastine	[no description available]	medium	1
ethambutol	[no description available]	medium	1	ethanolamines; ethylenediamine derivative	antitubercular agent; environmental contaminant; xenobiotic
vancomycin	[no description available]	high	2	glycopeptide	antibacterial drug; antimicrobial agent; bacterial metabolite
metylperon	[no description available]	medium	1	aromatic ketone
dronabinol	[no description available]	medium	1	benzochromene; diterpenoid; phytocannabinoid; polyketide	cannabinoid receptor agonist; epitope; hallucinogen; metabolite; non-narcotic analgesic
benperidol	[no description available]	medium	1	aromatic ketone
chlordesmethyldiazepam	[no description available]	medium	1	benzodiazepine
stavudine	[no description available]	medium	1	dihydrofuran; nucleoside analogue; organic molecular entity	antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
doxifluridine	[no description available]	medium	1	organofluorine compound; pyrimidine 5'-deoxyribonucleoside	antimetabolite; antineoplastic agent; prodrug
dicloxacillin	[no description available]	medium	1	dichlorobenzene; penicillin	antibacterial drug
cladribine	[no description available]	medium	1	organochlorine compound; purine 2'-deoxyribonucleoside	antineoplastic agent; immunosuppressive agent
carbenicillin	[no description available]	high	2	penicillin allergen; penicillin	antibacterial drug
floxacillin	[no description available]	medium	1	penicillin allergen; penicillin	antibacterial drug
beclomethasone dipropionate	[no description available]	medium	1	11beta-hydroxy steroid; 20-oxo steroid; 3-oxo-Delta(1),Delta(4)-steroid; chlorinated steroid; corticosteroid; enone; glucocorticoid; propanoate ester; steroid ester	anti-arrhythmia drug; anti-asthmatic drug; anti-inflammatory drug; prodrug
olsalazine	[no description available]	medium	1	azobenzenes; dicarboxylic acid	non-steroidal anti-inflammatory drug; prodrug
terodiline	[no description available]	medium	1	diarylmethane
1-(4-carboxyphenyl)-3,3-dimethyltriazene	[no description available]	medium	1
zalcitabine	[no description available]	medium	1	pyrimidine 2',3'-dideoxyribonucleoside	antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor
metocurine iodide	[no description available]	medium	1	aromatic ether
apazone	[no description available]	medium	1	benzotriazines	non-steroidal anti-inflammatory drug; uricosuric drug
selegiline	[no description available]	medium	1	selegiline; terminal acetylenic compound	geroprotector
cephalexin	[no description available]	medium	1	beta-lactam antibiotic allergen; cephalosporin; semisynthetic derivative	antibacterial drug
isosorbide-5-mononitrate	[no description available]	medium	1	glucitol derivative; nitrate ester	nitric oxide donor; vasodilator agent
cephapirin	[no description available]	medium	1	cephalosporin	antibacterial drug
pregnanolone	[no description available]	medium	1	3-hydroxy-5beta-pregnan-20-one; 3alpha-hydroxy steroid	human metabolite; intravenous anaesthetic; sedative
du-21220	[no description available]	medium	1	benzyl alcohols; polyphenol; secondary alcohol; secondary amino compound
cefazolin	[no description available]	medium	1	beta-lactam antibiotic allergen; cephalosporin; tetrazoles; thiadiazoles	antibacterial drug
amoxicillin	[no description available]	medium	1	penicillin allergen; penicillin	antibacterial drug
timolol	[no description available]	medium	1	timolol	anti-arrhythmia drug; antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist
indoramin	[no description available]	medium	1	tryptamines
toloxatone	[no description available]	medium	1	oxazolidinone; primary alcohol; toluenes
zidovudine	[no description available]	medium	1	azide; pyrimidine 2',3'-dideoxyribonucleoside	antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor
amdinocillin	[no description available]	medium	1	penicillin	antibacterial drug; antiinfective agent
paclitaxel	[no description available]	medium	1	taxane diterpenoid; tetracyclic diterpenoid	antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent
etoposide	[no description available]	medium	1	beta-D-glucoside; furonaphthodioxole; organic heterotetracyclic compound	antineoplastic agent; DNA synthesis inhibitor
ticarcillin	[no description available]	medium	1	penicillin allergen; penicillin	antibacterial drug
trimazosin	[no description available]	medium	1	N-arylpiperazine
ribavirin	[no description available]	medium	1	1-ribosyltriazole; aromatic amide; monocarboxylic acid amide; primary carboxamide	anticoronaviral agent; antiinfective agent; antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
adinazolam	[no description available]	medium	1	triazolobenzodiazepine	anticonvulsant; antidepressant; anxiolytic drug; sedative
tolamolol	[no description available]	medium	1
cephradine	[no description available]	medium	1	beta-lactam antibiotic allergen; cephalosporin	antibacterial drug
methyldopa	[no description available]	medium	1	L-tyrosine derivative; non-proteinogenic L-alpha-amino acid	alpha-adrenergic agonist; antihypertensive agent; hapten; peripheral nervous system drug; sympatholytic agent
tocainide	[no description available]	medium	1	monocarboxylic acid amide	anti-arrhythmia drug; local anaesthetic; sodium channel blocker
sulbenicillin	[no description available]	medium	1	penicillin
sq-11725	[no description available]	medium	1
diltiazem	[no description available]	medium	1	5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate	antihypertensive agent; calcium channel blocker; vasodilator agent
vecuronium bromide	[no description available]	medium	1	organic bromide salt; quaternary ammonium salt	muscle relaxant; neuromuscular agent; nicotinic antagonist
meptazinol	[no description available]	medium	1	azepanes
sufentanil	[no description available]	medium	1	anilide; ether; piperidines; thiophenes	anaesthesia adjuvant; intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic
torsemide	[no description available]	medium	1	aminopyridine; N-sulfonylurea; secondary amino compound	antihypertensive agent; loop diuretic
medroxalol	[no description available]	medium	1	salicylamides
epirubicin	[no description available]	medium	1	aminoglycoside; anthracycline antibiotic; anthracycline; deoxy hexoside; monosaccharide derivative; p-quinones; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	antimicrobial agent; antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
cefmetazole	[no description available]	medium	1	cephalosporin	antibacterial drug
lorcainide	[no description available]	medium	1	acetamides
idarubicin	[no description available]	medium	1	anthracycline antibiotic; deoxy hexoside; monosaccharide derivative
ceforanide	[no description available]	medium	1	cephalosporin	antibacterial drug
piperacillin	[no description available]	medium	1	penicillin allergen; penicillin	antibacterial drug
paroxetine	[no description available]	medium	1	aromatic ether; benzodioxoles; organofluorine compound; piperidines	antidepressant; anxiolytic drug; hepatotoxic agent; P450 inhibitor; serotonin uptake inhibitor
captopril	[no description available]	medium	1	alkanethiol; L-proline derivative; N-acylpyrrolidine; pyrrolidinemonocarboxylic acid	antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
cefoperazone	[no description available]	medium	1	cephalosporin	antibacterial drug
atracurium	[no description available]	medium	1	diester; quaternary ammonium ion	muscle relaxant; nicotinic antagonist
moxalactam	[no description available]	medium	1	cephalosporin; oxacephem	antibacterial drug
endralazine	[no description available]	medium	1	benzamides
cefadroxil anhydrous	[no description available]	medium	1	cephalosporin	antibacterial drug
encainide	[no description available]	medium	1	benzamides; piperidines	anti-arrhythmia drug; sodium channel blocker
pefloxacin	[no description available]	medium	1	fluoroquinolone antibiotic; monocarboxylic acid; N-alkylpiperazine; N-arylpiperazine; quinolone antibiotic; quinolone	antibacterial drug; antiinfective agent; DNA synthesis inhibitor
alfentanil	[no description available]	medium	1	monocarboxylic acid amide; piperidines	central nervous system depressant; intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic; peripheral nervous system drug
cefotetan	[no description available]	medium	1
recainam	[no description available]	medium	1
lovastatin	[no description available]	medium	1	delta-lactone; fatty acid ester; hexahydronaphthalenes; polyketide; statin (naturally occurring)	anticholesteremic drug; antineoplastic agent; Aspergillus metabolite; prodrug
flupirtine	[no description available]	medium	1	aminopyridine
enoximone	[no description available]	medium	1	aromatic ketone
idazoxan	[no description available]	medium	1	benzodioxine; imidazolines	alpha-adrenergic antagonist
remoxipride	[no description available]	medium	1	dimethoxybenzene
pravastatin	[no description available]	medium	1	3-hydroxy carboxylic acid; carbobicyclic compound; carboxylic ester; hydroxy monocarboxylic acid; secondary alcohol; statin (semi-synthetic)	anticholesteremic drug; environmental contaminant; metabolite; xenobiotic
bambuterol	[no description available]	medium	1	carbamate ester; phenylethanolamines	anti-asthmatic drug; beta-adrenergic agonist; bronchodilator agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; prodrug; sympathomimetic agent; tocolytic agent
atomoxetine	[no description available]	medium	1	aromatic ether; secondary amino compound; toluenes	adrenergic uptake inhibitor; antidepressant; environmental contaminant; xenobiotic
trospectomycin	[no description available]	medium	1	dioxanes
finasteride	[no description available]	medium	1	3-oxo steroid; aza-steroid; delta-lactam	androgen antagonist; antihyperplasia drug; EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor
sematilide	[no description available]	medium	1
esmolol	[no description available]	medium	1	aromatic ether; ethanolamines; methyl ester; secondary alcohol; secondary amino compound
clinafloxacin	[no description available]	medium	1	quinolines
adefovir	[no description available]	medium	1	6-aminopurines; ether; phosphonic acids	antiviral drug; DNA synthesis inhibitor; drug metabolite; HIV-1 reverse transcriptase inhibitor; nephrotoxic agent
loxiglumide	[no description available]	medium	1	organic molecular entity
sparfloxacin	[no description available]	medium	1	fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone
cidofovir anhydrous	[no description available]	medium	1	phosphonic acids; pyrimidone	anti-HIV agent; antineoplastic agent; antiviral drug; photosensitizing agent
tiagabine	[no description available]	medium	1	beta-amino acid; piperidinemonocarboxylic acid; tertiary amino compound; thiophenes	anticonvulsant; GABA reuptake inhibitor
mibefradil	[no description available]	medium	1	tetralins	T-type calcium channel blocker
topotecan	[no description available]	medium	1	pyranoindolizinoquinoline	antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor
bromfenac	[no description available]	medium	1	aromatic amino acid; benzophenones; organobromine compound; substituted aniline	non-narcotic analgesic; non-steroidal anti-inflammatory drug
gemcitabine	[no description available]	medium	1	organofluorine compound; pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent; antiviral drug; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; environmental contaminant; immunosuppressive agent; photosensitizing agent; prodrug; radiosensitizing agent; xenobiotic
ibutilide	[no description available]	medium	1	benzenes; organic amino compound
aripiprazole	[no description available]	medium	1	aromatic ether; delta-lactam; dichlorobenzene; N-alkylpiperazine; N-arylpiperazine; quinolone	drug metabolite; H1-receptor antagonist; second generation antipsychotic; serotonergic agonist
remifentanil	[no description available]	medium	1	alpha-amino acid ester; anilide; monocarboxylic acid amide; piperidinecarboxylate ester	intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic; sedative
lamivudine	[no description available]	medium	1	monothioacetal; nucleoside analogue; oxacycle; primary alcohol	allergen; anti-HBV agent; antiviral drug; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor; HIV-1 reverse transcriptase inhibitor; prodrug
irinotecan	[no description available]	medium	1	carbamate ester; delta-lactone; N-acylpiperidine; pyranoindolizinoquinoline; ring assembly; tertiary alcohol; tertiary amino compound	antineoplastic agent; apoptosis inducer; EC 5.99.1.2 (DNA topoisomerase) inhibitor; prodrug
valsartan	[no description available]	medium	1	biphenylyltetrazole; monocarboxylic acid amide; monocarboxylic acid	angiotensin receptor antagonist; antihypertensive agent; environmental contaminant; xenobiotic
ibandronic acid	[no description available]	medium	1
ziprasidone	[no description available]	medium	1	1,2-benzisothiazole; indolones; organochlorine compound; piperazines	antipsychotic agent; dopaminergic antagonist; histamine antagonist; muscarinic antagonist; psychotropic drug; serotonergic antagonist
zanamivir	[no description available]	medium	1	guanidines	antiviral agent; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor
zolmitriptan	[no description available]	medium	1	oxazolidinone; tryptamines	anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent
tirofiban	[no description available]	medium	1	L-tyrosine derivative; piperidines; sulfonamide	anticoagulant; fibrin modulating drug; platelet glycoprotein-IIb/IIIa receptor antagonist
cisatracurium	[no description available]	medium	1	diester; quaternary ammonium ion	muscle relaxant; nicotinic antagonist
fosinoprilat	[no description available]	medium	1	L-proline derivative; phosphinic acids	antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
trovafloxacin	[no description available]	medium	1
cefprozil	[no description available]	medium	1	cephalosporin; semisynthetic derivative	antibacterial drug
iopamidol	[no description available]	medium	1	benzenedicarboxamide; organoiodine compound; pentol	environmental contaminant; radioopaque medium; xenobiotic
imipramine n-oxide	[no description available]	medium	1	dibenzooxazepine
dexloxiglumide	[no description available]	medium	1	glutamic acid derivative
intoplicine	[no description available]	medium	1	pyridoindole
repaglinide	[no description available]	medium	1	piperidines
telmisartan	[no description available]	medium	1	benzimidazoles; biphenyls; carboxybiphenyl	angiotensin receptor antagonist; antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; environmental contaminant; xenobiotic
dexfenfluramine	[no description available]	medium	1	fenfluramine	appetite depressant; serotonergic agonist; serotonin uptake inhibitor
ethinyl estradiol-17-sulfate	[no description available]	medium	1
ethinylestradiol-3-sulfate	[no description available]	medium	1	17beta-hydroxy steroid; steroid sulfate	antineoplastic agent; estrogen
cefcanel	[no description available]	medium	1
zoledronic acid	[no description available]	medium	1	1,1-bis(phosphonic acid); imidazoles	bone density conservation agent
epristeride	[no description available]	medium	1	steroid acid
talinolol	[no description available]	medium	1	ureas
denaverine	[no description available]	medium	1	diarylmethane
diprafenone	[no description available]	medium	1	aromatic compound
nebivolol	[no description available]	medium	1	chromanes; diol; organofluorine compound; secondary alcohol; secondary amino compound
uk 68798	[no description available]	medium	1	aromatic ether; sulfonamide; tertiary amino compound	anti-arrhythmia drug; potassium channel blocker
ljc 10627	[no description available]	medium	1	carbapenems; organic sulfide; pyrazolotriazole	antibacterial drug
dexrazoxane	[no description available]	medium	1	razoxane	antineoplastic agent; cardiovascular drug; chelator; immunosuppressive agent
voriconazole	[no description available]	medium	1	conazole antifungal drug; difluorobenzene; pyrimidines; tertiary alcohol; triazole antifungal drug	P450 inhibitor
betamipron	[no description available]	medium	1	organonitrogen compound; organooxygen compound
bufuralol	[no description available]	medium	1	benzofurans
panipenem	[no description available]	medium	1	organic molecular entity
perindoprilat	[no description available]	medium	1	dicarboxylic acid; dipeptide; L-alanine derivative; organic heterobicyclic compound	antihypertensive agent; drug metabolite; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
7-hydroxystaurosporine	[no description available]	medium	1
methotrimeprazine	[no description available]	medium	1	phenothiazines; tertiary amine	anticoronaviral agent; cholinergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; non-narcotic analgesic; phenothiazine antipsychotic drug; serotonergic antagonist
9-aminocamptothecin	[no description available]	medium	1	pyranoindolizinoquinoline
sch 34343	[no description available]	medium	1
squalamine	[no description available]	medium	1	bile acid
atovaquone	[no description available]	medium	1	hydroxy-1,2-naphthoquinone
rivastigmine	[no description available]	medium	1	carbamate ester; tertiary amino compound	cholinergic drug; EC 3.1.1.8 (cholinesterase) inhibitor; neuroprotective agent
frovatriptan	[no description available]	medium	1	carbazoles
eletriptan	[no description available]	medium	1	indoles; N-alkylpyrrolidine; sulfone	non-steroidal anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent
rosiglitazone	[no description available]	medium	1	aminopyridine; thiazolidinediones	EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; insulin-sensitizing drug
clarithromycin	[no description available]	medium	1	macrolide antibiotic	antibacterial drug; environmental contaminant; protein synthesis inhibitor; xenobiotic
nicotine	[no description available]	medium	1	3-(1-methylpyrrolidin-2-yl)pyridine	anxiolytic drug; biomarker; immunomodulator; mitogen; neurotoxin; nicotinic acetylcholine receptor agonist; peripheral nervous system drug; phytogenic insecticide; plant metabolite; psychotropic drug; teratogenic agent; xenobiotic
mci 9038	[no description available]	medium	1	peptide
imipenem, anhydrous	[no description available]	medium	1	beta-lactam antibiotic allergen; carbapenems; zwitterion	antibacterial drug
bosentan anhydrous	[no description available]	medium	1	primary alcohol; pyrimidines; sulfonamide	antihypertensive agent; endothelin receptor antagonist
asulacrine	[no description available]	medium	1	acridines
hydroxycotinine	[no description available]	medium	1	N-alkylpyrrolidine; pyridines; pyrrolidin-2-ones; pyrrolidine alkaloid
quinaprilat	[no description available]	medium	1	dicarboxylic acid; isoquinolines; tertiary carboxamide	antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; vasodilator agent
2-hydroxyimipramine	[no description available]	medium	1	dibenzoazepine
ecteinascidin 743	[no description available]	medium	1	acetate ester; azaspiro compound; bridged compound; hemiaminal; isoquinoline alkaloid; lactone; organic heteropolycyclic compound; organic sulfide; oxaspiro compound; polyphenol; tertiary amino compound	alkylating agent; angiogenesis modulating agent; anti-inflammatory agent; antineoplastic agent; marine metabolite
almotriptan	[no description available]	medium	1	indoles; sulfonamide; tertiary amine	non-steroidal anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent
mk 0663	[no description available]	medium	1	bipyridines; organochlorine compound; sulfone	cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug
gefitinib	[no description available]	medium	1	aromatic ether; monochlorobenzenes; monofluorobenzenes; morpholines; quinazolines; secondary amino compound; tertiary amino compound	antineoplastic agent; epidermal growth factor receptor antagonist
methotrexate	[no description available]	medium	1	dicarboxylic acid; monocarboxylic acid amide; pteridines	abortifacient; antimetabolite; antineoplastic agent; antirheumatic drug; dermatologic drug; DNA synthesis inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; immunosuppressive agent
tamsulosin	[no description available]	medium	1	5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamide	alpha-adrenergic antagonist; antineoplastic agent
sulbactam	[no description available]	medium	1	penicillanic acids
dilevalol	[no description available]	medium	1	2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide
docetaxel	[no description available]	medium	1	hydrate; secondary alpha-hydroxy ketone	antineoplastic agent
irofulven	[no description available]	medium	1	cyclohexenones
ym 872	[no description available]	medium	1
levofloxacin	[no description available]	medium	1	9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; fluoroquinolone antibiotic; quinolone antibiotic	antibacterial drug; DNA synthesis inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor
ertapenem	[no description available]	medium	1	carbapenemcarboxylic acid; pyrrolidinecarboxamide	antibacterial drug
dx 8951	[no description available]	medium	1	pyranoindolizinoquinoline
cilomilast	[no description available]	medium	1	methoxybenzenes
conivaptan	[no description available]	medium	1	benzazepine	aquaretic; vasopressin receptor antagonist
tezosentan	[no description available]	medium	1
sabarubicin	[no description available]	medium	1
moxifloxacin	[no description available]	medium	1	aromatic ether; cyclopropanes; fluoroquinolone antibiotic; pyrrolidinopiperidine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone	antibacterial drug
clevidipine	[no description available]	medium	1	dihydropyridine
solifenacin	[no description available]	medium	1	isoquinolines
xamoterol	[no description available]	medium	1	morpholines
abanoquil	[no description available]	medium	1
anidulafungin	[no description available]	medium	1	antibiotic antifungal drug; azamacrocycle; echinocandin; heterodetic cyclic peptide; semisynthetic derivative
atropine	[no description available]	medium	1
ropivacaine	[no description available]	medium	1	piperidinecarboxamide; ropivacaine	local anaesthetic
melagatran	[no description available]	medium	1	azetidines; carboxamidine; dicarboxylic acid monoamide; non-proteinogenic alpha-amino acid; secondary amino compound	anticoagulant; EC 3.4.21.5 (thrombin) inhibitor; serine protease inhibitor
tesaglitazar	[no description available]	medium	1
bms204352	[no description available]	medium	1
fosfluconazole	[no description available]	medium	1	conazole antifungal drug; triazole antifungal drug; triazoles	prodrug
cp 101,606	[no description available]	medium	1
nsc-89199	[no description available]	medium	1	carbamate ester; organochlorine compound; steroid phosphate
phenethicillin	[no description available]	medium	1	penicillin allergen; penicillin
acivicin	[no description available]	medium	1	isoxazoles; non-proteinogenic L-alpha-amino acid; organochlorine compound	antileishmanial agent; antimetabolite; antimicrobial agent; antineoplastic agent; EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor; glutamine antagonist; metabolite
bortezomib	[no description available]	medium	1	amino acid amide; L-phenylalanine derivative; pyrazines	antineoplastic agent; antiprotozoal drug; protease inhibitor; proteasome inhibitor
quinidine	[no description available]	medium	1	cinchona alkaloid	alpha-adrenergic antagonist; anti-arrhythmia drug; antimalarial; drug allergen; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; muscarinic antagonist; P450 inhibitor; potassium channel blocker; sodium channel blocker
meropenem	[no description available]	high	2	alpha,beta-unsaturated monocarboxylic acid; carbapenemcarboxylic acid; organic sulfide; pyrrolidinecarboxamide	antibacterial agent; antibacterial drug; drug allergen
cefoxitin	[no description available]	medium	1	beta-lactam antibiotic allergen; cephalosporin; cephamycin; semisynthetic derivative	antibacterial drug
digitoxin	[no description available]	medium	1	cardenolide glycoside	EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
saquinavir	[no description available]	medium	1	L-asparagine derivative; quinolines	antiviral drug; HIV protease inhibitor
pancuronium	[no description available]	medium	1	acetate ester; steroid ester	cholinergic antagonist; muscle relaxant; nicotinic antagonist
rocuronium	[no description available]	medium	1	3alpha-hydroxy steroid; acetate ester; androstane; morpholines; quaternary ammonium ion; tertiary amino compound	drug allergen; muscle relaxant; neuromuscular agent
abacavir	[no description available]	medium	1	2,6-diaminopurines	antiviral drug; drug allergen; HIV-1 reverse transcriptase inhibitor
miglitol	[no description available]	medium	1	piperidines
linezolid	[no description available]	medium	1	acetamides; morpholines; organofluorine compound; oxazolidinone	antibacterial drug; protein synthesis inhibitor
tolterodine	[no description available]	medium	1	tertiary amine	antispasmodic drug; muscarinic antagonist; muscle relaxant
darifenacin	[no description available]	medium	1	1-benzofurans; monocarboxylic acid amide; pyrrolidines	antispasmodic drug; muscarinic antagonist
fluticasone propionate	[no description available]	medium	1	11beta-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; corticosteroid; fluorinated steroid; propanoate ester; steroid ester; thioester	adrenergic agent; anti-allergic agent; anti-asthmatic drug; anti-inflammatory drug; bronchodilator agent; dermatologic drug
acarbose	[no description available]	medium	1	amino cyclitol; glycoside
tacrolimus	[no description available]	medium	1	macrolide lactam	bacterial metabolite; immunosuppressive agent
cerivastatin	[no description available]	medium	1	dihydroxy monocarboxylic acid; pyridines; statin (synthetic)
rosuvastatin	[no description available]	medium	1	dihydroxy monocarboxylic acid; monofluorobenzenes; pyrimidines; statin (synthetic); sulfonamide	anti-inflammatory agent; antilipemic drug; cardioprotective agent; CETP inhibitor; environmental contaminant; xenobiotic
cocaine	[no description available]	medium	1	benzoate ester; methyl ester; tertiary amino compound; tropane alkaloid	adrenergic uptake inhibitor; central nervous system stimulant; dopamine uptake inhibitor; environmental contaminant; local anaesthetic; mouse metabolite; plant metabolite; serotonin uptake inhibitor; sodium channel blocker; sympathomimetic agent; vasoconstrictor agent; xenobiotic
clindamycin	[no description available]	medium	1
fosfomycin	[no description available]	medium	1	epoxide; phosphonic acids	antimicrobial agent; EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor
zithromax	[no description available]	medium	1	macrolide antibiotic	antibacterial drug; environmental contaminant; xenobiotic
bms 214662	[no description available]	medium	1	benzenes; benzodiazepine; imidazoles; nitrile; sulfonamide; thiophenes	antineoplastic agent; apoptosis inducer; EC 2.5.1.58 (protein farnesyltransferase) inhibitor
eptifibatide	[no description available]	medium	1	homodetic cyclic peptide; macrocycle; organic disulfide	anticoagulant; platelet aggregation inhibitor
gs 4071	[no description available]	medium	1	acetate ester; amino acid; cyclohexenecarboxylic acid; primary amino compound	antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; marine xenobiotic metabolite
decitabine	[no description available]	medium	1	2'-deoxyribonucleoside
sm 8668	[no description available]	medium	1
teniposide	[no description available]	medium	1	aromatic ether; beta-D-glucoside; cyclic acetal; furonaphthodioxole; gamma-lactone; monosaccharide derivative; phenols; thiophenes	antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
troxacitabine	[no description available]	medium	1	carbohydrate derivative; nucleobase-containing molecular entity
cefamandole	[no description available]	medium	1	cephalosporin; semisynthetic derivative	antibacterial drug
tiazofurin	[no description available]	medium	1	1,3-thiazoles; C-glycosyl compound; monocarboxylic acid amide	antineoplastic agent; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; prodrug
melphalan	[no description available]	medium	1	L-phenylalanine derivative; nitrogen mustard; non-proteinogenic L-alpha-amino acid; organochlorine compound	alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent
sitafloxacin	[no description available]	medium	1	fluoroquinolone antibiotic; quinolines; quinolone antibiotic
tenofovir	[no description available]	medium	1	nucleoside analogue; phosphonic acids	antiviral drug; drug metabolite; HIV-1 reverse transcriptase inhibitor
micafungin	[no description available]	medium	1	antibiotic antifungal drug; echinocandin	antiinfective agent
mezlocillin	[no description available]	high	2	penicillin allergen; penicillin	antibacterial drug
tropisetron	[no description available]	medium	1	indolyl carboxylic acid
leuprolide	[no description available]	medium	1	oligopeptide	anti-estrogen; antineoplastic agent; gonadotropin releasing hormone agonist
fludarabine	[no description available]	medium	1	purine nucleoside
propylthiouracil	[no description available]	medium	1	pyrimidinethione	antidote to paracetamol poisoning; antimetabolite; antioxidant; antithyroid drug; carcinogenic agent; EC 1.14.13.39 (nitric oxide synthase) inhibitor; hormone antagonist
etomidate	[no description available]	medium	1	ethyl ester; imidazoles	intravenous anaesthetic; sedative
mercaptopurine	[no description available]	medium	1	aryl thiol; purines; thiocarbonyl compound	anticoronaviral agent; antimetabolite; antineoplastic agent
cotinine	[no description available]	medium	1	N-alkylpyrrolidine; pyridines; pyrrolidin-2-ones; pyrrolidine alkaloid	antidepressant; biomarker; human xenobiotic metabolite; plant metabolite
methimazole	[no description available]	medium	1	1,3-dihydroimidazole-2-thiones	antithyroid drug
drotaverin	[no description available]	medium	1	isoquinolines
digoxin	[no description available]	medium	1	cardenolide glycoside; steroid saponin	anti-arrhythmia drug; cardiotonic drug; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; epitope
cancidas	[no description available]	medium	1
lincomycin	[no description available]	high	3	carbohydrate-containing antibiotic; L-proline derivative; monocarboxylic acid amide; pyrrolidinecarboxamide; S-glycosyl compound	antimicrobial agent; bacterial metabolite
thiopental	[no description available]	medium	1	barbiturates	anticonvulsant; drug allergen; environmental contaminant; intravenous anaesthetic; sedative; xenobiotic
hmr 3647	[no description available]	medium	1
nelarabine	[no description available]	medium	1	beta-D-arabinoside; monosaccharide derivative; purine nucleoside	antineoplastic agent; DNA synthesis inhibitor; prodrug
2-[(2-ethoxyphenoxy)-phenylmethyl]morpholine	[no description available]	medium	1	aromatic ether
dolasetron	[no description available]	medium	1	indolyl carboxylic acid
or 1259	[no description available]	medium	1	hydrazone; nitrile; pyridazinone	anti-arrhythmia drug; cardiotonic drug; EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor; vasodilator agent
gestodene	[no description available]	medium	1	steroid	estrogen
quinine	[no description available]	medium	1	cinchona alkaloid	antimalarial; muscle relaxant; non-narcotic analgesic
ifetroban	[no description available]	medium	1	benzenes; monocarboxylic acid
lamifiban	[no description available]	medium	1	N-acylglycine
telavancin	[no description available]	medium	1	glycopeptide	antibacterial drug; antimicrobial agent
sitagliptin	[no description available]	medium	1	triazolopyrazine; trifluorobenzene	EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; environmental contaminant; hypoglycemic agent; serine proteinase inhibitor; xenobiotic
tolcapone	[no description available]	medium	1	2-nitrophenols; benzophenones; catechols	antiparkinson drug; EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
quercetin	[no description available]	medium	1	7-hydroxyflavonol; pentahydroxyflavone	antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger
clavulanic acid	[no description available]	medium	1	oxapenam	antibacterial drug; anxiolytic drug; bacterial metabolite; EC 3.5.2.6 (beta-lactamase) inhibitor
pulmicort	[no description available]	medium	1	11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; cyclic acetal; glucocorticoid; primary alpha-hydroxy ketone	anti-inflammatory drug; bronchodilator agent; drug allergen
eprosartan	[no description available]	medium	1	dicarboxylic acid; imidazoles; thiophenes	angiotensin receptor antagonist; antihypertensive agent; environmental contaminant; xenobiotic
montelukast	[no description available]	medium	1	aliphatic sulfide; monocarboxylic acid; quinolines	anti-arrhythmia drug; anti-asthmatic drug; leukotriene antagonist
mivacurium	[no description available]	medium	1	isoquinolines
entacapone	[no description available]	medium	1	2-nitrophenols; catechols; monocarboxylic acid amide; nitrile	antidyskinesia agent; antiparkinson drug; central nervous system drug; EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
paricalcitol	[no description available]	medium	1	hydroxy seco-steroid; seco-cholestane	antiparathyroid drug
sdz psc 833	[no description available]	medium	1	homodetic cyclic peptide
indocyanine green	[no description available]	medium	1	1,1-diunsubstituted alkanesulfonate; benzoindole; cyanine dye
codeine	[no description available]	medium	1	morphinane alkaloid; organic heteropentacyclic compound	antitussive; drug allergen; environmental contaminant; opioid analgesic; opioid receptor agonist; prodrug; xenobiotic
cyclosporine	[no description available]	medium	1	homodetic cyclic peptide	anti-asthmatic drug; anticoronaviral agent; antifungal agent; antirheumatic drug; carcinogenic agent; dermatologic drug; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; geroprotector; immunosuppressive agent; metabolite
hydromorphone	[no description available]	medium	1	morphinane alkaloid; organic heteropentacyclic compound	mu-opioid receptor agonist; opioid analgesic
nalmefene	[no description available]	medium	1	morphinane alkaloid
naloxone	[no description available]	medium	1	morphinane alkaloid; organic heteropentacyclic compound; tertiary alcohol	antidote to opioid poisoning; central nervous system depressant; mu-opioid receptor antagonist
oxycodone	[no description available]	medium	1	organic heteropentacyclic compound; semisynthetic derivative	antitussive; mu-opioid receptor agonist; opioid analgesic
alvocidib	[no description available]	medium	1	dihydroxyflavone; hydroxypiperidine; monochlorobenzenes; tertiary amino compound	antineoplastic agent; antirheumatic drug; apoptosis inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
morphine	[no description available]	medium	1	morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound	anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic
cicaprost	[no description available]	medium	1	monoterpenoid
dexmedetomidine	[no description available]	medium	1	medetomidine	alpha-adrenergic agonist; analgesic; non-narcotic analgesic; sedative
iloprost	[no description available]	medium	1	carbobicyclic compound; monocarboxylic acid; secondary alcohol	platelet aggregation inhibitor; vasodilator agent
nalbuphine	[no description available]	medium	1	organic heteropentacyclic compound	mu-opioid receptor antagonist; opioid analgesic
nateglinide	[no description available]	medium	1	phenylalanine derivative
vinorelbine	[no description available]	medium	1	acetate ester; methyl ester; organic heteropentacyclic compound; organic heterotetracyclic compound; ring assembly; vinca alkaloid	antineoplastic agent; photosensitizing agent
romidepsin	[no description available]	medium	1	cyclodepsipeptide; heterocyclic antibiotic; organic disulfide	antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor
(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid	[no description available]	medium	1	dihydroxy monocarboxylic acid; indoles; organofluorine compound
naltrexone	[no description available]	medium	1	cyclopropanes; morphinane-like compound; organic heteropentacyclic compound	antidote to opioid poisoning; central nervous system depressant; environmental contaminant; mu-opioid receptor antagonist; xenobiotic
morphine-6-glucuronide	[no description available]	medium	1	morphinane alkaloid
butorphanol	[no description available]	medium	1	morphinane alkaloid	antitussive; kappa-opioid receptor agonist; mu-opioid receptor agonist; opioid analgesic
cefodizime	[no description available]	medium	1	1,3-thiazoles; cephalosporin; oxime O-ether	antibacterial drug; EC 1.14.18.1 (tyrosinase) inhibitor
methylnaltrexone	[no description available]	medium	1	phenanthrenes
cefixime	[no description available]	medium	1	cephalosporin	antibacterial drug; drug allergen
lisinopril	[no description available]	medium	1	dipeptide	EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
indinavir sulfate	[no description available]	medium	1	dicarboxylic acid diamide; N-(2-hydroxyethyl)piperazine; piperazinecarboxamide	HIV protease inhibitor
enalaprilat anhydrous	[no description available]	medium	1	dicarboxylic acid; dipeptide	antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
cefuroxime	[no description available]	medium	1	3-(carbamoyloxymethyl)cephalosporin; furans; oxime O-ether	drug allergen
ceftriaxone	[no description available]	medium	1	1,2,4-triazines; 1,3-thiazoles; cephalosporin; oxime O-ether	antibacterial drug; drug allergen; EC 3.5.2.6 (beta-lactamase) inhibitor
cefepime	[no description available]	medium	1	cephalosporin; oxime O-ether	antibacterial drug
hr 810	[no description available]	medium	1	cephalosporin; cyclopentapyridine
ceftazidime	[no description available]	medium	1	cephalosporin; oxime O-ether	antibacterial drug; drug allergen; EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor
cefetamet	[no description available]	medium	1	cephalosporin
famotidine	[no description available]	medium	1	1,3-thiazoles; guanidines; sulfonamide	anti-ulcer drug; H2-receptor antagonist; P450 inhibitor
cefotaxime	[no description available]	medium	1	1,3-thiazoles; cephalosporin; oxime O-ether	antibacterial drug; drug allergen
aztreonam	[no description available]	medium	1	beta-lactam antibiotic allergen; monobactam	antibacterial drug; drug allergen; EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor
ginkgolide b	[no description available]	medium	1
palonosetron	[no description available]	medium	1	azabicycloalkane; delta-lactam; organic heterotricyclic compound	antiemetic; serotonergic antagonist
cefatrizine	[no description available]	medium	1	amino acid amide; carboxylic acid; cephalosporin; phenols; semisynthetic derivative; triazoles	antibacterial drug; EC 2.7.11.20 (elongation factor 2 kinase) inhibitor
eniporide	[no description available]	medium	1
cilastatin	[no description available]	medium	1	carboxamide; L-cysteine derivative; non-proteinogenic L-alpha-amino acid; organic sulfide	EC 3.4.13.19 (membrane dipeptidase) inhibitor; environmental contaminant; protease inhibitor; xenobiotic
ixabepilone	[no description available]	medium	1	1,3-thiazoles; beta-hydroxy ketone; epoxide; lactam; macrocycle	antineoplastic agent; microtubule-destabilising agent
azlocillin	[no description available]	medium	1	penicillin allergen; penicillin; semisynthetic derivative	antibacterial drug
verlukast	[no description available]	medium	1
ceftizoxime	[no description available]	medium	1	cephalosporin	antibacterial drug
carumonam	[no description available]	medium	1	monobactam	antibacterial drug
nitrofurantoin	[no description available]	medium	1	imidazolidine-2,4-dione; nitrofuran antibiotic; organonitrogen heterocyclic antibiotic; organooxygen heterocyclic antibiotic	antibacterial drug; antiinfective agent; hepatotoxic agent
eritoran	[no description available]	medium	1	lipid As
dantrolene	[no description available]	medium	1
artesunate	[no description available]	medium	1	artemisinin derivative; cyclic acetal; dicarboxylic acid monoester; hemisuccinate; semisynthetic derivative; sesquiterpenoid	antimalarial; antineoplastic agent; ferroptosis inducer
dexniguldipine	[no description available]	medium	1	diarylmethane
napsagatran	[no description available]	medium	1
temsirolimus	[no description available]	medium	1	macrolide lactam
bms188797	[no description available]	medium	1
azimilide	[no description available]	medium	1	imidazolidine-2,4-dione
tomopenem	[no description available]	medium	1
bb-83698	[no description available]	medium	1
zotarolimus	[no description available]	medium	1	lactam; macrolide
bn 52020	[no description available]	medium	1
vindesine	[no description available]	medium	1
scopolamine hydrobromide	[no description available]	medium	1
bisaramil	[no description available]	medium	1
teicoplanin	[no description available]	medium	1
ly-146032	[no description available]	medium	1	heterodetic cyclic peptide; lipopeptide antibiotic; lipopeptide; macrocycle; macrolide	antibacterial drug; bacterial metabolite; calcium-dependent antibiotics
dalbavancin	[no description available]	medium	1	carbohydrate acid derivative; glycopeptide; monosaccharide derivative; semisynthetic derivative	antibacterial drug; antimicrobial agent
cetrorelix	[no description available]	medium	1	oligopeptide	antineoplastic agent; GnRH antagonist
chlortetracycline	[no description available]	medium	1
oxytetracycline, anhydrous	[no description available]	medium	1
minocycline	[no description available]	medium	1
roquinimex	[no description available]	medium	1	aromatic amide
mobic	[no description available]	medium	1	1,3-thiazoles; benzothiazine; monocarboxylic acid amide	analgesic; antirheumatic drug; cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug
mobiflex	[no description available]	medium	1	heteroaryl hydroxy compound; monocarboxylic acid amide; pyridines; thienothiazine	antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug
isoxicam	[no description available]	medium	1	benzothiazine; isoxazoles; monocarboxylic acid amide	antirheumatic drug; non-steroidal anti-inflammatory drug
warfarin	[no description available]	medium	1	benzenes; hydroxycoumarin; methyl ketone
demeclocycline	[no description available]	medium	1
rolitetracycline	[no description available]	medium	1
tigecycline	[no description available]	medium	1
acyclovir	[no description available]	medium	1	2-aminopurines; oxopurine	antimetabolite; antiviral drug
rifampin	[no description available]	medium	2	cyclic ketal; hydrazone; N-iminopiperazine; N-methylpiperazine; rifamycins; semisynthetic derivative; zwitterion	angiogenesis inhibitor; antiamoebic agent; antineoplastic agent; antitubercular agent; DNA synthesis inhibitor; EC 2.7.7.6 (RNA polymerase) inhibitor; Escherichia coli metabolite; geroprotector; leprostatic drug; neuroprotective agent; pregnane X receptor agonist; protein synthesis inhibitor
clozapine	[no description available]	medium	1	benzodiazepine; N-arylpiperazine; N-methylpiperazine; organochlorine compound	adrenergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; GABA antagonist; histamine antagonist; muscarinic antagonist; second generation antipsychotic; serotonergic antagonist; xenobiotic
dacarbazine	[no description available]	medium	1	dacarbazine
didanosine	[no description available]	medium	1	purine 2',3'-dideoxyribonucleoside	antimetabolite; antiviral drug; EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor; geroprotector; HIV-1 reverse transcriptase inhibitor
ganciclovir	[no description available]	medium	1	2-aminopurines; oxopurine	antiinfective agent; antiviral drug
sildenafil	[no description available]	medium	1	piperazines; pyrazolopyrimidine; sulfonamide	EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent
penciclovir	[no description available]	medium	1	2-aminopurines; propane-1,3-diols	antiviral drug
vardenafil	[no description available]	medium	1	imidazotriazine; N-alkylpiperazine; N-sulfonylpiperazine	EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent
allopurinol	[no description available]	medium	1	nucleobase analogue; organic heterobicyclic compound	antimetabolite; EC 1.17.3.2 (xanthine oxidase) inhibitor; gout suppressant; radical scavenger
leucovorin	[no description available]	medium	1	formyltetrahydrofolic acid	Escherichia coli metabolite; mouse metabolite
tegaserod	[no description available]	medium	1	carboxamidine; guanidines; hydrazines; indoles	gastrointestinal drug; serotonergic agonist
tirapazamine	[no description available]	medium	1	aromatic amine; benzotriazines; N-oxide	antibacterial agent; antineoplastic agent; apoptosis inducer
aprepitant	[no description available]	medium	1	(trifluoromethyl)benzenes; cyclic acetal; morpholines; triazoles	antidepressant; antiemetic; neurokinin-1 receptor antagonist; peripheral nervous system drug; substance P receptor antagonist
ceftobiprole	[no description available]	medium	1	cephalosporin; thiadiazoles	antimicrobial agent
rifabutin	[no description available]	medium	1
acridines	[no description available]	medium	1	acridines; mancude organic heterotricyclic parent; polycyclic heteroarene	genotoxin
1,2-Dihydroquinolin-2-imine	[no description available]	medium	1	aminoquinoline
tylosin	[no description available]	medium	1	aldehyde; disaccharide derivative; enone; leucomycin; macrolide antibiotic; monosaccharide derivative	allergen; bacterial metabolite; environmental contaminant; xenobiotic
viomycin	[no description available]	medium	1	heterodetic cyclic peptide; peptide antibiotic	antitubercular agent
oligonucleotides	[no description available]	medium	2
pyridoxal phosphate	[no description available]	medium	1	methylpyridines; monohydroxypyridine; pyridinecarbaldehyde; vitamin B6 phosphate	coenzyme; cofactor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
gold	[no description available]	medium	1	copper group element atom; elemental gold
nad	[no description available]	medium	1	organophosphate oxoanion	cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite
nadp	[no description available]	medium	1
butirosin sulfate	[no description available]	medium	10
gentamicin	[no description available]	medium	20
neomycin c	[no description available]	medium	1	aminoglycoside
hydrogen	[no description available]	medium	1	elemental hydrogen; elemental molecule; gas molecular entity	antioxidant; electron donor; food packaging gas; fuel; human metabolite
guanine	[no description available]	medium	1	2-aminopurines; oxopurine; purine nucleobase	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
erythrosine	[no description available]	medium	1
sesquiterpenes	[no description available]	medium	1
propylparaben	[no description available]	medium	1	benzoate ester; paraben; phenols	antifungal agent; antimicrobial agent
ribose	[no description available]	medium	1	D-ribose; ribopyranose
anticodon	[no description available]	medium	1
adenine	[no description available]	medium	2	6-aminopurines; purine nucleobase	Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
gentamicin c	[no description available]	medium	2
2-aminopurine	[no description available]	medium	1	2-aminopurines; nucleobase analogue	antimetabolite
glucosamine	[no description available]	medium	1	D-glucosamine	Escherichia coli metabolite; geroprotector; mouse metabolite
neosamine c	[no description available]	medium	1
nalidixic acid	[no description available]	medium	1	1,8-naphthyridine derivative; monocarboxylic acid; quinolone antibiotic	antibacterial drug; antimicrobial agent; DNA synthesis inhibitor
glucaric acid	[no description available]	medium	1	glucaric acid	antineoplastic agent
d-glucaro-delta-lactam	[no description available]	medium	1
neostigmine	[no description available]	medium	1	quaternary ammonium ion	antidote to curare poisoning; EC 3.1.1.7 (acetylcholinesterase) inhibitor
fusidic acid	[no description available]	medium	1	11alpha-hydroxy steroid; 3alpha-hydroxy steroid; alpha,beta-unsaturated monocarboxylic acid; steroid acid; steroid antibiotic; sterol ester	EC 2.7.1.33 (pantothenate kinase) inhibitor; Escherichia coli metabolite; protein synthesis inhibitor
aztreonam	[no description available]	medium	1
cyclohexanol	[no description available]	medium	1	cyclohexanols; secondary alcohol	solvent
succinylcholine	[no description available]	medium	1	quaternary ammonium ion; succinate ester	drug allergen; muscle relaxant; neuromuscular agent
edrophonium	[no description available]	medium	1	phenols; quaternary ammonium ion	antidote; diagnostic agent; EC 3.1.1.8 (cholinesterase) inhibitor
tubocurarine	[no description available]	medium	2	bisbenzylisoquinoline alkaloid	drug allergen; muscle relaxant; nicotinic antagonist
xylose	[no description available]	medium	1	D-xylose
hexylamine	[no description available]	medium	1	primary aliphatic amine	metabolite
fortimicin a sulfate	[no description available]	medium	1	aminoglycoside sulfate salt
sf-2052	[no description available]	medium	1	aminoglycoside
ammonium hydroxide	[no description available]	medium	1	azane; gas molecular entity; mononuclear parent hydride	EC 3.5.1.4 (amidase) inhibitor; metabolite; mouse metabolite; neurotoxin; NMR chemical shift reference compound; nucleophilic reagent; refrigerant
hygromycin b	[no description available]	medium	1
isomethyleugenol	[no description available]	medium	1	isomethyleugenol
alpha-hydroxyglutarate	[no description available]	low	0	2-hydroxydicarboxylic acid; dicarboxylic fatty acid	metabolite; mouse metabolite
alpha-isopropylmalate	[no description available]	low	0	2-hydroxy carboxylic acid; 3-hydroxy carboxylic acid; dicarboxylic acid	metabolite
acetoacetic acid	[no description available]	low	0	3-oxo fatty acid; ketone body	metabolite
3-hydroxybenzyl alcohol	[no description available]	low	0	hydroxybenzyl alcohol; phenols	metabolite
n-carbamoyl-beta-alanine	[no description available]	low	0	beta-alanine derivative	metabolite; mouse metabolite
ethylene glycol	[no description available]	low	0	ethanediol; glycol	metabolite; mouse metabolite; solvent; toxin
acetoin	[no description available]	low	0	methyl ketone; secondary alpha-hydroxy ketone	metabolite
benzyl alcohol	[no description available]	low	0	benzyl alcohols	antioxidant; fragrance; metabolite; solvent
carbon monoxide	[no description available]	low	0	carbon oxide; gas molecular entity; one-carbon compound	biomarker; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; human metabolite; ligand; metabolite; mitochondrial respiratory-chain inhibitor; mouse metabolite; neurotoxin; neurotransmitter; P450 inhibitor; probe; signalling molecule; vasodilator agent
formic acid	[no description available]	low	0	monocarboxylic acid	antibacterial agent; astringent; metabolite; protic solvent; solvent
4-hydroxymandelic acid	[no description available]	low	0	2-hydroxy carboxylic acid; phenols	metabolite
aminoethylphosphonic acid	[no description available]	low	0	phosphonic acids; primary amino compound; zwitterion	human metabolite; metabolite; mouse metabolite
hydrogen sulfide	[no description available]	low	0	gas molecular entity; hydracid; mononuclear parent hydride; sulfur hydride	Escherichia coli metabolite; genotoxin; metabolite; signalling molecule; toxin; vasodilator agent
4-aminophenol	[no description available]	low	0	aminophenol	allergen; metabolite
n(1)-acetylspermidine	[no description available]	low	0	acetylspermidine	Escherichia coli metabolite; metabolite
dihydrouracil	[no description available]	low	0	pyrimidone	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite
dihydroxyacetone	[no description available]	low	0	ketotriose; primary alpha-hydroxy ketone	antifungal agent; Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
dimethylamine	[no description available]	low	0	methylamines; secondary aliphatic amine	metabolite
glycolic acid	[no description available]	low	0	2-hydroxy monocarboxylic acid; primary alcohol	keratolytic drug; metabolite
hydantoin-5-propionic acid	[no description available]	low	0	imidazolidine-2,4-dione; monocarboxylic acid	metabolite; mouse metabolite
niacinamide	[no description available]	low	0	pyridine alkaloid; pyridinecarboxamide; vitamin B3	anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor
niacin	[no description available]	low	0	pyridine alkaloid; pyridinemonocarboxylic acid; vitamin B3	antidote; antilipemic drug; EC 3.5.1.19 (nicotinamidase) inhibitor; Escherichia coli metabolite; human urinary metabolite; metabolite; mouse metabolite; plant metabolite; vasodilator agent
orotic acid	[no description available]	low	0	pyrimidinemonocarboxylic acid	Escherichia coli metabolite; metabolite; mouse metabolite
oxaloacetic acid	[no description available]	low	0	C4-dicarboxylic acid; oxo dicarboxylic acid	geroprotector; metabolite
porphobilinogen	[no description available]	low	0	aralkylamino compound; dicarboxylic acid; pyrroles	Escherichia coli metabolite; metabolite; mouse metabolite
1-propanol	[no description available]	low	0	propan-1-ols; short-chain primary fatty alcohol	metabolite; protic solvent
trimethyloxamine	[no description available]	low	0	tertiary amine oxide	Escherichia coli metabolite; metabolite; osmolyte
6-hydroxymelatonin	[no description available]	low	0	acetamides; tryptamines	metabolite; mouse metabolite
n-acetylphenylalanine	[no description available]	low	0	N-acetyl-amino acid; phenylalanine derivative	antidepressant; metabolite
n-acetyltryptophan	[no description available]	low	0	N-acetyl-amino acid; tryptophan derivative	metabolite
arecoline	[no description available]	low	0	enoate ester; methyl ester; pyridine alkaloid; tetrahydropyridine	metabolite; muscarinic agonist
aristolochic acid i	[no description available]	low	0	aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound	carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin
berberine	[no description available]	low	0	alkaloid antibiotic; berberine alkaloid; botanical anti-fungal agent; organic heteropentacyclic compound	antilipemic drug; antineoplastic agent; antioxidant; EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor; EC 1.21.3.3 (reticuline oxidase) inhibitor; EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.11.10 (IkappaB kinase) inhibitor; EC 3.1.1.4 (phospholipase A2) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor; EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; geroprotector; hypoglycemic agent; metabolite; potassium channel blocker
dibutyl phthalate	[no description available]	low	0	diester; phthalate ester	EC 3.2.1.20 (alpha-glucosidase) inhibitor; environmental contaminant; metabolite; plasticiser; teratogenic agent
hydroxymethyltolbutamide	[no description available]	low	0	benzyl alcohols; sulfonamide; ureas	metabolite
methyl salicylate	[no description available]	low	0	benzoate ester; methyl ester; salicylates	flavouring agent; insect attractant; metabolite
myristicin	[no description available]	low	0	organic molecular entity	metabolite
phenmetrazine	[no description available]	low	0	morpholines	metabolite; sympathomimetic agent
phenylbutazone	[no description available]	low	0	pyrazolidines	antirheumatic drug; EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor; metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug
safrole	[no description available]	low	0	benzodioxoles	flavouring agent; insecticide; metabolite; plant metabolite
2,2'-thiodiethanol	[no description available]	low	0	aliphatic sulfide; diol	antineoplastic agent; antioxidant; metabolite; solvent
sorbitol	[no description available]	low	0	glucitol	cathartic; Escherichia coli metabolite; food humectant; human metabolite; laxative; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite; sweetening agent
alloxan	[no description available]	low	0	pyrimidone	hyperglycemic agent; metabolite
thymidine	[no description available]	low	0	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite
glutamine	[no description available]	low	0	amino acid zwitterion; glutamine family amino acid; glutamine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid	EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
allyl isothiocyanate	[no description available]	low	0	alkenyl isothiocyanate; isothiocyanate	antimicrobial agent; antineoplastic agent; apoptosis inducer; lachrymator; metabolite
n-methyltryptamine	[no description available]	low	0	tryptamine alkaloid; tryptamines	metabolite
4-deoxypyridoxine	[no description available]	low	0	hydroxymethylpyridine; methylpyridines; monohydroxypyridine	metabolite
cycloserine	[no description available]	low	0	4-amino-1,2-oxazolidin-3-one; organonitrogen heterocyclic antibiotic; organooxygen heterocyclic antibiotic; zwitterion	antiinfective agent; antimetabolite; antitubercular agent; metabolite; NMDA receptor agonist
17-alpha-hydroxyprogesterone	[no description available]	low	0	17alpha-hydroxy-C21-steroid; 17alpha-hydroxy steroid; tertiary alpha-hydroxy ketone	human metabolite; metabolite; mouse metabolite; progestin
mannitol	[no description available]	low	0	mannitol	allergen; antiglaucoma drug; compatible osmolytes; Escherichia coli metabolite; food anticaking agent; food bulking agent; food humectant; food stabiliser; food thickening agent; hapten; metabolite; osmotic diuretic; sweetening agent
phenacyl bromide	[no description available]	low	0	acetophenones; alpha-bromoketone	metabolite
trichloroacetic acid	[no description available]	low	0	monocarboxylic acid; organochlorine compound	carcinogenic agent; metabolite; mouse metabolite
acrylic acid	[no description available]	low	0	alpha,beta-unsaturated monocarboxylic acid	metabolite
n-methylacetamide	[no description available]	low	0	acetamides; monocarboxylic acid amide	metabolite
bis(4-hydroxyphenyl)sulfone	[no description available]	low	0	bisphenol; sulfone	endocrine disruptor; metabolite
rotenone	[no description available]	low	0	organic heteropentacyclic compound; rotenones	antineoplastic agent; metabolite; mitochondrial NADH:ubiquinone reductase inhibitor; phytogenic insecticide; piscicide; toxin
7-amino-4-hydroxy-2-naphthalenesulfonic acid	[no description available]	low	0	aminonaphthalenesulfonic acid; naphthols	metabolite
methyl benzoate	[no description available]	low	0	benzoate ester; methyl ester	insect attractant; metabolite
2-dichlorobenzene	[no description available]	low	0	dichlorobenzene	hepatotoxic agent; metabolite
2,4-diaminotoluene	[no description available]	low	0	aminotoluene	metabolite
4-butyrolactone	[no description available]	low	0	butan-4-olide	metabolite; neurotoxin
sulfosalicylic acid	[no description available]	low	0	arenesulfonic acid; benzoic acids; phenols	metabolite
ethyl lactate	[no description available]	low	0	ethyl ester; lactate ester; secondary alcohol	metabolite
furaldehyde	[no description available]	low	0	aldehyde; furans	Maillard reaction product; metabolite
thiophene-2-carboxaldehyde	[no description available]	low	0	aldehyde; thiophenes	metabolite
alpha-resorcylic acid	[no description available]	low	0	dihydroxybenzoic acid; resorcinols	metabolite
methylenebis(chloroaniline)	[no description available]	low	0	chloroaniline	metabolite
2-phenylethyl acetate	[no description available]	low	0	acetate ester	metabolite; Saccharomyces cerevisiae metabolite
dibenzyl ether	[no description available]	low	0	benzyl ether	metabolite
ethyl propionate	[no description available]	low	0	propanoate ester	metabolite
citronellal	[no description available]	low	0	aldehyde; monoterpenoid	antifungal agent; metabolite
ethyl oenanthate	[no description available]	low	0	fatty acid ethyl ester	metabolite
ethyl caprylate	[no description available]	low	0	fatty acid ethyl ester; octanoate ester	metabolite
ethyl laurate	[no description available]	low	0	fatty acid ethyl ester	metabolite
acetic anhydride	[no description available]	low	0	acyclic carboxylic anhydride	metabolite; reagent
ethyl isovalerate	[no description available]	low	0	fatty acid ethyl ester; olefinic compound	metabolite
n-butyl n-butyrate	[no description available]	low	0	butyrate ester	metabolite
ethyl decanoate	[no description available]	low	0	decanoate ester; fatty acid ethyl ester	metabolite
methyl octanoate	[no description available]	low	0	fatty acid methyl ester; octanoate ester	metabolite
2-octanone	[no description available]	low	0	methyl ketone	metabolite
lauric acid methyl ester	[no description available]	low	0	dodecanoate ester; fatty acid methyl ester	metabolite
octylamine	[no description available]	low	0	primary aliphatic amine	metabolite
n-decyl alcohol	[no description available]	low	0	decanol; primary alcohol	metabolite; pheromone; protic solvent
methyl palmitate	[no description available]	low	0	fatty acid methyl ester	metabolite
maltol	[no description available]	low	0	4-pyranones	metabolite
chloranil	[no description available]	low	0	1,4-benzoquinones; organochlorine compound	EC 2.7.1.33 (pantothenate kinase) inhibitor; metabolite
dibenzoylmethane	[no description available]	low	0	aromatic ketone; beta-diketone	antimutagen; antineoplastic agent; metabolite
methyl anthranilate	[no description available]	low	0	benzoate ester	flavouring agent; metabolite
benzyl acetate	[no description available]	low	0	acetate ester; benzyl ester	metabolite
ethyl acetate	[no description available]	low	0	acetate ester; ethyl ester; volatile organic compound	EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor; metabolite; polar aprotic solvent; Saccharomyces cerevisiae metabolite
dibenzyl disulfide	[no description available]	low	0	organic aromatic compound; organic disulfide	metabolite
mequinol	[no description available]	low	0	methoxybenzenes; phenols	metabolite
gamma-resorcylic acid	[no description available]	low	0	dihydroxybenzoic acid	metabolite
kynuramine	[no description available]	low	0	kynurenamines; primary amino compound	metabolite
5-methylpyrazole-3-carboxylic acid	[no description available]	low	0	monocarboxylic acid; pyrazoles	metabolite
4-trifluoromethylaniline	[no description available]	low	0	(trifluoromethyl)benzenes; substituted aniline	metabolite
methylguanidine	[no description available]	low	0	guanidines	EC 1.14.13.39 (nitric oxide synthase) inhibitor; metabolite; uremic toxin
liriodenine	[no description available]	low	0	alkaloid antibiotic; cyclic ketone; organic heteropentacyclic compound; oxacycle; oxoaporphine alkaloid	antifungal agent; antimicrobial agent; antineoplastic agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite
plumbagin	[no description available]	low	0	hydroxy-1,4-naphthoquinone; phenols	anticoagulant; antineoplastic agent; immunological adjuvant; metabolite
imperatorin	[no description available]	low	0	psoralens	EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite
osthol	[no description available]	low	0	botanical anti-fungal agent; coumarins	metabolite
Dillapiole	[no description available]	low	0	benzodioxoles	metabolite
coumaran	[no description available]	low	0	1-benzofurans	metabolite
1,3-propanediol	[no description available]	low	0	propane-1,3-diols	metabolite; protic solvent
tridecanedioic acid	[no description available]	low	0	alpha,omega-dicarboxylic acid	metabolite
physcione	[no description available]	low	0	dihydroxyanthraquinone	anti-inflammatory agent; antibacterial agent; antifungal agent; antineoplastic agent; apoptosis inducer; hepatoprotective agent; metabolite
apiole	[no description available]	low	0	benzodioxoles	metabolite
flavone	[no description available]	low	0	flavones	metabolite; nematicide
cetyl palmitate	[no description available]	low	0	hexadecanoate ester	metabolite
n-amyl butyrate	[no description available]	low	0	butyrate ester	metabolite
3-aminobutyric acid	[no description available]	low	0	amino acid zwitterion; beta-amino acid; monocarboxylic acid	metabolite
methyl lactate	[no description available]	low	0	lactate ester; methyl ester	metabolite
paeonol	[no description available]	low	0	methoxybenzenes; phenols	metabolite
2,2-dimethylbutyric acid	[no description available]	low	0	dimethylbutyric acid	metabolite
2-chloroacrylic acid	[no description available]	low	0	alpha,beta-unsaturated monocarboxylic acid; chlorocarboxylic acid	metabolite
galactitol	[no description available]	low	0	hexitol	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite
1-methyluracil	[no description available]	low	0	nucleobase analogue; pyrimidone	metabolite
2-pyrrolidone	[no description available]	low	0	pyrrolidin-2-ones	metabolite; polar solvent
n-ethylacetamide	[no description available]	low	0	acetamides	metabolite
6-methyluracil	[no description available]	low	0	pyrimidone	metabolite
3-methylglutaric acid	[no description available]	low	0	alpha,omega-dicarboxylic acid	metabolite
amyl acetate	[no description available]	low	0	acetate ester	metabolite
dibenzothiophene 5-oxide	[no description available]	low	0	dibenzothiophenes	metabolite
2-acetamidoethanethiol	[no description available]	low	0	acetamides	metabolite
2-hydroxyquinoxaline	[no description available]	low	0	hydroxyquinoxaline	metabolite
3,4-dihydroxyacetophenone	[no description available]	low	0	acetophenones; catechols; dihydroxyacetophenone	metabolite
methyl hippurate	[no description available]	low	0	glycine derivative; methyl ester	metabolite
isobarbaloin	[no description available]	low	0	anthracenes; C-glycosyl compound; cyclic ketone; phenols	laxative; metabolite
vincamine	[no description available]	low	0	alkaloid ester; hemiaminal; methyl ester; organic heteropentacyclic compound; vinca alkaloid	antihypertensive agent; metabolite; vasodilator agent
methyl tert-butyl ether	[no description available]	low	0	ether	fuel additive; metabolite; non-polar solvent
4-octylphenol	[no description available]	low	0	phenols	metabolite; surfactant; xenoestrogen
phenethyl isothiocyanate	[no description available]	low	0	isothiocyanate	antineoplastic agent; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; metabolite
2-methoxy-1,4-naphthoquinone	[no description available]	low	0	1,4-naphthoquinones; enol ether	antimicrobial agent; metabolite; plant metabolite
aviprin	[no description available]	low	0	furanocoumarin	metabolite
hydroxyphenytoin	[no description available]	low	0	imidazolidine-2,4-dione; phenols	metabolite
squaric acid	[no description available]	low	0	alicyclic ketone; carbon oxoacid	metabolite
methyl methanethiosulfonate	[no description available]	low	0	sulfonic acid derivative; thiosulfonate ester	metabolite
arabinofuranosyluracil	[no description available]	low	0	N-glycosyl compound	metabolite
6-aminonicotinic acid	[no description available]	low	0	aminonicotinic acid; aminopyridine; aromatic amine	metabolite
mannose	[no description available]	low	0	D-aldohexose; D-mannose; mannopyranose	metabolite
2,3-hexanedione	[no description available]	low	0	alpha-diketone	metabolite
tabersonine	[no description available]	low	0	alkaloid ester; methyl ester; monoterpenoid indole alkaloid; organic heteropentacyclic compound	antineoplastic agent; metabolite
3,3-dimethylglutarate	[no description available]	low	0	alpha,omega-dicarboxylic acid	metabolite
raspberry ketone	[no description available]	low	0	methyl ketone; phenols	androgen antagonist; cosmetic; flavouring agent; fragrance; hepatoprotective agent; metabolite
laurolitsine	[no description available]	low	0	aporphine alkaloid; aromatic ether; phenols	HIV-1 integrase inhibitor; metabolite
helenalin	[no description available]	low	0	cyclic ketone; gamma-lactone; organic heterotricyclic compound; secondary alcohol; sesquiterpene lactone	anti-inflammatory agent; antineoplastic agent; metabolite; plant metabolite
diethyl malate	[no description available]	low	0	malate ester	metabolite
carbendazim	[no description available]	low	0	benzimidazole fungicide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester	antifungal agrochemical; antinematodal drug; metabolite; microtubule-destabilising agent
glucoheptonate	[no description available]	low	0	carbohydrate acid; monocarboxylic acid	metabolite
deslanoside	[no description available]	low	0	12beta-hydroxy steroid; 14beta-hydroxy steroid; cardenolide glycoside; tetrasaccharide derivative	anti-arrhythmia drug; cardiotonic drug; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; metabolite
streptozocin	[no description available]	low	0	N-acylglucosamine; N-nitrosoureas	antimicrobial agent; antineoplastic agent; DNA synthesis inhibitor; metabolite
pedalitin	[no description available]	low	0	monomethoxyflavone; tetrahydroxyflavone	EC 1.17.3.2 (xanthine oxidase) inhibitor; metabolite
ethyl nonanoate	[no description available]	low	0	fatty acid ethyl ester	metabolite
ethyl hexanoate	[no description available]	low	0	fatty acid ethyl ester; hexanoate ester	metabolite
butyl acetate	[no description available]	low	0	acetate ester	metabolite
1,4-dioxane	[no description available]	low	0	dioxane; volatile organic compound	carcinogenic agent; metabolite; NMR chemical shift reference compound; non-polar solvent
isoamyl acetate	[no description available]	low	0	acetate ester	metabolite; Saccharomyces cerevisiae metabolite
tramadol	[no description available]	low	0	2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol	adrenergic uptake inhibitor; antitussive; capsaicin receptor antagonist; delta-opioid receptor agonist; kappa-opioid receptor agonist; metabolite; mu-opioid receptor agonist; muscarinic antagonist; nicotinic antagonist; NMDA receptor antagonist; opioid analgesic; serotonergic antagonist; serotonin uptake inhibitor
6-pentylpyrone	[no description available]	low	0	2-pyranones	metabolite
4-methylhistamine	[no description available]	low	0	aralkylamino compound; imidazoles	histamine agonist; metabolite
perfosfamide	[no description available]	low	0	nitrogen mustard; organochlorine compound; peroxol; phosphorodiamide	alkylating agent; antineoplastic agent; drug allergen; immunosuppressive agent; metabolite
castanospermine	[no description available]	low	0	indolizidine alkaloid	anti-HIV-1 agent; anti-inflammatory agent; EC 3.2.1.* (glycosidase) inhibitor; metabolite
3-methyl-2-butenal	[no description available]	low	0	enal	metabolite
ethyl 3-hydroxybutyrate	[no description available]	low	0	fatty acid ethyl ester	metabolite
4,5-dimethyl-3-hydroxy-2(5h)-furanone	[no description available]	low	0	butenolide	metabolite
n-methylnicotinamide	[no description available]	low	0	pyridinecarboxamide	metabolite
3-aminoisobutyric acid	[no description available]	low	0	amino acid zwitterion; beta-amino acid	metabolite
platanic acid	[no description available]	low	0	hydroxy monocarboxylic acid; methyl ketone; pentacyclic triterpenoid	anti-HIV agent; metabolite
2'-deoxyuridylic acid	[no description available]	low	0	deoxyuridine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate	Escherichia coli metabolite; metabolite; mouse metabolite
gallocatechol	[no description available]	low	0	gallocatechin	antioxidant; metabolite; radical scavenger
1-methylinosine	[no description available]	low	0	inosines	metabolite
dihydrobetulinic acid	[no description available]	low	0	hydroxy monocarboxylic acid; pentacyclic triterpenoid	anti-HIV agent; antileishmanial agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; metabolite
bergenin	[no description available]	low	0	trihydroxybenzoic acid	metabolite
2-methoxyestradiol	[no description available]	low	0	17beta-hydroxy steroid; 3-hydroxy steroid	angiogenesis modulating agent; antimitotic; antineoplastic agent; human metabolite; metabolite; mouse metabolite
3'-cmp	[no description available]	low	0	cytidine 3'-phosphate; pyrimidine ribonucleoside 3'-monophosphate	Escherichia coli metabolite; metabolite; mouse metabolite
xanthoxyletin	[no description available]	low	0	coumarins	metabolite
pinocembrin	[no description available]	low	0	(2S)-flavan-4-one; dihydroxyflavanone	antineoplastic agent; antioxidant; metabolite; neuroprotective agent; vasodilator agent
orsellinic acid	[no description available]	low	0	dihydroxybenzoic acid; resorcinols	fungal metabolite; marine metabolite; metabolite
isoimperatorin	[no description available]	low	0	psoralens	EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite
rotenolone	[no description available]	low	0	organic molecular entity	metabolite
seselin	[no description available]	low	0	coumarins	metabolite
perillene	[no description available]	low	0	furans; monoterpenoid	fragrance; metabolite; semiochemical
glycine methyl ester	[no description available]	low	0	glycinyl ester	metabolite
hexadecanamide	[no description available]	low	0	primary fatty amide	metabolite
benzocyclobutene	[no description available]	low	0	carbobicyclic compound	metabolite
9-methyladenine	[no description available]	low	0	methyladenine	metabolite
n'-methyl-2-pyridone-5-carboxamide	[no description available]	low	0	methylpyridines; pyridinecarboxamide; pyridone	metabolite; mouse metabolite
1,3-dimethyluracil	[no description available]	low	0	pyrimidone	metabolite
3-methoxysalicylic acid	[no description available]	low	0	methoxysalicylic acid	metabolite
1,3-dimethyluric acid	[no description available]	low	0	oxopurine	metabolite
leucyltyrosine	[no description available]	low	0	dipeptide	metabolite
3-methylxanthine	[no description available]	low	0	3-methylxanthine	metabolite
leucyl-glycyl-glycine	[no description available]	low	0	tripeptide	metabolite
acetylleucine	[no description available]	low	0	L-leucine derivative; N-acetyl-L-amino acid	metabolite
n-benzoylalanine, (dl-ala)-isomer	[no description available]	low	0	alanine derivative; N-acyl-amino acid	metabolite
dipropylacetamide	[no description available]	low	0	fatty amide	geroprotector; metabolite; teratogenic agent
masoprocol	[no description available]	low	0	nordihydroguaiaretic acid	antineoplastic agent; hypoglycemic agent; lipoxygenase inhibitor; metabolite
7-methyladenine	[no description available]	low	0	methyladenine	metabolite
acetylisoniazid	[no description available]	low	0	carbohydrazide	metabolite
illimaquinone	[no description available]	low	0	monohydroxy-1,4-benzoquinones; prenylquinone	metabolite
coptisine	[no description available]	low	0	alkaloid	metabolite
betulin	[no description available]	low	0	diol; pentacyclic triterpenoid	analgesic; anti-inflammatory agent; antineoplastic agent; antiviral agent; metabolite
narciclasine	[no description available]	low	0	phenanthridines	metabolite
dmp 323	[no description available]	low	0	diazepanone; ureas	anti-HIV agent; metabolite
eupolauridine	[no description available]	low	0	naphthyridine derivative	metabolite
zaluzanin C	[no description available]	low	0	gamma-lactone; guaiane sesquiterpenoid; organic heterotricyclic compound; secondary alcohol; sesquiterpene lactone	EC 1.14.13.39 (nitric oxide synthase) inhibitor; metabolite
2-aminonicotinic acid	[no description available]	low	0	aminonicotinic acid; aminopyridine	metabolite
(-)-catechin	[no description available]	low	0	catechin	metabolite
dehydrocostus lactone	[no description available]	low	0	gamma-lactone; guaiane sesquiterpenoid; organic heterotricyclic compound; sesquiterpene lactone	antimycobacterial drug; antineoplastic agent; apoptosis inducer; cyclooxygenase 2 inhibitor; metabolite; trypanocidal drug
Tormentic acid	[no description available]	low	0	triterpenoid	metabolite
pinobanksin	[no description available]	low	0	secondary alpha-hydroxy ketone; trihydroxyflavanone	antimutagen; antioxidant; metabolite
sigmoidin a	[no description available]	low	0	4'-hydroxyflavanones; tetrahydroxyflavanone	anti-inflammatory agent; anti-obesity agent; antibacterial agent; metabolite; radical scavenger
xanthosine 5'-triphosphate	[no description available]	low	0	purine ribonucleoside 5'-monophosphate; xanthosine 5'-phosphate	Escherichia coli metabolite; metabolite; mouse metabolite
monotropein	[no description available]	low	0	beta-D-glucoside; cyclopentapyran; iridoid monoterpenoid; monocarboxylic acid; monosaccharide derivative	anti-inflammatory agent; metabolite
glycyl-histidyl-lysine	[no description available]	low	0	tripeptide	chelator; hepatoprotective agent; metabolite; vulnerary
homoeriodictyol	[no description available]	low	0	3'-methoxyflavanones; 4'-hydroxyflavanones; monomethoxyflavanone; trihydroxyflavanone	flavouring agent; metabolite
arjunolic acid	[no description available]	low	0	hydroxy monocarboxylic acid; pentacyclic triterpenoid	antibacterial agent; antifungal agent; antioxidant; metabolite
oxazolidin-2-one	[no description available]	low	0	carbamate ester; oxazolidinone	metabolite
monoethyl phthalate	[no description available]	low	0	ethyl ester; phthalic acid monoester	metabolite
methylimidazoleacetic acid	[no description available]	low	0	imidazoles; monocarboxylic acid	GABA agonist; metabolite
2-(2-aminoethyl)pyridine	[no description available]	low	0	aminoalkylpyridine; primary amine	histamine agonist; metabolite
xanthurenic acid 8-methyl ether	[no description available]	low	0	aromatic ether; monohydroxyquinoline; quinolinemonocarboxylic acid	carcinogenic agent; metabolite; mouse metabolite
methyl orsellinate	[no description available]	low	0	hydroxybenzoic acid	metabolite
2,2-di(4-methacryloxyphenyl)propane	[no description available]	low	0	bisphenol; enoate ester	metabolite
sofosbuvir	[no description available]	low	0	aminopyrimidine; aromatic carboxylic acid; nucleobase analogue; pyrimidone	metabolite
3-methyluracil	[no description available]	low	0	nucleobase analogue; pyrimidone	metabolite
1-methylcytosine	[no description available]	low	0	aminopyrimidine; methylcytosine; pyrimidone	metabolite
leucyl-alanine	[no description available]	low	0	dipeptide	metabolite
leucyl-leucyl-leucine	[no description available]	low	0	tripeptide	metabolite
3,4-dihydroxyphenylethanol	[no description available]	low	0	catechols; primary alcohol	antineoplastic agent; antioxidant; metabolite
3,7-dimethyluric acid	[no description available]	low	0	oxopurine	metabolite; mouse metabolite
alanylproline	[no description available]	low	0	dipeptide zwitterion; dipeptide	metabolite
d-biotin-d-sulfoxide	[no description available]	low	0	biotins; sulfoxide	metabolite
biotin sulfone	[no description available]	low	0	biotins; sulfone	metabolite
asperuloside	[no description available]	low	0	acetate ester; beta-D-glucoside; gamma-lactone; iridoid monoterpenoid; monosaccharide derivative	metabolite
primin	[no description available]	low	0	1,4-benzoquinones	allergen; antifeedant; antimicrobial agent; hapten; metabolite
2-(hydroxymethyl)anthraquinone	[no description available]	low	0	anthraquinone	metabolite
tyrosylleucine	[no description available]	low	0	dipeptide	metabolite
o-methylserine	[no description available]	low	0	L-serine derivative; non-proteinogenic L-alpha-amino acid	metabolite
cinchonine	[no description available]	low	0	(8xi)-cinchonan-9-ol; cinchona alkaloid	metabolite
aucubin	[no description available]	low	0	organic molecular entity	metabolite
catalpol	[no description available]	low	0	organic molecular entity	metabolite
3,4-dihydroxyphenylglycol	[no description available]	low	0	catechols; tetrol	metabolite; mouse metabolite
2-methylhistamine	[no description available]	low	0	aralkylamino compound; imidazoles	histamine agonist; metabolite
2-methylhippuric acid	[no description available]	low	0	N-acylglycine	metabolite
taraxerol	[no description available]	low	0	pentacyclic triterpenoid; secondary alcohol	metabolite
alpha-peltatin	[no description available]	low	0	furonaphthodioxole; gamma-lactone; lignan; organic heterotetracyclic compound; phenols	antineoplastic agent; metabolite
3-acetyllupeol	[no description available]	low	0	organic molecular entity	metabolite
lupenone	[no description available]	low	0	triterpenoid	metabolite
glycyltryptophan	[no description available]	low	0	dipeptide	metabolite
monocerin	[no description available]	low	0	hydroxybenzoic acid	metabolite
propionyl-coenzyme a	[no description available]	low	0	acyl-CoA	Escherichia coli metabolite; metabolite; mouse metabolite
alpha-hydroxyisocaproic acid	[no description available]	low	0	2-hydroxy fatty acid; branched-chain fatty acid	metabolite
totarol	[no description available]	low	0	diterpenoid	metabolite
taraxerone	[no description available]	low	0	scalarane sesterterpenoid	metabolite
prunin protein, prunus	[no description available]	low	0	(2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; flavanone 7-O-beta-D-glucoside; monosaccharide derivative	antibacterial agent; antilipemic drug; hypoglycemic agent; metabolite
uvaol	[no description available]	low	0	triterpenoid	metabolite
glycyltyrosine	[no description available]	low	0	dipeptide	metabolite
glycylleucine	[no description available]	low	0	dipeptide zwitterion; dipeptide	metabolite
alanyltyrosine	[no description available]	low	0	dipeptide	metabolite
glycyl-l-phenylalanine	[no description available]	low	0	dipeptide zwitterion; dipeptide	human metabolite; metabolite
digoxigenin-mono(digitoxoside)	[no description available]	low	0	cardenolide glycoside; digitoxoside; monosaccharide derivative; steroid saponin	metabolite
thiazolidine-4-carboxylic acid, (r)-isomer	[no description available]	low	0	thiazolidinemonocarboxylic acid; thioproline	geroprotector; metabolite
5,6-dihydrothymine	[no description available]	low	0	pyrimidone	human metabolite; metabolite; mouse metabolite
dehydroabietic acid	[no description available]	low	0	abietane diterpenoid; carbotricyclic compound; monocarboxylic acid	allergen; metabolite
palmitone	[no description available]	low	0	dialkyl ketone	anticonvulsant; metabolite
1-methylthymine	[no description available]	low	0	methylthymine	metabolite
imidazoleacetic acid	[no description available]	low	0	imidazoles; monocarboxylic acid	metabolite; mouse metabolite
1-methylguanosine	[no description available]	low	0	methylguanosine	metabolite
alanylphenylalanine	[no description available]	low	0	dipeptide	metabolite
murrayanine	[no description available]	low	0	carbazoles	metabolite
girinimbine	[no description available]	low	0	carbazoles	metabolite
tryptophylglycine	[no description available]	low	0	dipeptide	metabolite
canthin-6-one	[no description available]	low	0	enone; indole alkaloid; organic heterotetracyclic compound	antimycobacterial drug; metabolite
glycylaspartic acid	[no description available]	low	0	dipeptide	metabolite
4-methylhippuric acid	[no description available]	low	0	N-acylglycine	metabolite
delta(9)-tetrahydrocannabinolic acid	[no description available]	low	0	benzochromene; diterpenoid; hydroxy monocarboxylic acid; phytocannabinoid; polyketide	anti-inflammatory agent; biomarker; metabolite; neuroprotective agent
3-methylhippuric acid	[no description available]	low	0	N-acylglycine	metabolite
n-glycylglutamic acid	[no description available]	low	0	dipeptide	metabolite
n-caproylglycine	[no description available]	low	0	N-acylglycine	metabolite
diosgenin	[no description available]	low	0	3beta-sterol; hexacyclic triterpenoid; sapogenin; spiroketal	antineoplastic agent; antiviral agent; apoptosis inducer; metabolite
s-2-aminoethyl cysteine	[no description available]	low	0	L-cysteine thioether; non-proteinogenic L-alpha-amino acid	EC 5.4.3.2 (lysine 2,3-aminomutase) inhibitor; metabolite; protein synthesis inhibitor
4-hydroxycyclophosphamide	[no description available]	low	0	nitrogen mustard; organochlorine compound; phosphorodiamide	alkylating agent; metabolite
alpha-glutamyltryptophan	[no description available]	low	0	dipeptide	angiogenesis modulating agent; antineoplastic agent; immunomodulator; metabolite
malabaricone c	[no description available]	low	0	butanone	metabolite
loliolide	[no description available]	low	0	benzofurans	metabolite
tuberostemonine	[no description available]	low	0	alkaloid	metabolite
pyrrole-3-carboxylic acid	[no description available]	low	0	pyrrolecarboxylic acid	metabolite; Penicillium metabolite
histidylglycine	[no description available]	low	0	dipeptide	metabolite
histidinoalanine	[no description available]	low	0	dipeptide zwitterion; dipeptide	metabolite
cinchonidine	[no description available]	low	0	(8xi)-cinchonan-9-ol; cinchona alkaloid	metabolite
quillaic acid	[no description available]	low	0	aldehyde; hydroxy monocarboxylic acid; pentacyclic triterpenoid	anti-inflammatory agent; metabolite
p-methoxy-n-methylphenethylamine	[no description available]	low	0	aromatic ether; secondary amino compound	metabolite
ecgonine methyl ester	[no description available]	low	0	methyl ester; tertiary amino compound; tropane alkaloid	analgesic; central nervous system depressant; metabolite; mouse metabolite; opioid analgesic; peripheral nervous system drug
n-acetylcytidine	[no description available]	low	0	acetamides; cytidines; secondary carboxamide	metabolite
4-hydroxydebrisoquin	[no description available]	low	0	carboxamidine; isoquinolines; secondary alcohol	metabolite
hypotaurine	[no description available]	low	0	aminosulfinic acid; zwitterion	human metabolite; metabolite; mouse metabolite
hc toxin	[no description available]	low	0	homodetic cyclic peptide; tetrapeptide	antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor; metabolite; phytotoxin
epicatechin gallate	[no description available]	low	0	catechin; gallate ester; polyphenol	EC 3.2.1.1 (alpha-amylase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite
versiconal hemiacetal acetate	[no description available]	low	0	acetate ester; anthrafuran; lactol; palmitoyl amino acid; polyphenol	metabolite
selenodiglutathione	[no description available]	low	0	glutathione derivative; thioselenide	Escherichia coli metabolite; metabolite
coprine	[no description available]	low	0	cyclopropanes; dicarboxylic acid monoamide; L-glutamine derivative; non-proteinogenic L-alpha-amino acid	EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; metabolite; mycotoxin
aristolochic acid ii	[no description available]	low	0	aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound	carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin
exp3174	[no description available]	low	0	biphenylyltetrazole; imidazoles; organochlorine compound	metabolite
ribonolactone	[no description available]	low	0	butan-4-olide; ribonolactone	metabolite
sulfamethoxazole hydroxylamine	[no description available]	low	0	isoxazoles; sulfonamide	allergen; metabolite
androsterone glucuronide	[no description available]	low	0	beta-D-glucosiduronic acid; steroid glucosiduronic acid	human metabolite; metabolite; mouse metabolite
tephrosin	[no description available]	low	0	aromatic ether; cyclic ketone; organic heteropentacyclic compound; rotenones	antineoplastic agent; metabolite; pesticide
sapintoxin d	[no description available]	low	0	phorbol ester; tertiary alpha-hydroxy ketone	fluorescent probe; metabolite
amarogentin	[no description available]	low	0	monosaccharide derivative; secoiridoid glycoside	EC 5.99.1.2 (DNA topoisomerase) inhibitor; metabolite
taraxasterol	[no description available]	low	0	pentacyclic triterpenoid; secondary alcohol	anti-inflammatory agent; metabolite
asiatic acid	[no description available]	low	0	monocarboxylic acid; pentacyclic triterpenoid; triol	angiogenesis modulating agent; metabolite
flavoglaucin	[no description available]	low	0	hydroquinones	metabolite
1-(6-hydroxy-2-isopropenyl-1-benzofuran-5-yl)-1-ethanone	[no description available]	low	0	benzofurans	metabolite
dioscin	[no description available]	low	0	hexacyclic triterpenoid; spiroketal; spirostanyl glycoside; trisaccharide derivative	anti-inflammatory agent; antifungal agent; antineoplastic agent; antiviral agent; apoptosis inducer; EC 1.14.18.1 (tyrosinase) inhibitor; hepatoprotective agent; metabolite
maculosin	[no description available]	low	0	dipeptide; homodetic cyclic peptide; phenols; pyrrolopyrazine	metabolite
n(4)-methylcytosine	[no description available]	low	0	aminopyrimidine; methylcytosine; pyrimidone	metabolite
n-acetylputrescine	[no description available]	low	0	N-monoacetylalkane-alpha,omega-diamine; N-substituted putrescine	metabolite; mouse metabolite
4'-demethylpodophyllotoxin	[no description available]	low	0	furonaphthodioxole; organic heterotetracyclic compound; phenols	metabolite
lysicamine	[no description available]	low	0	alkaloid antibiotic; oxoaporphine alkaloid	metabolite
celastrol	[no description available]	low	0	monocarboxylic acid; pentacyclic triterpenoid	anti-inflammatory drug; antineoplastic agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Hsp90 inhibitor; metabolite
procyanidin b2	[no description available]	low	0	biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin	antioxidant; metabolite
aromadedrin	[no description available]	low	0	4'-hydroxyflavanones; dihydroflavonols; secondary alpha-hydroxy ketone; tetrahydroxyflavanone	metabolite
3-methylthymine	[no description available]	low	0	methylthymine; pyrimidone	metabolite
tyrosyl-glycyl-glycine	[no description available]	low	0	tripeptide zwitterion; tripeptide	metabolite
cyclic adp-ribose	[no description available]	low	0	cyclic purine nucleotide; nucleotide-sugar	metabolite; ryanodine receptor agonist
glycylglutamine	[no description available]	low	0	dipeptide zwitterion; dipeptide	metabolite; protective agent
alanylglutamine	[no description available]	low	0	dipeptide zwitterion; dipeptide	metabolite
naadp	[no description available]	low	0	nicotinic acid dinucleotide	calcium channel agonist; metabolite; signalling molecule
procyanidin b5	[no description available]	low	0	biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin	metabolite
proanthocyanidin a2	[no description available]	low	0	hydroxyflavan; proanthocyanidin	angiogenesis modulating agent; anti-HIV agent; antioxidant; metabolite
dihydrosanguinarine	[no description available]	low	0	benzophenanthridine alkaloid	antifungal agent; metabolite
tetrahydrocurcumin	[no description available]	low	0	beta-diketone; diarylheptanoid; polyphenol	metabolite
eriodictyol 7-glucuronide	[no description available]	low	0	3'-hydroxyflavonoid; beta-D-glucosiduronic acid	EC 1.1.1.21 (aldehyde reductase) inhibitor; metabolite
beta-lipotropin, gln(9)-	[no description available]	low	0	catechols; crown compound; macrocyclic lactone	bacterial metabolite; metabolite
4-nitrososulfamethoxazole	[no description available]	low	0	isoxazoles; nitroso compound; sulfonamide	allergen; metabolite
protosappanin a	[no description available]	low	0	catechols	metabolite
3,3'-neotrehalosadiamine	[no description available]	low	0	amino disaccharide; glycosyl glycoside derivative	antimicrobial agent; metabolite
salvinorin a	[no description available]	low	0	organic heterotricyclic compound; organooxygen compound	metabolite; oneirogen
cyanidin	[no description available]	low	0	5-hydroxyanthocyanidin	antioxidant; metabolite; neuroprotective agent
yakuchinone-a	[no description available]	low	0	ketone; monomethoxybenzene; phenols	antineoplastic agent; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; EC 1.14.13.39 (nitric oxide synthase) inhibitor; metabolite
marsupsin	[no description available]	low	0	1-benzofurans; aromatic ether; polyphenol	antilipemic drug; hypoglycemic agent; metabolite
6,6'-bieckol	[no description available]	low	0	aromatic ether; oxacycle; phlorotannin	anti-HIV-1 agent; metabolite; radical scavenger
3-methylcytosine	[no description available]	low	0	aminopyrimidine; methylcytosine; pyrimidone	metabolite
eckol	[no description available]	low	0	phlorotannin	antioxidant; metabolite
procyanidin b3	[no description available]	low	0	biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin	anti-inflammatory agent; antioxidant; EC 2.3.1.48 (histone acetyltransferase) inhibitor; metabolite
aclacinomycin	[no description available]	low	0	aminoglycoside; anthracycline; deoxy hexoside; methyl ester; monosaccharide derivative; phenols; polyketide; tertiary alcohol; tetracenequinones; zwitterion	antimicrobial agent; antineoplastic agent; metabolite
phenylalanylarginine	[no description available]	low	0	dipeptide	metabolite
prolylarginine	[no description available]	low	0	dipeptide	metabolite
5-methoxytryptophan	[no description available]	low	0	L-alpha-amino acid zwitterion; L-tryptophan derivative	metabolite
phenylalanylglutamate	[no description available]	low	0	dipeptide	metabolite
aspartylglycine	[no description available]	low	0	dipeptide	metabolite
aspartylglutamate	[no description available]	low	0	dipeptide	metabolite
5-hydroxypipecolic acid	[no description available]	low	0	piperidinemonocarboxylic acid	metabolite
prolyl-tyrosine	[no description available]	low	0	dipeptide	metabolite
histidylproline	[no description available]	low	0	dipeptide zwitterion; dipeptide	metabolite
phenylalanyl-glycyl-glycine	[no description available]	low	0	tripeptide	metabolite
leucylarginine	[no description available]	low	0	dipeptide	metabolite
pendolmycin	[no description available]	low	0	indoles	metabolite
atractylenolide iii	[no description available]	low	0	naphthofuran	metabolite
malvidin	[no description available]	low	0	5-hydroxyanthocyanidin	biological pigment; metabolite
5-hydroxytryptoline	[no description available]	low	0	beta-carbolines	metabolite
perlolyrine	[no description available]	low	0	organic molecular entity	metabolite
endocrocin	[no description available]	low	0	monocarboxylic acid; phenols; trihydroxyanthraquinone	metabolite
sulochrin	[no description available]	low	0	benzophenones; carboxylic ester; phenols	metabolite
i-677	[no description available]	low	0	L-serine derivative; non-proteinogenic L-alpha-amino acid	antimetabolite; antimicrobial agent; antineoplastic agent; metabolite
isohomovanillic acid	[no description available]	low	0	aromatic ether; phenols; phenylacetic acids	metabolite
4-amino-2-methoxypyrimidine	[no description available]	low	0	aminopyrimidine; aromatic ether; methylcytosine	metabolite
asimilobine	[no description available]	low	0	aporphine alkaloid	metabolite
aristolochic acid D	[no description available]	low	0	aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound	carcinogenic agent; metabolite; nephrotoxin; toxin
leukodopachrome	[no description available]	low	0	hydroxy monocarboxylic acid; indoles	metabolite
ampelopsin	[no description available]	low	0	dihydromyricetin; secondary alpha-hydroxy ketone	antineoplastic agent; antioxidant; metabolite
pinusolide	[no description available]	low	0	diterpene lactone	metabolite
2,4,5-trihydroxypentanoic acid gamma-lactone	[no description available]	low	0	ribonolactone	metabolite
hydroxysitosterol	[no description available]	low	0	3beta-hydroxy-Delta(5)-steroid; 7alpha-hydroxy steroid	metabolite; plant metabolite
jolkinolide a	[no description available]	low	0	diterpene lactone	metabolite
jolkinolide b	[no description available]	low	0	diterpene lactone	metabolite
1-o-hexadecyl-2-lyso-glycero-3-phosphorylcholine	[no description available]	low	0	1-alkyl-sn-glycero-3-phosphocholine; lysophosphatidylcholine O-16:0	metabolite
isovitexin	[no description available]	low	0	C-glycosyl compound; trihydroxyflavone	EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite
dopamine quinone	[no description available]	low	0	1,2-benzoquinones; primary amino compound	metabolite
platycodin d	[no description available]	low	0	triterpenoid saponin	metabolite
frenolicin b	[no description available]	low	0	benzoisochromanequinone; p-quinones	metabolite
4-oxopentanal	[no description available]	low	0	ketoaldehyde	metabolite
my 12-62c	[no description available]	low	0	monohydroxyquinoline; quinolone	antibacterial agent; iron chelator; metabolite; signalling molecule
3,4-dihydroxyphenylpyruvic acid	[no description available]	low	0	2-oxo monocarboxylic acid	metabolite
proximadiol	[no description available]	low	0	eudesmane sesquiterpenoid	metabolite
aristolochic acid c	[no description available]	low	0	aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound	carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin
phenylacetyl-coenzyme a	[no description available]	low	0	acyl-CoA	Escherichia coli metabolite; metabolite; mouse metabolite
taxusin	[no description available]	low	0	acetate ester; carbotricyclic compound; taxane diterpenoid	metabolite
confertin	[no description available]	low	0	cyclic ketone; gamma-lactone; organic heterotricyclic compound; pseudoguaianolide	anti-inflammatory agent; metabolite; plant metabolite
beta-methylcrotonylglycine	[no description available]	low	0	N-acylglycine	metabolite
tracheloside	[no description available]	low	0	glycoside; lignan	metabolite
maytenonic acid	[no description available]	low	0	triterpenoid	metabolite
procyanidin C1	[no description available]	low	0	hydroxyflavan; polyphenol; proanthocyanidin	anti-inflammatory agent; antioxidant; EC 1.17.3.2 (xanthine oxidase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; lipoxygenase inhibitor; metabolite
3-methyleneindolenine	[no description available]	low	0	indoles	metabolite
isopulegol	[no description available]	low	0	p-menthane monoterpenoid	metabolite
kadsurin	[no description available]	low	0	tannin	metabolite
lysylproline	[no description available]	low	0	dipeptide	metabolite
5-o-methylembelin	[no description available]	low	0	enol ether; monohydroxy-1,4-benzoquinones	antileishmanial agent; antineoplastic agent; hepatitis C protease inhibitor; metabolite
dihydrodaidzein	[no description available]	low	0	hydroxyisoflavanone	metabolite
4'-o-methylepigallocatechin	[no description available]	low	0	catechin	metabolite
corynoline	[no description available]	low	0	benzophenanthridine alkaloid; cyclic acetal; isoquinolines; organic heterohexacyclic compound; secondary alcohol	antineoplastic agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; hepatoprotective agent; metabolite
limonin	[no description available]	low	0	epoxide; furans; hexacyclic triterpenoid; lactone; limonoid; organic heterohexacyclic compound	inhibitor; metabolite; volatile oil component
dichamanetin	[no description available]	low	0	diarylheptanoid	metabolite
brevianamide f	[no description available]	low	0	dipeptide; indoles; pyrrolopyrazine	metabolite
ergolide	[no description available]	low	0	acetate ester; cyclic ketone; gamma-lactone; organic heterotricyclic compound; sesquiterpene lactone	anti-inflammatory agent; antineoplastic agent; metabolite; NF-kappaB inhibitor; plant metabolite
4-sulfocatechol	[no description available]	low	0	dihydroxybenzenesulfonic acid	metabolite
histidylleucine	[no description available]	low	0	dipeptide zwitterion; dipeptide	metabolite
7-methoxyheptaphylline	[no description available]	low	0	carbazoles	metabolite
phenylalanylserine	[no description available]	low	0	dipeptide	metabolite
phellamurin	[no description available]	low	0	4'-hydroxyflavanones; beta-D-glucoside; dihydroflavonols; flavanone glycoside; monosaccharide derivative; trihydroxyflavanone	metabolite
prolylglutamic acid	[no description available]	low	0	dipeptide	metabolite
nantenine	[no description available]	low	0	oxoaporphine alkaloid	metabolite
hydrastine	[no description available]	low	0	isoquinolines	metabolite
butyrylcarnitine	[no description available]	low	0	O-butanoylcarnitine; saturated fatty acyl-L-carnitine	metabolite
2-hydroxyestradiol	[no description available]	low	0	17beta-hydroxy steroid; 2-hydroxy steroid	carcinogenic agent; human metabolite; metabolite; mouse metabolite; prodrug
aromaticin	[no description available]	low	0	cyclic ketone; gamma-lactone; organic heterotricyclic compound; sesquiterpene lactone	anti-inflammatory agent; metabolite; plant metabolite
n-methylcorydaldine	[no description available]	low	0	quinolone	metabolite
2-amino-3,3-dimethylbutanoic acid	[no description available]	low	0	non-proteinogenic alpha-amino acid	metabolite
pentabromopseudilin	[no description available]	low	0	pyrroles	metabolite
rocaglamide	[no description available]	low	0	monocarboxylic acid amide; monomethoxybenzene; organic heterotricyclic compound	antileishmanial agent; antineoplastic agent; metabolite
dentatin	[no description available]	low	0	coumarins	metabolite
acronine	[no description available]	low	0	acridone derivatives; alkaloid	antineoplastic agent; metabolite
enmein	[no description available]	low	0	delta-lactone	metabolite
5-aminonicotinic acid	[no description available]	low	0	aminonicotinic acid; aminopyridine; aromatic amine	metabolite
pomolic acid	[no description available]	low	0	triterpenoid	metabolite
aglafoline	[no description available]	low	0	methyl ester; organic heterotricyclic compound	metabolite; platelet aggregation inhibitor
isomaltose	[no description available]	low	0	glycosylglucose	human metabolite; metabolite; mouse metabolite
deoxyglucose	[no description available]	low	0	2-deoxy-D-glucose	metabolite
vestitone	[no description available]	low	0	(3R)-2'-hydroxyisoflavanones; hydroxyisoflavanone; methoxyisoflavanone	antibacterial agent; metabolite
pantetheine	[no description available]	low	0	pantetheines; thiol	human metabolite; metabolite; mouse metabolite
salicin	[no description available]	low	0	aromatic primary alcohol; aryl beta-D-glucoside; benzyl alcohols	antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug
taxifolin	[no description available]	low	0	taxifolin	metabolite
n-formylmethionine	[no description available]	low	0	L-methionine derivative; N-formyl amino acid; proteinogenic amino acid	metabolite
fucose	[no description available]	low	0	deoxygalactose	metabolite
saponarin	[no description available]	low	0	C-glycosyl compound; dihydroxyflavone; glycosyloxyflavone; monosaccharide derivative	metabolite
hippeastrine	[no description available]	low	0	delta-lactone; indole alkaloid; organic heteropentacyclic compound; secondary alcohol	antineoplastic agent; metabolite
cyanidin 3-o-beta-d-glucopyranoside	[no description available]	low	0	anthocyanin cation; beta-D-glucoside; monosaccharide derivative	metabolite
silychristin	[no description available]	low	0	1-benzofurans; aromatic ether; flavonolignan; polyphenol; secondary alpha-hydroxy ketone	lipoxygenase inhibitor; metabolite; prostaglandin antagonist; radical scavenger
peonidin	[no description available]	low	0	5-hydroxyanthocyanidin	antineoplastic agent; antioxidant; apoptosis inducer; metabolite
convallatoxin	[no description available]	low	0	14beta-hydroxy steroid; 19-oxo steroid; 5beta-hydroxy steroid; alpha-L-rhamnoside; steroid aldehyde; steroid lactone	metabolite; vasodilator agent
furostanol i	[no description available]	low	0	beta-D-glucoside; cyclic hemiketal; pentacyclic triterpenoid; steroid saponin; trisaccharide derivative	metabolite
decursinol	[no description available]	low	0	cyclic ether; delta-lactone; organic heterotricyclic compound; secondary alcohol	analgesic; antineoplastic agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite
abyssinone v	[no description available]	low	0	4'-hydroxyflavanones; phenols; trihydroxyflavanone	metabolite
davidigenin	[no description available]	low	0	dihydrochalcones; polyphenol	anti-allergic agent; anti-asthmatic agent; antioxidant; metabolite
farrerol	[no description available]	low	0	organic molecular entity	metabolite
naringin	[no description available]	low	0	(2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; disaccharide derivative; neohesperidoside	anti-inflammatory agent; antineoplastic agent; metabolite
isonaringin	[no description available]	low	0	(2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; disaccharide derivative; rutinoside	anti-inflammatory agent; antioxidant; metabolite
cleomiscosin a	[no description available]	low	0	aromatic ether; delta-lactone; organic heterotricyclic compound; phenols; primary alcohol	anti-inflammatory agent; metabolite
vicenin ii	[no description available]	low	0	C-glycosyl compound; trihydroxyflavone	metabolite
eugeniin	[no description available]	low	0	beta-D-glucoside; ellagitannin; gallate ester; lactone	anti-HSV-1 agent; antifungal agent; antineoplastic agent; EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite
knipholone	[no description available]	low	0	aromatic ketone; dihydroxyanthraquinone; methoxybenzenes; methyl ketone; polyphenol; resorcinols	antineoplastic agent; antioxidant; antiplasmodial drug; leukotriene antagonist; metabolite
alpha bitter acid	[no description available]	low	0	aromatic ketone; cyclic ketone; diketone; tertiary alpha-hydroxy ketone; triol	antibacterial drug; antioxidant; cyclooxygenase 2 inhibitor; metabolite
acanthoside b	[no description available]	low	0	beta-D-glucoside	metabolite
chlorpromazine n-oxide	[no description available]	low	0	organochlorine compound; phenothiazines; tertiary amine oxide	metabolite
3-hydroxyaspartic acid, (threo-l)-isomer	[no description available]	low	0	3-hydroxy-L-aspartic acid	metabolite
cyclo(l-phe-l-pro)	[no description available]	low	0	organic molecular entity	metabolite
pyochelin	[no description available]	low	0	monocarboxylic acid; phenols; thiazolidines	metabolite; siderophore
surfactin c	[no description available]	low	0	cyclodepsipeptide; lipopeptide antibiotic; macrocyclic lactone	antibacterial agent; antifungal agent; antineoplastic agent; antiviral agent; metabolite; platelet aggregation inhibitor; surfactant
petunidin-3-glucoside	[no description available]	low	0	anthocyanin cation; aromatic ether; beta-D-glucoside	antioxidant; metabolite
malvidin-3-glucoside	[no description available]	low	0	anthocyanin cation; aromatic ether; beta-D-glucoside	metabolite
dioncophylline a	[no description available]	low	0	biaryl; isoquinoline alkaloid; isoquinolines; methoxynaphthalene; methylnaphthalenes; naphthalenes	antifungal agent; antimalarial; metabolite; molluscicide
dioncophylline c	[no description available]	low	0	aromatic ether; biaryl; isoquinoline alkaloid; isoquinolines; methoxynaphthalene; methylnaphthalenes; naphthols	antimalarial; antiplasmodial drug; metabolite
latrunculin a	[no description available]	low	0	cyclic hemiketal; macrolide; oxabicycloalkane; thiazolidinone	actin polymerisation inhibitor; metabolite; toxin
aglucovancomycin b	[no description available]	low	0	cyclic ether; heterodetic cyclic peptide; peptide antibiotic; peptide zwitterion; polyphenol	metabolite
(S)-ATPA	[no description available]	low	0	isoxazoles; non-proteinogenic L-alpha-amino acid	metabolite
epothilone a	[no description available]	low	0	epothilone; epoxide	antineoplastic agent; metabolite; microtubule-stabilising agent; tubulin modulator
alitretinoin	[no description available]	low	0	retinoic acid	antineoplastic agent; keratolytic drug; metabolite; retinoid X receptor agonist
isoleucylvaline	[no description available]	low	0	dipeptide	metabolite
afimoxifene	[no description available]	low	0	phenols; tertiary amino compound	antineoplastic agent; estrogen receptor antagonist; metabolite
3-hydroxyhippuric acid	[no description available]	low	0	N-acylglycine; phenols	metabolite
12-deoxyphorbol 13-acetate	[no description available]	low	0	phorbol ester	metabolite
conidendrin	[no description available]	low	0	lignan	metabolite
bevirimat	[no description available]	low	0	dicarboxylic acid monoester; monocarboxylic acid; pentacyclic triterpenoid	HIV-1 maturation inhibitor; metabolite
azaserine	[no description available]	low	0	carboxylic ester; diazo compound; L-serine derivative; non-proteinogenic L-alpha-amino acid	antifungal agent; antimetabolite; antimicrobial agent; antineoplastic agent; glutamine antagonist; immunosuppressive agent; metabolite
16beta,17-dihydroxy-ent-kaurane-19-oic acid	[no description available]	low	0	bridged compound; diol; ent-kaurane diterpenoid; hydroxy monocarboxylic acid; primary alcohol; tertiary alcohol	anti-HIV agent; metabolite
glycyrin	[no description available]	low	0	aromatic ether; coumarins; hydroxyisoflavans	antibacterial agent; metabolite; plant metabolite
reynosin	[no description available]	low	0	organic heterotricyclic compound; sesquiterpene lactone	metabolite
moronic acid	[no description available]	low	0	pentacyclic triterpenoid	anti-HIV agent; anti-HSV-1 agent; metabolite
maltitol	[no description available]	low	0	alpha-D-glucoside; glycosyl alditol	laxative; metabolite; sweetening agent
Phe-Tyr	[no description available]	low	0	dipeptide	metabolite
2-acetyl-1-pyrroline	[no description available]	low	0	acylimine; methyl ketone; pyrroline	flavouring agent; Maillard reaction product; metabolite
methyl indole-3-carboxylate	[no description available]	low	0	indoles; methyl ester	metabolite
camalexin	[no description available]	low	0	1,3-thiazoles; indole phytoalexin	metabolite
komaroviquinone	[no description available]	low	0	bridged compound; lactol; p-quinones; tetracyclic diterpenoid	metabolite; trypanocidal drug
2-hydroxycinnamic acid	[no description available]	low	0	2-coumaric acid; phenols	antioxidant; metabolite
16-epivincamine	[no description available]	low	0	alkaloid	metabolite
diethyl fumarate	[no description available]	low	0	diester	metabolite
isoliquiritigenin	[no description available]	low	0	chalcones	antineoplastic agent; biological pigment; EC 1.14.18.1 (tyrosinase) inhibitor; GABA modulator; geroprotector; metabolite; NMDA receptor antagonist
1-acetyl-beta-carboline	[no description available]	low	0	harmala alkaloid	metabolite
propolin c	[no description available]	low	0	4'-hydroxyflavanones; tetrahydroxyflavanone	metabolite; radical scavenger
xanthohumol	[no description available]	low	0	aromatic ether; chalcones; polyphenol	anti-HIV-1 agent; antineoplastic agent; antiviral agent; apoptosis inducer; EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor; metabolite
butylidenephthalide	[no description available]	low	0	2-benzofurans; gamma-lactone	EC 3.2.1.20 (alpha-glucosidase) inhibitor; hypoglycemic agent; metabolite
malonyl coenzyme a	[no description available]	low	0	malonyl-CoAs	EC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor; Escherichia coli metabolite; metabolite; mouse metabolite
imidazol-1-ylacetic acid	[no description available]	low	0	imidazolyl carboxylic acid	metabolite
captax	[no description available]	low	0	aryl thiol; benzothiazoles	carcinogenic agent; metabolite
n-acetyltryptophan	[no description available]	low	0	L-tryptophan derivative; N-acetyl-L-amino acid	metabolite
cinnamoylglycine	[no description available]	low	0	N-acylglycine	metabolite
n-benzoylalanine	[no description available]	low	0	N-acyl-L-alanine; N-benzoylalanine	metabolite
isoferulic acid	[no description available]	low	0	ferulic acids	antioxidant; biomarker; metabolite
oxypeucadanin, (r)-(+)-isomer	[no description available]	low	0	furanocoumarin	metabolite
curcumin	[no description available]	low	0	aromatic ether; beta-diketone; diarylheptanoid; enone; polyphenol	anti-inflammatory agent; antifungal agent; antineoplastic agent; biological pigment; contraceptive drug; dye; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; flavouring agent; food colouring; geroprotector; hepatoprotective agent; immunomodulator; iron chelator; ligand; lipoxygenase inhibitor; metabolite; neuroprotective agent; nutraceutical; radical scavenger
thiouracil	[no description available]	low	0	nucleobase analogue; thiocarbonyl compound	antithyroid drug; metabolite
allylthiourea	[no description available]	low	0	thioureas	metabolite
n-glycylalanine	[no description available]	low	0	dipeptide	metabolite
caryophyllene oxide	[no description available]	low	0	epoxide	metabolite
fumonisin b1	[no description available]	low	0	diester; fumonisin; primary amino compound; triol	carcinogenic agent; metabolite
olivetolic acid	[no description available]	low	0	benzoic acids; monocarboxylic acid; polyketide; resorcinols	metabolite
hirsutine, (16e,20beta)-isomer	[no description available]	low	0	alkaloid	metabolite
Ganodermanontriol	[no description available]	low	0	triterpenoid	metabolite
dieckol	[no description available]	low	0	aromatic ether; oxacycle; phlorotannin	anticoagulant; EC 3.2.1.20 (alpha-glucosidase) inhibitor; hepatoprotective agent; metabolite; radical scavenger
glycylproline	[no description available]	low	0	dipeptide zwitterion; dipeptide	metabolite
tamoxifen n-oxide	[no description available]	low	0	aromatic ether; tertiary amine oxide	anti-estrogen; metabolite
7-deacetylgedunin	[no description available]	low	0	cyclic terpene ketone; delta-lactone; enone; epoxide; furans; limonoid; pentacyclic triterpenoid	anti-inflammatory agent; antimalarial; metabolite; plant metabolite
galactose-6-phosphate	[no description available]	low	0	D-galactose 6-phosphate	metabolite
nicotine n-glucuronide	[no description available]	low	0	iminium betaine; N-glycosylpyridine	metabolite
isorhyncophylline	[no description available]	low	0	indolizines	metabolite
cysteinylproline	[no description available]	low	0	dipeptide	metabolite
glycyllysine	[no description available]	low	0	dipeptide	metabolite
methionyltryptophan	[no description available]	low	0	dipeptide	metabolite
ascorbigen	[no description available]	low	0	indolyl carbohydrate	metabolite
pimeloyl-coenzyme a	[no description available]	low	0	omega-carboxyacyl-CoA	metabolite
1-salicylate glucuronide	[no description available]	low	0	benzoic acids; beta-D-glucosiduronic acid	metabolite
isoschaftoside	[no description available]	low	0	C-glycosyl compound; trihydroxyflavone	metabolite
croomine	[no description available]	low	0	alkaloid	metabolite
3-hydroxyflavanone	[no description available]	low	0	3'-hydroxyflavanones; monohydroxyflavanone	metabolite
ungeremine	[no description available]	low	0	organic molecular entity	metabolite
seryl-proline	[no description available]	low	0	dipeptide	metabolite
4-hydroxy-5-methyl-3(2h)-furanone	[no description available]	low	0	cyclic ketone; enol; furans	metabolite
annomontine	[no description available]	low	0	alkaloid; aminopyrimidine; beta-carbolines	antiparasitic agent; metabolite
8-hydroxymanzamine a	[no description available]	low	0	alkaloid; beta-carbolines; isoquinolines	anti-HSV-2 agent; EC 2.7.11.26 (tau-protein kinase) inhibitor; metabolite
ginkgetin	[no description available]	low	0	biflavonoid; hydroxyflavone; methoxyflavone; ring assembly	anti-HSV-1 agent; antineoplastic agent; cyclooxygenase 2 inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; metabolite
calceolarioside b	[no description available]	low	0	hydroxycinnamic acid	metabolite
eupatilin	[no description available]	low	0	dihydroxyflavone; trimethoxyflavone	anti-inflammatory agent; anti-ulcer drug; antineoplastic agent; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; metabolite
quercetin 3-o-glucuronide	[no description available]	low	0	beta-D-glucosiduronic acid; quercetin O-glycoside	antidepressant; antioxidant; metabolite
australifungin	[no description available]	low	0	carbobicyclic compound; enol; enone; secondary alcohol	antifungal agent; EC 2.3.1.24 (sphingosine N-acyltransferase) inhibitor; HIV-1 integrase inhibitor; metabolite
catechin gallate	[no description available]	low	0	flavans; gallate ester; polyphenol	metabolite
sterigmatocystin	[no description available]	low	0	sterigmatocystins	metabolite
3,7-dimethoxy-5,3',4'-trihydroxyflavone	[no description available]	low	0	dimethoxyflavone; trihydroxyflavone	EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor; metabolite
apigenin	[no description available]	low	0	trihydroxyflavone	antineoplastic agent; metabolite
7,3'-dihydroxy-4'-methoxyisoflavone	[no description available]	low	0	4'-methoxyisoflavones; 7-hydroxyisoflavones	antioxidant; metabolite
calcitriol	[no description available]	low	0	D3 vitamins; hydroxycalciol; triol	antineoplastic agent; antipsoriatic; bone density conservation agent; calcium channel agonist; calcium channel modulator; hormone; human metabolite; immunomodulator; metabolite; mouse metabolite; nutraceutical
vomifoliol	[no description available]	low	0	(6S)-vomifoliol	metabolite; phytotoxin
feruloyltyramine	[no description available]	low	0	tyramines	metabolite
luteolin-7-glucuronide	[no description available]	low	0	glycosyloxyflavone; luteolin O-glucuronoside; monosaccharide derivative; trihydroxyflavone	metabolite
chrysoeriol	[no description available]	low	0	monomethoxyflavone; trihydroxyflavone	antineoplastic agent; antioxidant; metabolite
quercetin 3-o-methyl ether	[no description available]	low	0	monomethoxyflavone; tetrahydroxyflavone	antimicrobial agent; metabolite
dexmedetomidine	[no description available]	low	0	trihydroxyflavone; trimethoxyflavone	antineoplastic agent; metabolite
apigetrin	[no description available]	low	0	beta-D-glucoside; dihydroxyflavone; glycosyloxyflavone; monosaccharide derivative	antibacterial agent; metabolite; non-steroidal anti-inflammatory drug
rutin	[no description available]	low	0	disaccharide derivative; quercetin O-glucoside; rutinoside; tetrahydroxyflavone	antioxidant; metabolite
6-ketoprostaglandin e1	[no description available]	low	0	prostaglandins E	metabolite; platelet aggregation inhibitor
lipoxin a4	[no description available]	low	0	hydroxy polyunsaturated fatty acid; lipoxin; long-chain fatty acid	human metabolite; metabolite
harmine	[no description available]	low	0	harmala alkaloid	anti-HIV agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; metabolite
naringenin chalcone	[no description available]	low	0	chalcones; polyphenol	anti-allergic agent; anti-inflammatory agent; metabolite
cornexistin	[no description available]	low	0	cyclic dicarboxylic anhydride; organic heterobicyclic compound; secondary alpha-hydroxy ketone	herbicide; metabolite
isobavachalcone	[no description available]	low	0	chalcones; polyphenol	antibacterial agent; metabolite; platelet aggregation inhibitor
daphnoretin	[no description available]	low	0	aromatic ether; hydroxycoumarin	antineoplastic agent; antiviral agent; metabolite
Rhynchophylline	[no description available]	low	0	indolizines	metabolite
esculin	[no description available]	low	0	beta-D-glucoside; hydroxycoumarin	antioxidant; metabolite
mammeisin	[no description available]	low	0	neoflavonoid	metabolite
ostruthin	[no description available]	low	0	terpene lactone	metabolite
costunolide	[no description available]	low	0	germacranolide; heterobicyclic compound	anthelminthic drug; antiinfective agent; antineoplastic agent; antiparasitic agent; antiviral drug; metabolite
caryophyllene	[no description available]	low	0	beta-caryophyllene	fragrance; insect attractant; metabolite; non-steroidal anti-inflammatory drug
phaseic acid	[no description available]	low	0	alpha,beta-unsaturated monocarboxylic acid; apo carotenoid sesquiterpenoid	metabolite
agathisflavone	[no description available]	low	0	biaryl; biflavonoid; hydroxyflavone	antineoplastic agent; antiviral agent; hepatoprotective agent; metabolite
cupressuflavone	[no description available]	low	0	biflavonoid; hydroxyflavone; ring assembly	EC 3.4.21.37 (leukocyte elastase) inhibitor; metabolite; radical scavenger
fisetin	[no description available]	low	0	3'-hydroxyflavonoid; 7-hydroxyflavonol; tetrahydroxyflavone	anti-inflammatory agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; metabolite; plant metabolite
genkwanin	[no description available]	low	0	dihydroxyflavone; monomethoxyflavone	metabolite
bellidifolin	[no description available]	low	0	polyphenol; xanthones	EC 3.1.1.7 (acetylcholinesterase) inhibitor; hypoglycemic agent; metabolite
demethylbellidifolin	[no description available]	low	0	tetrol; xanthones	antioxidant; EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite; mutagen; radical scavenger
hinokiflavone	[no description available]	low	0	aromatic ether; biflavonoid; hydroxyflavone	antineoplastic agent; metabolite; neuroprotective agent
euxanthone	[no description available]	low	0	phenols; xanthones	metabolite; plant metabolite
3-methylquercetin	[no description available]	low	0	7-hydroxyflavonol; monomethoxyflavone; tetrahydroxyflavone	anticoagulant; EC 1.14.18.1 (tyrosinase) inhibitor; metabolite
norswertianolin	[no description available]	low	0	beta-D-glucoside; xanthones	EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite
swerchirin	[no description available]	low	0	aromatic ether; phenols; xanthones	hypoglycemic agent; metabolite
isoscutellarein	[no description available]	low	0	tetrahydroxyflavone	metabolite
kaempferide	[no description available]	low	0	7-hydroxyflavonol; monomethoxyflavone; trihydroxyflavone	antihypertensive agent; metabolite
morin	[no description available]	low	0	7-hydroxyflavonol; pentahydroxyflavone	angiogenesis modulating agent; anti-inflammatory agent; antibacterial agent; antihypertensive agent; antineoplastic agent; antioxidant; EC 5.99.1.2 (DNA topoisomerase) inhibitor; hepatoprotective agent; metabolite; neuroprotective agent
norwogonin	[no description available]	low	0	trihydroxyflavone	antioxidant; metabolite
orientin	[no description available]	low	0	3'-hydroxyflavonoid; C-glycosyl compound; tetrahydroxyflavone	antioxidant; metabolite
patuletin	[no description available]	low	0	flavonols; monomethoxyflavone; pentahydroxyflavone	analgesic; antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor; lipoxygenase inhibitor; metabolite
rhamnetin	[no description available]	low	0	monomethoxyflavone; tetrahydroxyflavone	anti-inflammatory agent; antioxidant; metabolite
robustaflavone	[no description available]	low	0	biflavonoid; hydroxyflavone; ring assembly	anti-HBV agent; antineoplastic agent; antioxidant; metabolite
scutellarein	[no description available]	low	0	tetrahydroxyflavone	metabolite
tamarixetin	[no description available]	low	0	7-hydroxyflavonol; monomethoxyflavone; tetrahydroxyflavone	antioxidant; metabolite
tricetin	[no description available]	low	0	pentahydroxyflavone	antineoplastic agent; metabolite
tricin	[no description available]	low	0	3'-methoxyflavones; dimethoxyflavone; trihydroxyflavone	EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; metabolite
astringin	[no description available]	low	0	beta-D-glucoside; monosaccharide derivative; polyphenol; stilbenoid	antineoplastic agent; antioxidant; metabolite
polydatin	[no description available]	low	0	beta-D-glucoside; monosaccharide derivative; polyphenol; stilbenoid	anti-arrhythmia drug; antioxidant; geroprotector; hepatoprotective agent; metabolite; nephroprotective agent; potassium channel modulator
epsilon-viniferin	[no description available]	low	0	1-benzofurans; polyphenol; stilbenoid	metabolite
irilone	[no description available]	low	0	hydroxyisoflavone; organic heterotricyclic compound; oxacycle	antineoplastic agent; immunomodulator; metabolite
caffeic acid phenethyl ester	[no description available]	low	0	alkyl caffeate ester	anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; antiviral agent; immunomodulator; metabolite; neuroprotective agent
licoisoflavone a	[no description available]	low	0	7-hydroxyisoflavones	metabolite
prunetin	[no description available]	low	0	7-methoxyisoflavones; hydroxyisoflavone	anti-inflammatory agent; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor; metabolite
wedelolactone	[no description available]	low	0	aromatic ether; coumestans; delta-lactone; polyphenol	antineoplastic agent; apoptosis inducer; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; hepatoprotective agent; metabolite
rottlerin	[no description available]	low	0	aromatic ketone; benzenetriol; chromenol; enone; methyl ketone	anti-allergic agent; antihypertensive agent; antineoplastic agent; apoptosis inducer; K-ATP channel agonist; metabolite
syringetin	[no description available]	low	0	3',5'-dimethoxyflavone; 3'-methoxyflavones; 7-hydroxyflavonol; dimethoxyflavone; tetrahydroxyflavone	metabolite; platelet aggregation inhibitor
10-deoxymethynolide	[no description available]	low	0	macrolide	metabolite
4',7-dihydroxyflavone	[no description available]	low	0	dihydroxyflavone	metabolite
rhoifolin	[no description available]	low	0	dihydroxyflavone; glycosyloxyflavone; neohesperidoside	metabolite
veronicastroside	[no description available]	low	0	disaccharide derivative; glycosyloxyflavone; neohesperidoside; trihydroxyflavone	antibacterial agent; metabolite
quercimeritrin	[no description available]	low	0	beta-D-glucoside; flavonols; monosaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone	antioxidant; metabolite
josamycin	[no description available]	low	0	acetate ester; aldehyde; disaccharide derivative; glycoside; macrolide antibiotic; tertiary alcohol; tertiary amino compound	antibacterial drug; metabolite
n,n-dimethylsphingenine	[no description available]	low	0	aminodiol; sphingoid; tertiary amino compound	EC 2.7.1.91 (sphingosine kinase) inhibitor; metabolite
4-hydroxyestradiol	[no description available]	low	0	4-hydroxy steroid	metabolite
9-hydroxy-10,12-octadecadienoic acid	[no description available]	low	0	HODE; octadecadienoic acid	human metabolite; metabolite; mouse metabolite; plant metabolite
9-oxo-10,12-octadecadienoic acid	[no description available]	low	0	enone; oxooctadecadienoic acid	metabolite
13-oxo-9,11-octadecadienoic acid	[no description available]	low	0	13-oxo-9,11-octadecadienoic acid; oxo fatty acid	metabolite
13,14-dihydro-15-ketoprostaglandin d2	[no description available]	low	0	prostaglandins D	metabolite
15-keto-13,14-dihydroprostaglandin f2alpha	[no description available]	low	0	ketone; prostaglandins Falpha	metabolite
2,3-dinor-6-ketoprostaglandin f1alpha	[no description available]	low	0	4-oxo monocarboxylic acid; prostanoid; secondary alcohol	metabolite
ergosta-7,22-dien-3-ol, (3beta,5alpha,6alpha,22e)-isomer	[no description available]	low	0	3beta-sterol	anti-HSV-1 agent; antifungal agent; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; metabolite
calcifediol	[no description available]	low	0	D3 vitamins; diol; hydroxycalciol	bone density conservation agent; human metabolite; metabolite; mouse metabolite; nutraceutical
oleyl alcohol	[no description available]	low	0	fatty alcohol 18:1; long-chain primary fatty alcohol	metabolite; nonionic surfactant
fortimicin a	[no description available]	medium	0	amino cyclitol glycoside; aminoglycoside antibiotic; diol; monocarboxylic acid amide; primary amino compound	antibacterial agent; metabolite
3',4',7-trihydroxyisoflavone	[no description available]	low	0	7-hydroxyisoflavones	antineoplastic agent; EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor; metabolite
6,7,4'-trihydroxyisoflavone	[no description available]	low	0	7-hydroxyisoflavones	anti-inflammatory agent; antimutagen; EC 1.14.18.1 (tyrosinase) inhibitor; metabolite; PPARalpha agonist; PPARgamma agonist
15-deoxy-delta(12,14)-prostaglandin j2	[no description available]	low	0	prostaglandins J	electrophilic reagent; insulin-sensitizing drug; metabolite
cytochalasin b	[no description available]	low	0	cytochalasin; lactam; lactone; organic heterotricyclic compound	actin polymerisation inhibitor; metabolite; mycotoxin; platelet aggregation inhibitor
ciguatoxins	[no description available]	low	0	ciguatoxin	metabolite
12-hydroxy-5,8,10-heptadecatrienoic acid	[no description available]	low	0	hydroxy polyunsaturated fatty acid; long-chain fatty acid; trienoic fatty acid	metabolite
bisdemethoxycurcumin	[no description available]	low	0	beta-diketone; diarylheptanoid; enone; polyphenol	EC 3.2.1.1 (alpha-amylase) inhibitor; metabolite
clausine e	[no description available]	low	0	carbazoles	metabolite
ethyl caffeate	[no description available]	low	0	alkyl caffeate ester; ethyl ester; hydroxycinnamic acid	anti-inflammatory agent; antineoplastic agent; metabolite
heptaphylline	[no description available]	low	0	carbazoles	metabolite
pellitorine	[no description available]	low	0	fatty amide	metabolite
andrographolide	[no description available]	low	0	carbobicyclic compound; gamma-lactone; labdane diterpenoid; primary alcohol; secondary alcohol	anti-HIV agent; anti-inflammatory drug; antineoplastic agent; metabolite
isorhamnetin-3-o-galactoside	[no description available]	low	0	beta-D-galactoside; glycosyloxyflavone; monomethoxyflavone; monosaccharide derivative; trihydroxyflavone	metabolite
isorhamnetin 3-o-glucoside	[no description available]	low	0	beta-D-glucoside; glycosyloxyflavone; monomethoxyflavone; monosaccharide derivative; trihydroxyflavone	metabolite
kaempferol-3-o-rutinoside	[no description available]	low	0	disaccharide derivative; kaempferol O-glucoside; rutinoside; trihydroxyflavone	metabolite; plant metabolite; radical scavenger
ligustilide	[no description available]	low	0	butenolide	metabolite
7,4'-dihydroxy-3'-methoxyisoflavone	[no description available]	low	0	7-hydroxyisoflavones; methoxyisoflavone	antiplasmodial drug; metabolite
sappanchalcone	[no description available]	low	0	catechols; chalcones; monomethoxybenzene	anti-allergic agent; anti-inflammatory agent; antioxidant; metabolite
methyl brevifolincarboxylate	[no description available]	low	0	cyclic ketone; delta-lactone; organic heterotricyclic compound; phenols	EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; metabolite; platelet aggregation inhibitor; radical scavenger; vasodilator agent
3-deoxysappanchalcone	[no description available]	low	0	chalcones; monomethoxybenzene; phenols	metabolite
nostocarboline	[no description available]	low	0	alkaloid; beta-carbolines; organic cation; organochlorine compound	antimalarial; EC 3.1.1.8 (cholinesterase) inhibitor; metabolite
ergosterol-5,8-peroxide	[no description available]	low	0	3beta-sterol; ergostanoid; organic peroxide; phytosterols	antimycobacterial drug; antineoplastic agent; metabolite; trypanocidal drug
3-(4-hydroxy-3-methoxyphenyl)-n-(2-(4-hydroxy-3-methoxyphenyl)ethyl)-2-propenamide	[no description available]	low	0	hydroxycinnamic acid	metabolite
macluraxanthone b	[no description available]	low	0	phenols; xanthones	anti-HIV agent; antineoplastic agent; metabolite
flavokawain b	[no description available]	low	0	chalcones; dimethoxybenzene; phenols	anti-inflammatory agent; antileishmanial agent; antineoplastic agent; apoptosis inducer; metabolite
alternariol	[no description available]	low	0	benzochromenone; phenols	EC 3.1.1.8 (cholinesterase) inhibitor; metabolite; mycotoxin
cis-3-hexenyl acetate	[no description available]	low	0	acetate ester; olefinic compound	metabolite
pipercallosidine	[no description available]	low	0	alkaloid; benzodioxoles; enamide; secondary carboxamide	apoptosis inducer; metabolite; plant metabolite
n-(4-hydroxy-beta-phenethyl)-4-hydroxycinnamide	[no description available]	low	0	hydroxycinnamic acid	metabolite
7-hydroxyisoflavone	[no description available]	low	0	7-hydroxyisoflavones	EC 1.14.14.14 (aromatase) inhibitor; metabolite
flazin	[no description available]	low	0	harmala alkaloid	metabolite
11-hydroxynoracronycine	[no description available]	low	0	acridines	metabolite
jaceosidin	[no description available]	low	0	dimethoxyflavone; trihydroxyflavone	anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; metabolite
5,7,3'-trihydroxy-3,4'-dimethoxyflavone	[no description available]	low	0	dimethoxyflavone; trihydroxyflavone	antineoplastic agent; metabolite
salutaridine	[no description available]	low	0	morphinane alkaloid	anti-HBV agent; metabolite
cytochalasin e	[no description available]	low	0	cytochalasan alkaloid	metabolite
artocarpin lectin	[no description available]	low	0	monomethoxyflavone; trihydroxyflavone	antineoplastic agent; metabolite
fumarates	[no description available]	low	0	butenedioate; C4-dicarboxylate	human metabolite; metabolite; Saccharomyces cerevisiae metabolite
bleomycin	[no description available]	low	0	bleomycin	antineoplastic agent; metabolite
1,7-dihydroxy-4-methoxyxanthone	[no description available]	low	0	aromatic ether; phenols; xanthones	metabolite; plant metabolite
demethoxycurcumin	[no description available]	low	0	beta-diketone; diarylheptanoid; enone; polyphenol	anti-inflammatory agent; antineoplastic agent; metabolite
bergamottin	[no description available]	low	0	furanocoumarin	metabolite
alanyl-alanyl-alanine	[no description available]	low	0	tripeptide	metabolite
24-ethyl-4-cholesten-3-one	[no description available]	low	0	C29-steroid; steroid	metabolite
myricetin 3-o-glucuronide	[no description available]	low	0	monosaccharide derivative; myricetin O-glucuronide; pentahydroxyflavone	metabolite
phenylalanylalanine	[no description available]	low	0	dipeptide zwitterion; dipeptide	metabolite
alpinumisoflavone	[no description available]	low	0	isoflavanones	metabolite
alpha-aspartylalanine	[no description available]	low	0	dipeptide	metabolite
arglabin	[no description available]	low	0	epoxide; gamma-lactone; organic heterotetracyclic compound; sesquiterpene lactone	antineoplastic agent; metabolite
ap 10	[no description available]	low	0	diterpene lactone	metabolite
quercetin 7-rhamnoside	[no description available]	low	0	alpha-L-rhamnoside; flavonols; monosaccharide derivative; quercetin O-glycoside; tetrahydroxyflavone	metabolite
albonoursin	[no description available]	low	0	2,5-diketopiperazines	metabolite
oroidin	[no description available]	low	0	pyrroles; secondary carboxamide	metabolite
monorden	[no description available]	low	0	cyclic ketone; enone; epoxide; macrolide antibiotic; monochlorobenzenes; phenols	antifungal agent; metabolite; tyrosine kinase inhibitor
apratoxin a	[no description available]	low	0	1,3-thiazoles; apratoxin	antineoplastic agent; metabolite
(-)-catechin-3-O-gallate	[no description available]	low	0	flavans; gallate ester; polyphenol	metabolite
aspartyllysine	[no description available]	low	0	dipeptide	metabolite
arginyllysine	[no description available]	low	0	dipeptide	metabolite
hygromycin a	[no description available]	low	0	hydroxycinnamic acid	metabolite
latrunculin b	[no description available]	low	0	cyclic hemiketal; macrolide; oxabicycloalkane; thiazolidinone	actin polymerisation inhibitor; metabolite; toxin
falcarindiol	[no description available]	low	0	organic molecular entity	metabolite
dehydroergosterol	[no description available]	low	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; ergostanoid; phytosterols	biomarker; metabolite
n-oleoylglycine	[no description available]	low	0	fatty amide; N-acylglycine 18:1	metabolite
rhizoxin	[no description available]	low	0	1,3-oxazoles; epoxide; macrolide antibiotic	antimitotic; antineoplastic agent; metabolite
manoalide	[no description available]	low	0	butenolide; lactol; sesterterpenoid	EC 3.1.1.4 (phospholipase A2) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; metabolite
concanamycin a	[no description available]	low	0	carbamate ester; concanamycin	antifungal agent; EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor; metabolite
n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid	[no description available]	low	0	enoate ester; methyl ester; monocarboxylic acid amide	metabolite
thunberginol f	[no description available]	low	0	catechols; gamma-lactone; isobenzofuranone	metabolite; plant metabolite
pyracrenic acid	[no description available]	low	0	triterpenoid	metabolite
eicosa-11,14-dienoic acid, (z,z)-isomer	[no description available]	low	0	icosadienoic acid	metabolite
yuanhuadine	[no description available]	low	0	diterpenoid	metabolite
tiglylglycine	[no description available]	low	0	N-acylglycine	metabolite
rhodiocyanoside a	[no description available]	low	0	aliphatic nitrile; beta-D-glucoside; cyanogenic glycoside; monosaccharide derivative	anti-allergic agent; metabolite
(2E,4E)-N-isobutyl-2,4-dodecadienamide	[no description available]	low	0	fatty amide	metabolite
mycothiazole	[no description available]	low	0	thiazoles	metabolite
13-oxo-9,11-octadecadienoic acid	[no description available]	low	0	13-oxo-9,11-octadecadienoic acid	metabolite; mouse metabolite
linderalactone	[no description available]	low	0	butenolide	metabolite
pros-methylimidazoleacetic acid	[no description available]	low	0	imidazolyl carboxylic acid	metabolite
cellobionic acid	[no description available]	low	0	carbohydrate acid; disaccharide	metabolite
pseudopteroxazole	[no description available]	low	0	tetralins	metabolite
sophoraflavanone a	[no description available]	low	0	(2S)-flavan-4-one; 4'-hydroxyflavanones; trihydroxyflavanone	antibacterial agent; antineoplastic agent; metabolite
panduratin a	[no description available]	low	0	diarylheptanoid	metabolite
stigmasterol 3-o-beta-d-glucopyranoside	[no description available]	low	0	beta-D-glucoside; monosaccharide derivative; phytosterols; steroid saponin	metabolite
17-hydroxyjolkinolide b	[no description available]	low	0	diterpene lactone	metabolite
sq-23377	[no description available]	low	0	cyclic ether; enol; polyunsaturated fatty acid; very long-chain fatty acid	calcium ionophore; metabolite
corosolic acid	[no description available]	low	0	triterpenoid	metabolite
cyclo(prolyl-valyl)	[no description available]	low	0	piperazinone	metabolite
phenylalanylglycine	[no description available]	low	0	dipeptide	metabolite
leucyl-phenylalanine	[no description available]	low	0	dipeptide	metabolite
glutamylalanine	[no description available]	low	0	dipeptide	metabolite
glutaminyl-glycine	[no description available]	low	0	dipeptide	metabolite
methionylglycine	[no description available]	low	0	dipeptide	metabolite
valylleucine	[no description available]	low	0	dipeptide	metabolite
phenylalanyl-valine	[no description available]	low	0	dipeptide	metabolite
cyclo(glycyltryptophyl)	[no description available]	low	0	indoles	metabolite
alanylglycine	[no description available]	low	0	dipeptide zwitterion; dipeptide	metabolite
valyltyrosine	[no description available]	low	0	dipeptide	metabolite
alpha-glutamyltryptophan	[no description available]	low	0	dipeptide	metabolite
lysylglutamic acid	[no description available]	low	0	dipeptide	metabolite
methionylglutamic acid	[no description available]	low	0	dipeptide	metabolite
seryl-histidine	[no description available]	low	0	dipeptide	metabolite
arginyl-glutamine	[no description available]	low	0	dipeptide	metabolite
phenylalanylproline	[no description available]	low	0	dipeptide	metabolite
lysylglycine	[no description available]	low	0	dipeptide	metabolite
glycylhistidine	[no description available]	low	0	dipeptide zwitterion; dipeptide	metabolite
kopsinine	[no description available]	low	0	indole alkaloid	metabolite
cyclo(leucyl-phenylalanyl)	[no description available]	low	0	2,5-diketopiperazines	metabolite
prolylisoleucine	[no description available]	low	0	dipeptide	metabolite
isoleucyl-tyrosine	[no description available]	low	0	dipeptide	metabolite
prolyl-serine	[no description available]	low	0	dipeptide	metabolite
grayanotoxin i	[no description available]	low	0	acetate ester; pentol; secondary alcohol; tertiary alcohol; tetracyclic diterpenoid	antihypertensive agent; metabolite; neuromuscular agent; phytotoxin
19-norandrosterone	[no description available]	low	0	17-oxo steroid	metabolite
s-allylcysteine	[no description available]	low	0	L-alpha-amino acid zwitterion; S-hydrocarbyl-L-cysteine	antineoplastic agent; metabolite
oleandrigenin	[no description available]	low	0	14beta-hydroxy steroid; 3beta-hydroxy steroid; steroid ester	EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; metabolite
valyl-prolyl-proline	[no description available]	low	0	tripeptide	metabolite
prolylvaline	[no description available]	low	0	dipeptide	metabolite
palbinone	[no description available]	low	0	16-oxo steroid	metabolite
pseurotin	[no description available]	low	0	azaspiro compound; lactam; oxaspiro compound	metabolite
gambogic acid	[no description available]	low	0	pyranoxanthones	metabolite
xenovulene a	[no description available]	low	0	cyclic ether; enone; organic heterotetracyclic compound; sesquiterpenoid	GABA antagonist; metabolite
fr 148083	[no description available]	low	0	aromatic ether; macrolide; phenols; secondary alcohol; secondary alpha-hydroxy ketone	antibacterial agent; antineoplastic agent; metabolite; NF-kappaB inhibitor
LL-Z1640-1	[no description available]	low	0	macrolide; resorcinols	metabolite
9-methoxycanthin-6-one	[no description available]	low	0	aromatic ether; indole alkaloid; organic heterotetracyclic compound	antineoplastic agent; antiplasmodial drug; metabolite
n-acetylcarnosine	[no description available]	low	0	dipeptide	metabolite
cholest-5-en-3-one	[no description available]	low	0	3-oxo-Delta(5)-steroid; cholestanoid	metabolite
kaempferol 3-O-beta-L-glucopyranoside	[no description available]	low	0	beta-L-glucoside; flavonols; kaempferol O-glucoside; monosaccharide derivative; trihydroxyflavone	metabolite
rubraxanthone	[no description available]	low	0	aromatic ether; polyphenol; xanthones	antibacterial agent; antineoplastic agent; metabolite
ubiquinol	[no description available]	low	0	polyprenylhydroquinone; ubiquinol	biomarker; metabolite
landomycin a	[no description available]	low	0	oligosaccharide	metabolite
ancistroealaine a	[no description available]	low	0	aromatic ether; biaryl; isoquinoline alkaloid; isoquinolines; methoxynaphthalene; methylnaphthalenes	antileishmanial agent; antiplasmodial drug; metabolite; trypanocidal drug
cerberin	[no description available]	low	0	acetate ester; cardenolide glycoside; monosaccharide derivative	antineoplastic agent; metabolite
actein	[no description available]	low	0	triterpenoid	metabolite
araloside a	[no description available]	low	0	triterpenoid saponin	metabolite
ageladine a	[no description available]	low	0	alkaloid; aromatic amine; imidazopyridine; organobromine compound; pyrroles	angiogenesis inhibitor; antineoplastic agent; matrix metalloproteinase inhibitor; metabolite
corynoxine b	[no description available]	low	0	indolizines	metabolite
kaempferol 7-o-glucoside	[no description available]	low	0	beta-D-glucoside; flavonols; kaempferol O-glucoside; monosaccharide derivative; trihydroxyflavone	metabolite; plant metabolite; radical scavenger
delphinidin 3-sambubioside	[no description available]	low	0	anthocyanidin 3-O-beta-D-sambubioside	apoptosis inducer; metabolite
nodosin	[no description available]	low	0	delta-lactone	metabolite
protylonolide	[no description available]	low	0	diol; enone; macrolide	metabolite
arisugacin	[no description available]	low	0	aromatic ether; delta-lactone; enone; organic heterotetracyclic compound; tertiary alcohol	antimicrobial agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite; Penicillium metabolite
nymphaeol c	[no description available]	low	0	4'-hydroxyflavanones; tetrahydroxyflavanone	metabolite; radical scavenger
thonningianin a	[no description available]	low	0	tannin	metabolite
cephalostatin i	[no description available]	low	0	oxo steroid	metabolite
papyriflavonol a	[no description available]	low	0	3'-hydroxyflavonoid; flavonols; pentahydroxyflavone	EC 1.14.18.1 (tyrosinase) inhibitor; EC 3.1.1.4 (phospholipase A2) inhibitor; metabolite
lactonamycin	[no description available]	low	0	gamma-lactone; organic heterohexacyclic compound; phenols; trideoxyhexose derivative	antibacterial agent; antimicrobial agent; metabolite
myrsinoic acid b	[no description available]	low	0	1-benzofurans; monocarboxylic acid	anti-inflammatory agent; EC 4.4.1.11 (methionine gamma-lyase) inhibitor; metabolite
betulone	[no description available]	low	0	triterpenoid	metabolite
eckstolonol	[no description available]	low	0	organic heteropentacyclic compound; oxacycle; phlorotannin	metabolite; radical scavenger
manassantin b	[no description available]	low	0	benzodioxoles; dimethoxybenzene; lignan; oxolanes; secondary alcohol	antineoplastic agent; metabolite
gitaloxin	[no description available]	low	0	cardenolide glycoside	metabolite
paeonilide	[no description available]	low	0	benzoate ester	metabolite
dihydroxanthohumol	[no description available]	low	0	aromatic ether; dihydrochalcones; polyphenol	EC 1.14.13.39 (nitric oxide synthase) inhibitor; metabolite
corynoxine	[no description available]	low	0	indolizines	metabolite
7-phloroeckol	[no description available]	low	0	aromatic ether; phlorotannin	antioxidant; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; metabolite
(+)-lyoniresinol-3-alpha-O-beta-D-glucopyranoside	[no description available]	low	0	beta-D-glucoside; dimethoxybenzene; lignan; monosaccharide derivative; polyphenol; primary alcohol; tetralins	antibacterial agent; antifungal agent; metabolite
Sphaeropsidin C	[no description available]	low	0	tricyclic diterpenoid	metabolite
kelampayoside a	[no description available]	low	0	glycoside	metabolite
3,5-dimethoxy-4-hydroxybenzyl alcohol-4-O-beta-D-glucopyranoside	[no description available]	low	0	aromatic ether; benzyl alcohols; beta-D-glucoside; monosaccharide derivative; primary alcohol	antineoplastic agent; metabolite
2,3-dihydro-3beta-methoxy withaferin A	[no description available]	low	0	27-hydroxy steroid; 4-hydroxy steroid; delta-lactone; epoxy steroid; ergostanoid; primary alcohol; secondary alcohol; withanolide	metabolite; plant metabolite
nigranoic acid	[no description available]	low	0	dicarboxylic acid; tetracyclic triterpenoid	antineoplastic agent; HIV-1 reverse transcriptase inhibitor; metabolite
esculeoside a	[no description available]	low	0	azaspiro compound; oxaspiro compound; saponin; steroid alkaloid; steroid saponin	antineoplastic agent; metabolite
aerothionin	[no description available]	low	0	isoxazoles	metabolite
artemisic acid	[no description available]	low	0	carbobicyclic compound; monocarboxylic acid; octahydronaphthalenes; sesquiterpenoid	metabolite
26-deoxyactein	[no description available]	low	0	triterpenoid	metabolite
5-formylcytosine	[no description available]	low	0	aminopyrimidine; heteroarenecarbaldehyde; nucleobase analogue; pyrimidone	metabolite
migrastatin	[no description available]	low	0	ether; macrolide antibiotic; piperidones; secondary alcohol	antineoplastic agent; metabolite
Lyngbic acid	[no description available]	low	0	long-chain fatty acid	metabolite
2,3,6,8-tetrahydroxy-1-(3-methylbut-2-enyl)-5-(2-methylbut-3-en-2-yl)-9h-xanthen-9-one	[no description available]	low	0	polyphenol; xanthones	anti-inflammatory agent; antineoplastic agent; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; metabolite
bielschowskysin	[no description available]	low	0	acetate ester; cyclic acetal; diterpenoid; gamma-lactone; organic heterohexacyclic compound	antimalarial; antineoplastic agent; metabolite
procyanidin b1	[no description available]	low	0	biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin	anti-inflammatory agent; EC 3.4.21.5 (thrombin) inhibitor; metabolite
cyclo(tyrosyl-tyrosyl)	[no description available]	low	0	cyclo(tyrosyl-tyrosyl)	metabolite
spiculoic acid a	[no description available]	low	0	carbobicyclic compound; cyclic ketone; oxo monocarboxylic acid; styrenes	antineoplastic agent; metabolite
myrocin a	[no description available]	low	0	tertiary alcohol	metabolite
3'-o-methylepicatechin	[no description available]	low	0	catechin	metabolite
episilvestrol	[no description available]	low	0	dioxanes; ether; methyl ester; organic heterotricyclic compound	antineoplastic agent; metabolite
protopanaxatriol	[no description available]	low	0	12beta-hydroxy steroid; 3beta-hydroxy-4,4-dimethylsteroid; 3beta-hydroxy steroid; 6alpha-hydroxy steroid; sapogenin; tetracyclic triterpenoid	metabolite
laurinterol	[no description available]	low	0	organobromine compound; phenols; sesquiterpenoid	antibacterial agent; apoptosis inducer; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; metabolite
Pseudopterosin G-J aglycone	[no description available]	low	0	diterpenoid	metabolite
ceratamine a	[no description available]	low	0	alkaloid; aromatic ether; cyclic ketone; organic heterobicyclic compound; organobromine compound; secondary amino compound; tertiary amine	antimitotic; metabolite
liphagal	[no description available]	low	0	aldehyde; cyclic ether; meroterpenoid; organic heterotetracyclic compound; polyphenol	EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; metabolite
pulsatilla saponin d	[no description available]	low	0	triterpenoid	metabolite
diversonol	[no description available]	low	0	phenols; tertiary alcohol	antibacterial agent; metabolite
neotuberostemonine	[no description available]	low	0	alkaloid	metabolite
drymaritin	[no description available]	low	0	enol ether; enone; indole alkaloid; organic heterotetracyclic compound	anti-HIV agent; metabolite
lyoniresinol	[no description available]	low	0	dimethoxybenzene; lignan; polyphenol; primary alcohol; tetralins	antineoplastic agent; metabolite
silvestrol	[no description available]	low	0	dioxanes; ether; methyl ester; organic heterotricyclic compound	antineoplastic agent; metabolite
ginsenoside ro	[no description available]	low	0	triterpenoid saponin	metabolite
diosgenin glucoside	[no description available]	low	0	hexacyclic triterpenoid; monosaccharide derivative; spiroketal; sterol 3-beta-D-glucoside	metabolite
pyripyropene a	[no description available]	low	0	organic heterotetracyclic compound; sesquiterpenoid	acyl-CoA:cholesterol acyltransferase 2 inhibitor; metabolite
3-epioleanolic acid	[no description available]	low	0	triterpenoid	metabolite
leucylproline	[no description available]	low	0	dipeptide zwitterion; dipeptide	metabolite
R-(-)-actinodaphnine	[no description available]	low	0	aporphine alkaloid	metabolite
cytotrienin a	[no description available]	low	0	cyclopropanecarboxylate ester; ether; hydroquinones; lactam; macrocycle; secondary alcohol	antibacterial agent; antimicrobial agent; antineoplastic agent; apoptosis inducer; metabolite
methylamphotericin b	[no description available]	low	0	macrolide; methyl ester; monosaccharide derivative	antifungal agent; antiinfective agent; metabolite
2'-methoxykurarinone	[no description available]	low	0	4'-hydroxyflavanones; dihydroxyflavanone; dimethoxyflavanone	antineoplastic agent; metabolite
verproside	[no description available]	low	0	glycoside	metabolite
verminoside	[no description available]	low	0	hydroxycinnamic acid	metabolite
minecoside	[no description available]	low	0	hydroxycinnamic acid	metabolite
(R)-(+)-6',7'-dihydroxybergamottin	[no description available]	low	0	furanocoumarin	metabolite
lapidilectine b	[no description available]	low	0	indolyl carboxylic acid	metabolite
batzelladine a	[no description available]	low	0	alkaloid; carboxylic ester; guanidines; organic heterotricyclic compound; pyrrolopyrimidine; triazaacenaphthylene	anti-HIV-1 agent; metabolite
alloin	[no description available]	low	0	anthracenes; C-glycosyl compound; cyclic ketone; phenols	laxative; metabolite
longipinene	[no description available]	low	0	alpha-longipinene	metabolite
parkeol	[no description available]	low	0	3beta-hydroxy-4,4-dimethylsteroid; 3beta-sterol; tetracyclic triterpenoid	metabolite
rutundic acid	[no description available]	low	0	triterpenoid	metabolite
a-factor (streptomyces)	[no description available]	low	0	butan-4-olide; primary alcohol	metabolite
taraxasteryl acetate	[no description available]	low	0	triterpenoid	metabolite
chikusetsu saponin iva	[no description available]	low	0	triterpenoid saponin	metabolite
xestoaminol c	[no description available]	low	0	amino alcohol; sphingoid	metabolite
malyngamide A	[no description available]	low	0	dicarboximide	metabolite
simalikalactone D	[no description available]	low	0	cyclic ether; delta-lactone; enone; organic heteropentacyclic compound; quassinoid; secondary alcohol; secondary alpha-hydroxy ketone; triol	antimalarial; antineoplastic agent; antiviral agent; metabolite
friedelane	[no description available]	low	0	triterpene	metabolite
shamixanthone	[no description available]	low	0	cyclic ketone; phenols; pyranoxanthene	metabolite
17,18-epoxy-5,8,11,14-eicosatetraenoic acid	[no description available]	low	0	EpETE	metabolite
chaetominine	[no description available]	low	0	indole alkaloid; lactam; organic heterotetracyclic compound; quinazolines	metabolite
schweinfurthin g	[no description available]	low	0	cyclic ether; organic heterotricyclic compound; resorcinols; stilbenoid	antineoplastic agent; metabolite
salmon calcitonin	[no description available]	low	0	heterodetic cyclic peptide; peptide hormone; polypeptide	bone density conservation agent; metabolite
complestatin	[no description available]	low	0	cyclic ether; heterodetic cyclic peptide; indoles; organic heterobicyclic compound; organochlorine compound; peptide antibiotic; polyphenol	anti-HIV-1 agent; antimicrobial agent; HIV-1 integrase inhibitor; metabolite
neuroprotectin a	[no description available]	low	0	cyclic ether; heterodetic cyclic peptide; indoles; organochlorine compound; polyphenol	HIV-1 integrase inhibitor; metabolite
alx-0600	[no description available]	low	0	polypeptide	antioxidant; glucagon-like peptide-2 receptor agonist; metabolite; protective agent
schweinfurthin f	[no description available]	low	0	cyclic ether; organic heterotricyclic compound; resorcinols; stilbenoid	metabolite
antrocamphin a	[no description available]	low	0	methoxybenzenes	anti-inflammatory agent; metabolite
respirantin	[no description available]	low	0	benzamides; cyclodepsipeptide; formamides; phenols	antimicrobial agent; antineoplastic agent; metabolite
streptobiosamine	[no description available]	low	0	amino disaccharide	metabolite
interiotherin b	[no description available]	low	0	aromatic ether; fatty acid ester; lignan; organic heteropentacyclic compound; oxacycle	anti-HIV agent; metabolite
succinyladenosine	[no description available]	low	0	adenosines; amino dicarboxylic acid; L-aspartic acid derivative	metabolite
6-tuliposide a	[no description available]	low	0	6-O-acyl-D-glucose; homoallylic alcohol	allergen; metabolite
glycochenodeoxycholate-3-sulfate	[no description available]	low	0	7alpha-hydroxy steroid; bile acid glycine conjugate; steroid sulfate	metabolite
wewakazole	[no description available]	low	0	cyclic peptide	metabolite
spongia-13(16),14-dien-19-oic acid	[no description available]	low	0	cyclic ether; monocarboxylic acid; tetracyclic diterpenoid	androgen antagonist; metabolite
Icariside E4	[no description available]	low	0	benzofurans	metabolite
lucidenic acid n	[no description available]	low	0	cyclic terpene ketone; dioxo monocarboxylic acid; secondary alcohol; tetracyclic triterpenoid	antineoplastic agent; EC 3.1.1.8 (cholinesterase) inhibitor; metabolite
dihydroagarofuran	[no description available]	low	0	bridged compound; cyclic ether; eudesmane sesquiterpenoid; organic heterotricyclic compound	metabolite
23-epi-26-deoxyactein	[no description available]	low	0	triterpenoid	metabolite
23-hydroxybetulinic acid	[no description available]	low	0	triterpenoid	metabolite
(1S,3aR,4S,6S,6aS,9aS,9bS)-9a-isocyano-6-(2-isocyano-2-methylpropyl)-1,4-dimethyl-7-methylidene-2,3,3a,4,5,6,6a,8,9,9b-decahydro-1H-phenalene	[no description available]	low	0	diterpenoid	metabolite
bromophycolide a	[no description available]	low	0	diterpenoid; macrolide; organobromine compound; phenols; tertiary alcohol	anti-HIV agent; antibacterial agent; antifungal agent; antimalarial; antineoplastic agent; metabolite
2-acetamidoglucal	[no description available]	low	0	acetamides; glycal derivative	metabolite
diorcinol	[no description available]	low	0	aromatic ether; phenols	fungal metabolite; marine metabolite; metabolite
caribenol a	[no description available]	low	0	organic heterotetracyclic compound; terpene lactone; tertiary alcohol	antimalarial; antitubercular agent; metabolite
halisulfate 1	[no description available]	low	0	organic molecular entity	metabolite
6-O-feruloylcatalpol	[no description available]	low	0	hydroxycinnamic acid	metabolite
grassypeptolide	[no description available]	low	0	cyclodepsipeptide; macrocycle	antineoplastic agent; metabolite
essramycin	[no description available]	low	0	triazolopyrimidines	metabolite
ainsliadimer a	[no description available]	low	0	sesquiterpene lactone; spiro compound	EC 1.14.13.39 (nitric oxide synthase) inhibitor; metabolite
salvileucalin b	[no description available]	low	0	bridged compound; diterpenoid; furans; gamma-lactone	antineoplastic agent; metabolite
ciliatamide a	[no description available]	low	0	caprolactams; lipopeptide	antileishmanial agent; metabolite
etnangien	[no description available]	low	0	hydroxy monocarboxylic acid; macrolide antibiotic	antibacterial agent; metabolite
latrunculol a	[no description available]	low	0	macrolide	metabolite
N-trans-sinapoyltyramine	[no description available]	low	0	hydroxycinnamic acid	metabolite
lycojapodine a	[no description available]	low	0	alkaloid; bridged compound; cyclic ketone; lactone; organic heterotetracyclic compound	anti-HIV-1 agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite
epi-maslinic acid	[no description available]	low	0	dihydroxy monocarboxylic acid; pentacyclic triterpenoid	anti-inflammatory agent; metabolite
eoxin c4	[no description available]	low	0	eoxin; leukotriene	metabolite
brartemicin	[no description available]	low	0	benzoate ester; glycosyl glycoside derivative; resorcinols	antimicrobial agent; metabolite
Majusculamide AB	[no description available]	low	0	amino acid amide	metabolite
7,8-dihydroxyflavanone	[no description available]	low	0	dihydroxyflavanone	antineoplastic agent; metabolite
antcin a	[no description available]	low	0	ergostanoid	metabolite
integric acid	[no description available]	low	0	carboxylic ester; cyclic ketone; dioxo monocarboxylic acid; enal; enone; eremophilane sesquiterpenoid	HIV-1 integrase inhibitor; metabolite
vanilloloside	[no description available]	low	0	glycoside	metabolite
2,3-dihydro-3beta-O-sulfate withaferin A	[no description available]	low	0	27-hydroxy steroid; 4-hydroxy steroid; delta-lactone; epoxy steroid; ergostanoid; primary alcohol; steroid sulfate; withanolide	antineoplastic agent; metabolite; plant metabolite
dicranin	[no description available]	low	0	acetylenic fatty acid; long-chain fatty acid; straight-chain fatty acid; trienoic fatty acid	antibacterial agent; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; metabolite
leachianone a	[no description available]	low	0	4'-hydroxyflavanones; monomethoxyflavanone; trihydroxyflavanone	antimalarial; antineoplastic agent; metabolite
hordatine a	[no description available]	low	0	aromatic ether; benzofurans; dicarboxylic acid diamide; guanidines; phenols	adrenergic antagonist; metabolite
englerin a	[no description available]	low	0	cinnamate ester; glycolate ester; guaiane sesquiterpenoid	antineoplastic agent; metabolite
monanchocidin	[no description available]	low	0	organic molecular entity	metabolite
eurycomanone	[no description available]	low	0	cyclic ether; delta-lactone; enone; organic heteropentacyclic compound; pentol; quassinoid; secondary alcohol; secondary alpha-hydroxy ketone; tertiary alcohol	antimalarial; antineoplastic agent; metabolite
sphaeropsidin a	[no description available]	low	0	gamma-lactone	metabolite
gardenoside	[no description available]	low	0	beta-D-glucoside; cyclopentapyran; enoate ester; methyl ester; monosaccharide derivative; tertiary alcohol	metabolite
landomycin d	[no description available]	low	0	anthraquinone	metabolite
3alpha,12alpha-dihydroxy-4alpha-methylergosta-8,24(28)-dien-7,11-dione-26-oic acid	[no description available]	low	0	11-oxo steroid; 12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7-oxo steroid; monocarboxylic acid; secondary alpha-hydroxy ketone; steroid acid	antineoplastic agent; metabolite
antcin k	[no description available]	low	0	bile acid	metabolite
3alpha-hydroxy-4alpha-methylergosta-8,24(28)-dien-7,11-dione-26-oic acid	[no description available]	low	0	11-oxo steroid; 3alpha-hydroxy steroid; 7-oxo steroid; monocarboxylic acid; steroid acid	antineoplastic agent; cholinergic antagonist; metabolite; serotonergic antagonist
shizukaol B	[no description available]	low	0	triterpenoid	metabolite
shizukaol f	[no description available]	low	0	triterpenoid	metabolite
calicheamicin gamma(1)i	[no description available]	low	0	calicheamicin; enediyne antibiotic; organoiodine compound	antineoplastic agent; metabolite
staphyloxanthin	[no description available]	low	0	apo carotenoid triterpenoid; D-aldohexose derivative; fatty acid ester; triol; xanthophyll	antioxidant; biological pigment; metabolite; virulence factor
sm 1 peptide	[no description available]	low	0	acetate ester; ergot alkaloid	metabolite
mycocyclosin	[no description available]	low	0	2,5-diketopiperazines; organic heterotetracyclic compound; polyphenol	metabolite
callipeltin a	[no description available]	low	0	cyclodepsipeptide; guanidines; lactone; oligopeptide; phenols	anti-HIV-1 agent; antifungal agent; metabolite
vinylamycin	[no description available]	low	0	cyclodepsipeptide; macrocycle; primary alcohol	antibacterial agent; antimicrobial agent; metabolite
promegestone	[no description available]	low	0	terpene lactone	metabolite
lancifodilactone g	[no description available]	low	0	cyclic ether; diol; enol; gamma-lactone; oxaspiro compound; triterpenoid	anti-HIV agent; metabolite
rediocide a	[no description available]	low	0	diterpenoid; epoxide; ortho ester; terpene lactone	insecticide; metabolite
lasiokaurin	[no description available]	low	0	kaurane diterpenoid	metabolite
longikaurin a	[no description available]	low	0	kaurane diterpenoid	metabolite
ponicidin	[no description available]	low	0	dioxanes	metabolite
(Z)-6,6',7,3'a-Diligustilide	[no description available]	low	0	butenolide	metabolite
suvanine	[no description available]	low	0	organic molecular entity	metabolite
shizukaol d	[no description available]	low	0	triterpenoid	metabolite
thailandepsin a	[no description available]	low	0	cyclodepsipeptide	metabolite
nordidemnin b	[no description available]	low	0	didemnin	metabolite
4-formylaminooxyvinylglycine	[no description available]	low	0	non-proteinogenic alpha-amino acid	metabolite
platycoside e	[no description available]	low	0	triterpenoid saponin	metabolite
leuconoxine	[no description available]	low	0	alkaloid	metabolite
epidermin	[no description available]	low	0	macrocycle; type A lantibiotic	antibacterial agent; metabolite
surfactin A	[no description available]	low	0	cyclodepsipeptide; lipopeptide antibiotic; macrocyclic lactone	antibacterial agent; antifungal agent; antineoplastic agent; antiviral agent; metabolite; surfactant
myriaporone 3	[no description available]	low	0	beta-hydroxy ketone; epoxide; lactol; oxanes; primary alcohol; secondary alcohol	antineoplastic agent; metabolite
avenacoside b	[no description available]	low	0	beta-D-glucoside; hexacyclic triterpenoid; spiroketal; steroid saponin; tetrasaccharide derivative	metabolite
3-methylglutarylcarnitine	[no description available]	low	0	O-methylglutarylcarnitine	metabolite
pivaloylcarnitine	[no description available]	low	0	C5-acylcarnitine	metabolite
levoleucovorin	[no description available]	low	0	5-formyltetrahydrofolic acid	antineoplastic agent; metabolite
7,8-dihydroneopterin	[no description available]	low	0	dihydropterin; neopterins	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
guanosine monophosphate	[no description available]	low	0	guanosine 5'-phosphate; purine ribonucleoside 5'-monophosphate	biomarker; Escherichia coli metabolite; metabolite; mouse metabolite
2-amino-4-oxo-6-acetyl-7,8-dihydro-3h,9h-pyrimidodiazepine	[no description available]	low	0	methyl ketone; pyrimidodiazepine	metabolite
dyspropterin	[no description available]	low	0	biopterins; tetrahydropterin	human metabolite; metabolite; mouse metabolite
2'-o-methylguanosine	[no description available]	low	0	methylguanosine	metabolite
allopurinol riboside	[no description available]	low	0	nucleoside analogue	metabolite
norclozapine	[no description available]	low	0	dibenzodiazepine; organochlorine compound; piperazines	delta-opioid receptor agonist; metabolite; serotonergic antagonist
7-methylguanosine	[no description available]	low	0	methylguanosine; organic cation	metabolite
3'-o-methylguanosine	[no description available]	low	0	methylguanosine	metabolite
primapterin	[no description available]	low	0	biopterins	metabolite
7-methylinosine	[no description available]	low	0	inosines; organic cation	metabolite
marineosin a	[no description available]	low	0	azaspiro compound; ether; macrocycle; oxaspiro compound; pyrroles	antineoplastic agent; metabolite
marineosin b	[no description available]	low	0	azaspiro compound; ether; macrocycle; oxaspiro compound; pyrroles	antineoplastic agent; metabolite
citric acid, anhydrous	[no description available]	low	0	tricarboxylic acid	antimicrobial agent; chelator; food acidity regulator; fundamental metabolite
fosmidomycin	[no description available]	low	0	hydroxamic acid; phosphonic acids	antimicrobial agent; bacterial metabolite; EC 1.1.1.267 (1-deoxy-D-xylulose-5-phosphate reductoisomerase) inhibitor
chlorocresol	[no description available]	low	0	hydroxytoluene; monochlorobenzenes	antimicrobial agent; disinfectant; ryanodine receptor agonist
bromodiphenhydramine	[no description available]	low	0	organobromine compound; tertiary amino compound	antimicrobial agent; H1-receptor antagonist; muscarinic antagonist
clioquinol	[no description available]	low	0	monohydroxyquinoline; organochlorine compound; organoiodine compound	antibacterial agent; antifungal agent; antimicrobial agent; antineoplastic agent; antiprotozoal drug; chelator; copper chelator
embelin	[no description available]	low	0	dihydroxy-1,4-benzoquinones	antimicrobial agent; antineoplastic agent; hepatitis C protease inhibitor; plant metabolite
lomefloxacin	[no description available]	low	0	fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone	antimicrobial agent; antitubercular agent; photosensitizing agent
oxolinic acid	[no description available]	low	0	aromatic carboxylic acid; organic heterotricyclic compound; oxacycle; quinolinemonocarboxylic acid; quinolone antibiotic	antibacterial drug; antifungal agent; antiinfective agent; antimicrobial agent; enzyme inhibitor
oxyphenbutazone	[no description available]	low	0	phenols; pyrazolidines	antimicrobial agent; antineoplastic agent; antipyretic; drug metabolite; gout suppressant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic metabolite
patulin	[no description available]	low	0	furopyran; gamma-lactone; lactol	antimicrobial agent; Aspergillus metabolite; carcinogenic agent; mutagen; mycotoxin; Penicillium metabolite
streptonigrin	[no description available]	low	0	pyridines; quinolone	antimicrobial agent; antineoplastic agent
sulfacetamide	[no description available]	low	0	N-sulfonylcarboxamide; substituted aniline	antibacterial drug; antiinfective agent; antimicrobial agent; EC 2.5.1.15 (dihydropteroate synthase) inhibitor
sulfadimethoxine	[no description available]	low	0	aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide	antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic
sulfamethazine	[no description available]	low	0	pyrimidines; sulfonamide antibiotic; sulfonamide	antibacterial drug; antiinfective agent; antimicrobial agent; carcinogenic agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; ligand; xenobiotic
sulfamethizole	[no description available]	low	0	sulfonamide antibiotic; sulfonamide; thiadiazoles	antiinfective agent; antimicrobial agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor
methylene blue	[no description available]	low	0	organic chloride salt	acid-base indicator; antidepressant; antimalarial; antimicrobial agent; antioxidant; cardioprotective agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 4.6.1.2 (guanylate cyclase) inhibitor; fluorochrome; histological dye; neuroprotective agent; physical tracer
linalool	[no description available]	low	0	monoterpenoid; tertiary alcohol	antimicrobial agent; fragrance; plant metabolite; volatile oil component
alpha phellandrene	[no description available]	low	0	cyclohexadiene; phellandrene	antimicrobial agent; plant metabolite; volatile oil component
triclocarban	[no description available]	low	0	dichlorobenzene; monochlorobenzenes; phenylureas	antimicrobial agent; antiseptic drug; disinfectant; environmental contaminant; xenobiotic
carvacrol	[no description available]	low	0	botanical anti-fungal agent; p-menthane monoterpenoid; phenols	agrochemical; antimicrobial agent; flavouring agent; TRPA1 channel agonist; volatile oil component
hadacidin	[no description available]	low	0	aldehyde; monocarboxylic acid; N-hydroxy-alpha-amino-acid	antimicrobial agent; antineoplastic agent; Penicillium metabolite; teratogenic agent
sulfamoxole	[no description available]	low	0	oxazole; sulfonamide antibiotic; sulfonamide	antimicrobial agent; drug allergen
pentadecanal	[no description available]	low	0	2,3-saturated fatty aldehyde; long-chain fatty aldehyde	antimicrobial agent; plant metabolite; volatile oil component
1-octen-3-ol	[no description available]	low	0	alkenyl alcohol; medium-chain fatty alcohol	antimicrobial agent; fungal metabolite; insect attractant; volatile oil component
cephaloglycin	[no description available]	low	0	beta-lactam antibiotic allergen; cephalosporin	antimicrobial agent
nitroxoline	[no description available]	low	0	C-nitro compound; monohydroxyquinoline	antifungal agent; antiinfective agent; antimicrobial agent; renal agent
mitomycin a	[no description available]	low	0	ether; mitomycin	alkylating agent; antimicrobial agent; antineoplastic agent; toxin
thiamphenicol	[no description available]	low	0	monocarboxylic acid amide; sulfone	antimicrobial agent; immunosuppressive agent
5-chloro-2-methyl-4-isothiazolin-3-one	[no description available]	low	0	1,2-thiazoles; organochlorine compound	antimicrobial agent; environmental contaminant; xenobiotic
nigericin	[no description available]	low	0	polycyclic ether	antibacterial agent; antimicrobial agent; bacterial metabolite; potassium ionophore
imidazolidinyl urea	[no description available]	low	0	ureas	antimicrobial agent
2-methyl-4-isothiazolin-3-one	[no description available]	low	0	1,2-thiazoles	antifouling biocide; antifungal agent; antimicrobial agent
spectinomycin dihydrochloride	[no description available]	low	0	hydrochloride	antibacterial drug; antimicrobial agent
propamidine	[no description available]	low	0	aromatic ether; guanidines; polyether	antimicrobial agent; antiseptic drug
hexamidine	[no description available]	low	0	aromatic ether; guanidines; polyether	antimicrobial agent; antiseptic drug
sinefungin	[no description available]	low	0	adenosines; non-proteinogenic alpha-amino acid	antifungal agent; antimicrobial agent
propamidine isethionate	[no description available]	low	0	guanidinium salt; organosulfonate salt	antimicrobial agent; antiseptic drug
lupulon	[no description available]	low	0	beta-bitter acid	angiogenesis inhibitor; antimicrobial agent; antineoplastic agent; apoptosis inducer
lomefloxacin hydrochloride	[no description available]	low	0	hydrochloride	antimicrobial agent; antitubercular agent; photosensitizing agent
enrofloxacin	[no description available]	low	0	cyclopropanes; N-alkylpiperazine; N-arylpiperazine; organofluorine compound; quinolinemonocarboxylic acid; quinolone	antibacterial agent; antimicrobial agent; antineoplastic agent
vexibinol	[no description available]	low	0	(2S)-flavan-4-one; 4'-hydroxyflavanones; tetrahydroxyflavanone	antimalarial; antimicrobial agent; antioxidant; plant metabolite
furanomycin	[no description available]	low	0	dihydrofuran; non-proteinogenic L-alpha-amino acid	antibacterial agent; antimicrobial agent; bacterial metabolite
benzoylmetronidazole	[no description available]	low	0	benzoate ester	antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; prodrug
tosufloxacin, 4-toluene sulfonate	[no description available]	low	0	racemate	antiinfective agent; antimicrobial agent; DNA synthesis inhibitor; hepatotoxic agent; topoisomerase IV inhibitor
1-phenazinecarboxylic acid	[no description available]	low	0	aromatic carboxylic acid; monocarboxylic acid; phenazines	antifungal agent; antimicrobial agent; bacterial metabolite
florfenicol	[no description available]	low	0	organochlorine compound; organofluorine compound; secondary alcohol; secondary carboxamide; sulfone	antimicrobial agent
cubebin	[no description available]	low	0	benzodioxoles; cyclic acetal; lactol; lignan; secondary alcohol	analgesic; anti-inflammatory agent; antimicrobial agent; histamine antagonist; plant metabolite; trypanocidal drug
olivomycin a	[no description available]	low	0	olivomycin; secondary alpha-hydroxy ketone	antimicrobial agent
tazobactam	[no description available]	low	0	penicillanic acids; triazoles	antiinfective agent; antimicrobial agent; EC 3.5.2.6 (beta-lactamase) inhibitor
ay 25545	[no description available]	low	0	acetate ester; aromatic ether; C-glycosyl compound; naphthoisochromene; olefinic compound; phenols; tertiary amine	antimicrobial agent; antineoplastic agent; bacterial metabolite
pannarin	[no description available]	low	0	aldehyde; aromatic ether; depsidones; organic heterotricyclic compound; organochlorine compound; phenols	antimicrobial agent; antineoplastic agent; apoptosis inducer; lichen metabolite
sclareol	[no description available]	low	0	labdane diterpenoid	antifungal agent; antimicrobial agent; apoptosis inducer; fragrance; plant metabolite
enniatin b	[no description available]	low	0	enniatin	antimicrobial agent
bisdechlorogeodin	[no description available]	low	0	1-benzofurans; cyclohexadiene; methyl ester; oxaspiro compound	antimicrobial agent
ml 236a	[no description available]	low	0	2-pyranones; carbobicyclic compound; hexahydronaphthalenes; polyketide; secondary alcohol	antiatherosclerotic agent; anticholesteremic drug; antilipemic drug; antimicrobial agent; EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor; fungal metabolite
chloroorienticin b	[no description available]	low	0	cyclic ether; glycopeptide; heterodetic cyclic peptide; monosaccharide derivative; organochlorine compound; polyphenol	antimicrobial agent; bacterial metabolite
fumagillol	[no description available]	low	0	secondary alcohol; sesquiterpenoid; spiro-epoxide	antimicrobial agent
anisomycin	[no description available]	low	0	monohydroxypyrrolidine; organonitrogen heterocyclic antibiotic	anticoronaviral agent; antimicrobial agent; antineoplastic agent; antiparasitic agent; bacterial metabolite; DNA synthesis inhibitor; protein synthesis inhibitor
puromycin	[no description available]	low	0	puromycins	antiinfective agent; antimicrobial agent; antineoplastic agent; EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor; EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor; nucleoside antibiotic; protein synthesis inhibitor
silver sulfadiazine	[no description available]	low	0	pyrimidines; silver salt; sulfonamidate	antibacterial drug; antimicrobial agent
mycophenolic acid	[no description available]	low	0	2-benzofurans; gamma-lactone; monocarboxylic acid; phenols	anticoronaviral agent; antimicrobial agent; antineoplastic agent; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; environmental contaminant; immunosuppressive agent; mycotoxin; Penicillium metabolite; xenobiotic
aclarubicin	[no description available]	low	0	aminoglycoside; anthracycline; methyl ester; phenols; polyketide; tetracenequinones; trisaccharide derivative; zwitterion	antimicrobial agent; antineoplastic agent; apoptosis inducer; bacterial metabolite; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
aphidicolin	[no description available]	low	0	tetracyclic diterpenoid	antimicrobial agent; antimitotic; antineoplastic agent; antiviral drug; apoptosis inducer; Aspergillus metabolite; DNA synthesis inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; fungal metabolite
antofine	[no description available]	low	0	alkaloid antibiotic; alkaloid; aromatic ether; organic heteropentacyclic compound	angiogenesis inhibitor; anti-inflammatory agent; antimicrobial agent; antineoplastic agent; antiviral agent; phytotoxin; plant metabolite
cannabidiol	[no description available]	low	0	olefinic compound; phytocannabinoid; resorcinols	antimicrobial agent; plant metabolite
valinomycin	[no description available]	low	0	cyclodepsipeptide; macrocycle	antimicrobial agent; antiviral agent; bacterial metabolite; potassium ionophore
sf 2370	[no description available]	low	0	bridged compound; gamma-lactam; methyl ester; organic heterooctacyclic compound	antimicrobial agent; bacterial metabolite; EC 2.7.11.13 (protein kinase C) inhibitor; tropomyosin-related kinase B receptor antagonist
chuangxinmycin	[no description available]	low	0	indole alkaloid; monocarboxylic acid; thiinoindole	antibacterial agent; antimicrobial agent; bacterial metabolite; EC 6.1.1.2 (tryptophan--tRNA ligase) inhibitor
apramycin	[no description available]	low	0	2-deoxystreptamine derivative; aminoglycoside; organic heterobicyclic compound	antibacterial drug; antimicrobial agent
fraxetin	[no description available]	low	0	aromatic ether; hydroxycoumarin	anti-inflammatory agent; antibacterial agent; antimicrobial agent; antioxidant; apoptosis inducer; apoptosis inhibitor; Arabidopsis thaliana metabolite; hepatoprotective agent; hypoglycemic agent
galangin	[no description available]	low	0	7-hydroxyflavonol; trihydroxyflavone	antimicrobial agent; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; plant metabolite
mangostin	[no description available]	low	0	aromatic ether; phenols; xanthones	antimicrobial agent; antineoplastic agent; antioxidant; plant metabolite
maytansine	[no description available]	low	0	alpha-amino acid ester; carbamate ester; epoxide; maytansinoid; organic heterotetracyclic compound; organochlorine compound	antimicrobial agent; antimitotic; antineoplastic agent; plant metabolite; tubulin modulator
cerulenin	[no description available]	low	0	epoxide; monocarboxylic acid amide	antifungal agent; antiinfective agent; antilipemic drug; antimetabolite; antimicrobial agent; fatty acid synthesis inhibitor
acetylspiramycin	[no description available]	low	0	acetate ester; aldehyde; disaccharide derivative; ether; macrolide; tertiary amino compound	antibacterial drug; antimicrobial agent; bacterial metabolite
ly 163892	[no description available]	low	0	carbacephem; zwitterion	antibacterial drug; antimicrobial agent
geldanamycin	[no description available]	low	0	1,4-benzoquinones; ansamycin; carbamate ester; organic heterobicyclic compound	antimicrobial agent; antineoplastic agent; antiviral agent; cysteine protease inhibitor; Hsp90 inhibitor
herbimycin	[no description available]	low	0	1,4-benzoquinones; lactam; macrocycle	antimicrobial agent; apoptosis inducer; herbicide; Hsp90 inhibitor; tyrosine kinase inhibitor
n-cinnamoyltyramine	[no description available]	low	0	cinnamamides; phenols; secondary carboxamide	allelochemical; antimicrobial agent; phytoalexin; platelet aggregation inhibitor
reumycin	[no description available]	low	0	carbonyl compound; pyrimidotriazine	antimicrobial agent; antineoplastic agent; bacterial metabolite
bialaphos	[no description available]	low	0	phosphinic acids; tripeptide	antimicrobial agent; bacterial metabolite
rifamycin sv	[no description available]	low	0	acetate ester; cyclic ketal; lactam; macrocycle; organic heterotetracyclic compound; polyphenol; rifamycins	antimicrobial agent; antitubercular agent; bacterial metabolite
mastoparan	[no description available]	low	0	mastoparans; peptidyl amide	antimicrobial agent
sulfacetamide sodium	[no description available]	low	0	hydrate; organic sodium salt	antiinfective agent; antimicrobial agent; EC 2.5.1.15 (dihydropteroate synthase) inhibitor
rifaximin	[no description available]	low	0	acetate ester; cyclic ketal; lactam; macrocycle; organic heterohexacyclic compound; rifamycins; semisynthetic derivative	antimicrobial agent; gastrointestinal drug; orphan drug
germacrone	[no description available]	low	0	germacrane sesquiterpenoid; olefinic compound	androgen antagonist; anti-inflammatory agent; antifeedant; antifungal agent; antimicrobial agent; antineoplastic agent; antioxidant; antitussive; antiviral agent; apoptosis inducer; autophagy inducer; hepatoprotective agent; insecticide; neuroprotective agent; plant metabolite; volatile oil component
piericidin a	[no description available]	low	0	aromatic ether; methylpyridines; monohydroxypyridine; secondary allylic alcohol	antimicrobial agent; bacterial metabolite; EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor; mitochondrial respiratory-chain inhibitor
manumycin	[no description available]	low	0	enamide; epoxide; organic heterobicyclic compound; polyketide; secondary carboxamide; tertiary alcohol	antiatherosclerotic agent; antimicrobial agent; antineoplastic agent; apoptosis inducer; bacterial metabolite; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.5.1.58 (protein farnesyltransferase) inhibitor; marine metabolite
thermozymocidin	[no description available]	low	0	alpha-amino fatty acid; hydroxy monocarboxylic acid; non-proteinogenic alpha-amino acid; sphingoid	antifungal agent; antimicrobial agent; antineoplastic agent; apoptosis inducer; EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor; fungal metabolite; immunosuppressive agent
demycarosylturimycin h	[no description available]	low	0	aldehyde; disaccharide derivative; ether; macrolide; tertiary amino compound	antibacterial drug; antimicrobial agent; bacterial metabolite
asukamycin	[no description available]	low	0	enamide; epoxide; organic heterobicyclic compound; polyketide; secondary carboxamide; tertiary alcohol	antibacterial agent; antifungal agent; antimicrobial agent; antineoplastic agent; bacterial metabolite
kalimantacin a	[no description available]	low	0	alpha,beta-unsaturated monocarboxylic acid; carbamate ester; fatty acid derivative; secondary carboxamide	antibacterial agent; antimicrobial agent; bacterial metabolite
cefluprenam	[no description available]	low	0	cephalosporin; thiadiazoles	antimicrobial agent
platensimycin	[no description available]	low	0	aromatic amide; cyclic ether; cyclic ketone; dihydroxybenzoic acid; monocarboxylic acid amide; polycyclic cage	antibacterial agent; antimicrobial agent; bacterial metabolite; EC 2.3.1.85 (fatty acid synthase) inhibitor
fumagillin	[no description available]	low	0	antibiotic antifungal drug; carboxylic ester; dicarboxylic acid monoester; meroterpenoid; organooxygen heterocyclic antibiotic; spiro-epoxide	angiogenesis inhibitor; antibacterial drug; antimicrobial agent; antiprotozoal drug; fungal metabolite; methionine aminopeptidase 2 inhibitor
gemifloxacin	[no description available]	low	0	1,8-naphthyridine derivative; fluoroquinolone antibiotic; monocarboxylic acid; quinolone antibiotic	antibacterial drug; antimicrobial agent; topoisomerase IV inhibitor
gemifloxacin mesylate	[no description available]	low	0	methanesulfonate salt	antimicrobial agent; topoisomerase IV inhibitor
avibactam	[no description available]	low	0	azabicycloalkane; hydroxylamine O-sulfonic acid; monocarboxylic acid amide; ureas	antibacterial drug; antimicrobial agent; EC 3.5.2.6 (beta-lactamase) inhibitor
ppi-0903	[no description available]	low	0	1,3-thiazoles; cephalosporin; iminium betaine; organic phosphoramidate; oxime O-ether; thiadiazoles	antibacterial drug; antimicrobial agent; prodrug
tmc-95a	[no description available]	low	0	indoles; lactam; macrocycle; phenols; secondary alcohol; tertiary alcohol	antimicrobial agent; antineoplastic agent; bacterial metabolite; fungal metabolite; proteasome inhibitor
topopyrone c	[no description available]	low	0	naphthochromene; p-quinones; phenols	antimicrobial agent; antineoplastic agent; antiviral agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; Penicillium metabolite
monacolin j	[no description available]	low	0	2-pyranones; carbobicyclic compound; hexahydronaphthalenes; polyketide; secondary alcohol	antimicrobial agent; EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor; fungal metabolite
nidulalin a	[no description available]	low	0	methyl ester; phenols; xanthones	antimicrobial agent; antineoplastic agent; Penicillium metabolite
elloramycin	[no description available]	low	0	alpha-L-rhamnoside; carboxylic ester; enol ether; enone; methyl ester; monosaccharide derivative; phenols; tertiary alpha-hydroxy ketone; tetracenomycin	antimicrobial agent; bacterial metabolite
tmc-95b	[no description available]	low	0	indoles; lactam; macrocycle; phenols; secondary alcohol; tertiary alcohol	antimicrobial agent; antineoplastic agent; fungal metabolite; proteasome inhibitor
fr 901464	[no description available]	low	0	acetate ester; cyclic hemiketal; monocarboxylic acid amide; pyrans; spiro-epoxide	antimicrobial agent; antineoplastic agent; bacterial metabolite
baci-im	[no description available]	low	0	homodetic cyclic peptide; polypeptide; zwitterion	antibacterial agent; antimicrobial agent
streptogramin b	[no description available]	low	0	cyclodepsipeptide	antibacterial drug; antimicrobial agent; bacterial metabolite
tedizolid	[no description available]	low	0	carbamate ester; organofluorine compound; oxazolidinone; primary alcohol; pyridines; tetrazoles	antimicrobial agent; drug metabolite; protein synthesis inhibitor
tedizolid phosphate	[no description available]	low	0	carbamate ester; organofluorine compound; oxazolidinone; phosphate monoester; pyridines; tetrazoles	antimicrobial agent; prodrug; protein synthesis inhibitor
32,33,34,35-bacteriohopanetetrol	[no description available]	low	0	hopanoid; tetrol	antimicrobial agent; bacterial metabolite; lipoxygenase inhibitor
chir 090	[no description available]	low	0	acetylenic compound; benzamides; hydroxamic acid; L-threonine derivative; morpholines	antimicrobial agent; EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor; lipopolysaccharide biosynthesis inhibitor
finafloxacin	[no description available]	low	0	cyclopropanes; monocarboxylic acid; nitrile; organofluorine compound; quinolone; secondary amino compound; tertiary amino compound	antibacterial drug; antimicrobial agent
physalin b	[no description available]	low	0	enone; lactone; organic heteroheptacyclic compound; physalin	antimalarial; antimicrobial agent; antineoplastic agent
anticapsin	[no description available]	low	0	alicyclic ketone; epoxide; L-alanine derivative; L-alpha-amino acid zwitterion; non-proteinogenic L-alpha-amino acid	antimetabolite; antimicrobial agent; bacterial metabolite; EC 2.6.1.16 (glutamine--fructose-6-phosphate transaminase (isomerizing)) inhibitor
oritavancin	[no description available]	low	0	disaccharide derivative; glycopeptide; semisynthetic derivative	antibacterial drug; antimicrobial agent
thiazomycin	[no description available]	low	0	heterodetic cyclic peptide	antibacterial agent; antimicrobial agent; bacterial metabolite
ristocetin	[no description available]	low	0	glycopeptide; heterodetic cyclic peptide; macrocycle; tetrasaccharide derivative	antibacterial drug; antimicrobial agent; bacterial metabolite; platelet-activating factor receptor agonist
platencin	[no description available]	low	0	aromatic amide; cyclic ketone; dihydroxybenzoic acid; monocarboxylic acid amide; polycyclic cage	antibacterial agent; antimicrobial agent; bacterial metabolite; EC 2.3.1.85 (fatty acid synthase) inhibitor
avilamycin a	[no description available]	low	0	benzoate ester; cyclic acetal; dichlorobenzene; oligosaccharide derivative; ortho ester; oxaspiro compound; phenols; tertiary alpha-hydroxy ketone	antimicrobial agent; bacterial metabolite
cathestatin b	[no description available]	low	0	dicarboxylic acid monoamide; epoxide; monocarboxylic acid; phenols; primary amino compound	antimicrobial agent; cysteine protease inhibitor; Penicillium metabolite
tazobactam sodium	[no description available]	low	0	organic sodium salt	antiinfective agent; antimicrobial agent; EC 3.5.2.6 (beta-lactamase) inhibitor
clavulanate potassium	[no description available]	low	0	potassium salt	antibacterial drug; antimicrobial agent; EC 3.5.2.6 (beta-lactamase) inhibitor
cefmetazole sodium	[no description available]	low	0	organic sodium salt	antimicrobial agent
borrelidin	[no description available]	low	0	aliphatic nitrile; diol; macrolide; monocarboxylic acid; secondary alcohol	antifungal agent; antimalarial; antimicrobial agent; antineoplastic agent; apoptosis inducer; bacterial metabolite
arenaemycin e	[no description available]	low	0	alpha,beta-unsaturated monocarboxylic acid; organic heterotricyclic compound; sesquiterpene lactone; spiro-epoxide	antimicrobial agent; bacterial metabolite; EC 1.2.1.12 [glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)] inhibitor
marinopyrrole a	[no description available]	low	0	aromatic ketone; organochlorine compound; phenols; pyrroles	antibacterial agent; antimicrobial agent; antineoplastic agent; bacterial metabolite; marine metabolite
nxl 104	[no description available]	low	0	organic sodium salt	antibacterial drug; antimicrobial agent; EC 3.5.2.6 (beta-lactamase) inhibitor
bacillaene	[no description available]	low	0	enamine; monocarboxylic acid amide; polyene antibiotic; polyketide; secondary alcohol	antibacterial agent; antimicrobial agent; bacterial metabolite
muraymycin d2	[no description available]	low	0	zwitterion	antimicrobial agent
roseoflavin	[no description available]	low	0	benzopteridine	antimicrobial agent; bacterial metabolite
coumermycin	[no description available]	low	0	aromatic amide; coumarins; glycoside; heteroarenecarboxylate ester; pyrroles	antimicrobial agent; antineoplastic agent; bacterial metabolite; DNA synthesis inhibitor; Hsp90 inhibitor; topoisomerase IV inhibitor
novobiocin	[no description available]	low	0	carbamate ester; ether; hexoside; hydroxycoumarin; monocarboxylic acid amide; monosaccharide derivative; phenols	antibacterial agent; antimicrobial agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Escherichia coli metabolite; hepatoprotective agent
ilicicolin h	[no description available]	low	0	aromatic ketone; carbobicyclic compound; ilicicolin; monohydroxypyridine; octahydronaphthalenes; phenols; pyridone	antimicrobial agent; mitochondrial respiratory-chain inhibitor
streptolydigin	[no description available]	low	0	bridged compound; cyclic ketal; enol; monocarboxylic acid amide; N-glycosyl compound; organic heterobicyclic compound; pyrrolidinone; spiro-epoxide	antimicrobial agent; bacterial metabolite; EC 2.7.7.6 (RNA polymerase) inhibitor
brasilicardin a	[no description available]	low	0	benzoate ester; carbotricyclic compound; diterpenoid; N-acetyl-D-glucosaminide; non-proteinogenic alpha-amino acid; phenols	antimicrobial agent; antineoplastic agent; bacterial metabolite; immunosuppressive agent
zorbamycin	[no description available]	low	0	glycopeptide	antimicrobial agent; bacterial metabolite
phleomycin d1	[no description available]	low	0	bi-1,3-thiazole; chelate-forming peptide; disaccharide derivative; glycopeptide; guanidines	antibacterial agent; antifungal agent; antimicrobial agent; antineoplastic agent; bacterial metabolite
duramycin	[no description available]	low	0	heterodetic cyclic peptide; macrocycle	antimicrobial agent; apoptosis inducer; bacterial metabolite
pyrazofurin	[no description available]	low	0	C-glycosyl compound; pyrazoles	antimetabolite; antimicrobial agent; antineoplastic agent; EC 4.1.1.23 (orotidine-5'-phosphate decarboxylase) inhibitor
indolmycin	[no description available]	low	0	1,3-oxazoles; indoles; secondary amino compound	antibacterial agent; antimicrobial agent; bacterial metabolite; EC 6.1.1.2 (tryptophan--tRNA ligase) inhibitor
streptothricin f	[no description available]	low	0	guanidinium ion; primary aliphatic ammonium ion	antimicrobial agent
nitrofurazone	[no description available]	low	0	nitrofuran antibiotic; semicarbazone	antibacterial drug
benzyl isothiocyanate	[no description available]	low	0	benzenes; isothiocyanate	antibacterial drug
cinoxacin	[no description available]	low	0	cinnolines; oxacycle; oxo carboxylic acid	antibacterial drug; antiinfective agent
furazolidone	[no description available]	low	0	nitrofuran antibiotic; oxazolidines	antibacterial drug; antiinfective agent; antitrichomonal drug; EC 1.4.3.4 (monoamine oxidase) inhibitor
methenamine	[no description available]	low	0	polyazaalkane; polycyclic cage; tetramine	antibacterial drug
nadifloxacin	[no description available]	low	0	heteroarylpiperidine; hydroxypiperidine; pyridoquinoline; quinolone antibiotic	antibacterial drug
norfloxacin	[no description available]	low	0	fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone	antibacterial drug; DNA synthesis inhibitor; environmental contaminant; xenobiotic
pipemidic acid	[no description available]	low	0	amino acid; monocarboxylic acid; N-arylpiperazine; pyridopyrimidine; quinolone antibiotic	antibacterial drug; DNA synthesis inhibitor
piromidic acid	[no description available]	low	0	monocarboxylic acid; pyridopyrimidine; pyrrolidines; quinolone antibiotic; tertiary amino compound	antibacterial drug; DNA synthesis inhibitor
roxarsone	[no description available]	low	0	2-nitrophenols; organoarsonic acid	agrochemical; animal growth promotant; antibacterial drug; coccidiostat
sulfabenzamide	[no description available]	low	0	benzenes; sulfonamide antibiotic; sulfonamide	antibacterial drug; antimicrobial drug
sulfaphenazole	[no description available]	low	0	primary amino compound; pyrazoles; substituted aniline; sulfonamide antibiotic; sulfonamide	antibacterial drug; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor; P450 inhibitor
thiram	[no description available]	low	0	organic disulfide	antibacterial drug; antifungal agrochemical; antiseptic drug
cloxacillin	[no description available]	low	0	penicillin allergen; penicillin; semisynthetic derivative	antibacterial agent; antibacterial drug
chlorquinaldol	[no description available]	low	0	monohydroxyquinoline; organochlorine compound	antibacterial drug; antiprotozoal drug; antiseptic drug
sulfachlorpyridazine	[no description available]	low	0	organochlorine compound; pyridazines; sulfonamide	antibacterial drug; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor
chlorphenesin	[no description available]	low	0	glycol; monochlorobenzenes; propane-1,2-diols	antibacterial drug; antifungal drug; muscle relaxant
sulfadoxine	[no description available]	low	0	pyrimidines; sulfonamide	antibacterial drug; antimalarial
cyclacillin	[no description available]	low	0	penicillin	antibacterial drug
ornidazole	[no description available]	low	0	C-nitro compound; imidazoles; organochlorine compound; secondary alcohol	antiamoebic agent; antibacterial drug; antiinfective agent; antiprotozoal drug; antitrichomonal drug; epitope
cefonicid	[no description available]	low	0	cephalosporin	antibacterial drug
cefotiam	[no description available]	low	0	beta-lactam antibiotic allergen; cephalosporin; semisynthetic derivative	antibacterial drug
cefaclor anhydrous	[no description available]	low	0	cephalosporin	antibacterial drug; drug allergen
difloxacin	[no description available]	low	0	fluoroquinolone antibiotic; monocarboxylic acid; monofluorobenzenes; N-alkylpiperazine; N-arylpiperazine; quinolone antibiotic; quinolone	antibacterial drug; Mycoplasma genitalium metabolite
ciprofloxacin hydrochloride anhydrous	[no description available]	low	0	hydrochloride	antibacterial drug; antiinfective agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor
flomoxef	[no description available]	low	0	N-acyl-amino acid; organonitrogen heterocyclic antibiotic; oxacephem	antibacterial drug
salicylhydroxamic acid	[no description available]	low	0	hydroxamic acid; phenols	antibacterial drug; EC 1.11.2.2 (myeloperoxidase) inhibitor; EC 3.5.1.5 (urease) inhibitor; trypanocidal drug
brodimoprim	[no description available]	low	0	aminopyrimidine; bromobenzenes; methoxybenzenes	antibacterial drug; antiinfective agent; EC 1.5.1.3 (dihydrofolate reductase) inhibitor
sulfaperine	[no description available]	low	0	pyrimidines; substituted aniline; sulfonamide antibiotic	antibacterial drug
cefaloram	[no description available]	low	0	cephalosporin	antibacterial drug
flurithromycin	[no description available]	low	0	cyclic ketone; erythromycin derivative; organofluorine compound; semisynthetic derivative	antibacterial drug
cefazedone	[no description available]	low	0	4-pyridones; carboxylic acid; cephalosporin; semisynthetic derivative; thiadiazoles	antibacterial drug
quinacillin	[no description available]	low	0	penicillin; quinoxaline derivative	antibacterial drug
moxifloxacin hydrochloride	[no description available]	low	0	hydrochloride	antibacterial drug
amdinocillin pivoxil	[no description available]	low	0	penicillanic acid ester; penicillin; pivaloyloxymethyl ester	antibacterial drug; antiinfective agent; prodrug
pefloxacin mesylate	[no description available]	low	0	methanesulfonate salt	antibacterial drug
garenoxacin	[no description available]	low	0	aromatic ether; cyclopropanes; isoindoles; organofluorine compound; quinolinemonocarboxylic acid; quinolone antibiotic	antibacterial drug; non-steroidal anti-inflammatory drug
a 195773	[no description available]	low	0	macrolide antibiotic; monosaccharide derivative; quinolines	antibacterial drug; protein synthesis inhibitor
rosoxacin	[no description available]	low	0	pyridines; quinolinemonocarboxylic acid; quinolone antibiotic	antibacterial drug; antiinfective agent
kanamycin sulfate	[no description available]	low	0	aminoglycoside sulfate salt	antibacterial drug; geroprotector
hetacillin	[no description available]	low	0	penicillin	antibacterial drug
roxithromycin	[no description available]	low	0	erythromycin derivative; macrolide; semisynthetic derivative	antibacterial drug
mupirocin	[no description available]	low	0	alpha,beta-unsaturated carboxylic ester; epoxide; monocarboxylic acid; oxanes; secondary alcohol; triol	antibacterial drug; bacterial metabolite; protein synthesis inhibitor
cefpiramide	[no description available]	low	0	carboxylic acid; cephalosporin	antibacterial drug
cefsulodin	[no description available]	low	0	cephalosporin; organosulfonic acid; primary carboxamide	antibacterial drug
tiamulin	[no description available]	low	0	carbotricyclic compound; carboxylic ester; cyclic ketone; organic sulfide; secondary alcohol; semisynthetic derivative; tertiary amino compound; tetracyclic diterpenoid	antibacterial drug
sulfathiourea	[no description available]	low	0	substituted aniline; sulfonamide antibiotic; thioureas	antibacterial drug; EC 2.5.1.15 (dihydropteroate synthase) inhibitor
7432 s	[no description available]	low	0	cephalosporin; dicarboxylic acid	antibacterial drug
tilmicosin	[no description available]	low	0	enone; macrolide antibiotic; monosaccharide derivative	antibacterial drug; calcium channel blocker; cardiotoxic agent
sirolimus	[no description available]	low	0	antibiotic antifungal drug; cyclic acetal; cyclic ketone; ether; macrolide lactam; organic heterotricyclic compound; secondary alcohol	antibacterial drug; anticoronaviral agent; antineoplastic agent; bacterial metabolite; geroprotector; immunosuppressive agent; mTOR inhibitor
virginiamycin factor s1	[no description available]	low	0	cyclodepsipeptide; macrolide antibiotic	antibacterial drug; bacterial metabolite
streptogramin a	[no description available]	low	0	1,3-oxazoles; cyclic ketone; enamide; lactam; macrolide antibiotic; macrolide; pyrroline; secondary alcohol; secondary carboxamide; tertiary carboxamide	antibacterial drug; Mycoplasma genitalium metabolite
cefpodoxime	[no description available]	low	0	carboxylic acid; cephalosporin	antibacterial drug
cefuzonam	[no description available]	low	0	cephalosporin	antibacterial drug
s 1006	[no description available]	low	0	1,3-thiazoles; carbamate ester; carboxylic acid; cephalosporin; enamide; secondary carboxamide	antibacterial drug
cefditoren pivoxil	[no description available]	low	0	1,3-thiazoles; cephams; oxime O-ether; pivaloyloxymethyl ester	antibacterial drug; prodrug
cefpodoxime proxetil	[no description available]	low	0	carboxylic acid; carboxylic ester; cephalosporin	antibacterial drug; prodrug
cefdinir	[no description available]	low	0	cephalosporin; ketoxime	antibacterial drug
cefmenoxime	[no description available]	low	0	cephalosporin	antibacterial drug
nifurtoinol	[no description available]	low	0	hydrazone; imidazolidine-2,4-dione; nitrofuran antibiotic; organonitrogen heterocyclic antibiotic	antibacterial drug; antiinfective agent; hepatotoxic agent
ru 29246	[no description available]	low	0	cephalosporin	antibacterial drug
cefditoren	[no description available]	low	0	carboxylic acid; cephalosporin	antibacterial drug
penamecillin	[no description available]	low	0	penicillanic acid ester; semisynthetic derivative	antibacterial drug; prodrug
l 749345	[no description available]	low	0	organic sodium salt	antibacterial drug
cefamandole nafate	[no description available]	low	0	organic sodium salt	antibacterial drug; prodrug
cefamandole nafate	[no description available]	low	0	organic sodium salt	antibacterial drug
cephapirin sodium	[no description available]	low	0	cephalosporin; organic sodium salt	antibacterial drug
gamithromycin	[no description available]	low	0	macrolide antibiotic; monosaccharide derivative	antibacterial drug; protein synthesis inhibitor
opt 80	[no description available]	low	0	carboxylic ester; glycoside; macrolide antibiotic; organochlorine compound; phenols	antibacterial drug; bacterial metabolite; EC 2.7.7.6 (RNA polymerase) inhibitor
cefiderocol	[no description available]	low	0	carboxylic acid; cephalosporin	antibacterial drug; siderophore
etimicin	[no description available]	low	0	amino cyclitol glycoside; aminoglycoside antibiotic	antibacterial agent
daunorubicin	[no description available]	low	0	aminoglycoside antibiotic; anthracycline; p-quinones; tetracenequinones	antineoplastic agent; bacterial metabolite
carubicin	[no description available]	low	0	aminoglycoside antibiotic; anthracycline antibiotic; p-quinones; tertiary alpha-hydroxy ketone; tetracenequinones	antineoplastic agent; apoptosis inducer
sibiromycin	[no description available]	low	0	aminoglycoside antibiotic; hemiaminal; phenols; pyrrolobenzodiazepine	antineoplastic agent; bacterial metabolite

Condition	Relationship Strength	Studies	Trials
Abnormalities, Drug-Induced	low	1	0
Abscess, Pulmonary	low	1	0
Abscesses, Pulmonary	low	1	0
Acute Disease	low	1	0
Adnexitis	low	1	0
Allergy, Drug	low	1	0
Anaphylactic Reaction	low	1	0
Anaphylactoid Reaction	low	1	0
Anaphylactoid Shock	low	1	0
Anaphylaxis	low	1	0
Bacterial Disease	medium	3	1
Bacterial Infection	medium	3	1
Benign Neoplasms	low	1	0
Birth Weight	low	1	0
Blood Pressure, High	low	1	0
Body Weight	low	1	0
Bronchiectasis	low	1	0
Bronchitis	low	1	0
Cancer	low	1	0
Cerebral Nocardiosis	low	1	0
Chronic Disease	low	1	0
Chronic Illness	low	1	0
Chronically Ill	low	1	0
Dermatitis Exfoliativa	low	1	0
Dermatitis Exfoliative	low	1	0
Dermatitis Exfoliative Generalised	low	1	0
Dermatitis Exfoliative Generalized	low	1	0
Dermatitis Medicamentosa	low	1	0
Dermatitis, Adverse Drug Reaction	low	1	0
Dermatitis, Exfoliative	low	1	0
Diarrhea	low	1	0
Disease Models, Animal	low	1	0
Drug Allergy	low	1	0
Drug Eruptions	low	1	0
Drug Hypersensitivity	low	1	0
Drug-Induced Abnormalities	low	1	0
Erythroderma	low	1	0
Experimental Lung Inflammation	low	1	0
Gonorrhea	low	1	0
Group A Strep Infection	low	1	0
Group A Streptococcal Infection	low	1	0
Group A Streptococcal Infections	low	1	0
Group B Strep Infection	low	1	0
Group B Streptococcal Infection	low	1	0
Group B Streptococcal Infections	low	1	0
Hypersensitivity, Drug	low	1	0
Hypertension	low	1	0
Infection, Bacterial	medium	3	1
Infection, Postoperative Wound	low	1	0
Infection, Surgical Wound	low	1	0
Infections, Bacterial	medium	3	1
Infections, Mycobacterium	low	1	0
Infections, Nocardia	low	1	0
Infections, Pseudomonas	low	1	0
Infections, Respiratory	medium	3	1
Infections, Respiratory Tract	medium	3	1
Infections, Staphylococcal	low	1	0
Infections, Streptococcal	low	1	0
Infections, Upper Respiratory	medium	3	1
Infections, Upper Respiratory Tract	medium	3	1
Infectious Skin Diseases	low	1	0
Inflammatory Disease, Pelvic	low	1	0
Inflammatory Pelvic Disease	low	1	0
Kidney Diseases	low	2	0
Lobar Pneumonia	low	1	0
Lung Abscess	low	1	0
Lung Inflammation	low	1	0
Maculopapular Drug Eruption	low	1	0
Maculopapular Exanthem	low	1	0
Malignancy	low	1	0
Malignant Neoplasms	low	1	0
Mastitis, Bovine	low	1	0
Morbilliform Drug Reaction	low	1	0
Morbilliform Exanthem	low	1	0
Muscle Contraction	low	3	0
Mycobacterium Infections	low	1	0
Necrotizing Pyelonephritis	low	1	0
Neisseria gonorrhoeae Infection	low	1	0
Neoplasia	low	1	0
Neoplasm	low	1	0
Neoplasms	low	1	0
Neoplasms, Benign	low	1	0
Nocardia asteroides Infection	low	1	0
Nocardia Infections	low	1	0
Nocardiosis	low	1	0
Pelvic Disease, Inflammatory	low	1	0
Pelvic Inflammatory Disease	low	1	0
Pneumonia	low	1	0
Pneumonia, Lobar	low	1	0
Pneumonitis	low	1	0
Polyuria	low	1	0
Postoperative Wound Infection	low	1	0
Pregnancy	low	1	0
Primary Cutaneous Nocardiosis	low	1	0
Proteinuria	low	1	0
Pseudomonas aeruginosa Infection	low	1	0
Pseudomonas Infections	low	1	0
Pulmonary Abscess	low	1	0
Pulmonary Abscesses	low	1	0
Pulmonary Consumption	low	1	0
Pulmonary Inflammation	low	1	0
Pulmonary Nocardiosis	low	1	0
Pulmonary Phthisis	low	1	0
Pulmonary Tuberculoses	low	1	0
Pulmonary Tuberculosis	low	1	0
Pyelonephritis	low	1	0
Pyelonephritis, Acute Necrotizing	low	1	0
Recrudescence	low	1	0
Recurrence	low	1	0
Relapse	low	1	0
Respiratory Infections	medium	3	1
Respiratory Tract Infections	medium	3	1
Shock, Anaphylactic	low	1	0
Skin Diseases, Infectious	low	1	0
Staphylococcal Infections	low	1	0
Staphylococcus aureus Infection	low	1	0
Streptococcal Infections	low	1	0
Surgical Site Infection	low	1	0
Surgical Wound Infection	low	1	0
Tuberculoses, Pulmonary	low	1	0
Tuberculosis, Pulmonary	low	1	0
Tumors	low	1	0
Upper Respiratory Infections	medium	3	1
Upper Respiratory Tract Infection	medium	3	1
Upper Respiratory Tract Infections	medium	3	1
Urinary Tract Infections	low	2	0
Wound Infection, Postoperative	low	1	0
Wound Infection, Surgical	low	1	0

Article	Year
Cochlear cytoarchitecture and ribostamycin ototoxicity. International journal of tissue reactions, Volume: 4, Issue: 1	1982
Ototoxic effects of a pseudodisaccharide aminoglycoside antibiotic, dactimicin, on the inner ears of guinea pigs. Chemotherapy, Volume: 35, Issue: 6	1989
Comparative nephrotoxicity of ribostamycin and gentamicin in rats evaluated by urinalysis. Drugs under experimental and clinical research, Volume: 15, Issue: 6-7	1989
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, Volume: 36, Issue: 7	2008
Pharmacokinetics of ribostamycin in healthy volunteers and patients with impaired renal function. The Japanese journal of antibiotics, Volume: 33, Issue: 12	1980
[Influence of carbenicillin on pharmacokinetics of ribostamycin in 7 volunteers when they were used combinedly]. Zhongguo yao li xue bao = Acta pharmacologica Sinica, Volume: 12, Issue: 3	1991
Pharmacokinetics of ribostamycin in paediatric patients. Clinical pharmacokinetics, Volume: 22, Issue: 2	1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Pharmacokinetics of ribostamycin in paediatric patients. Clinical pharmacokinetics, Volume: 22, Issue: 2	1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
[Animal studies on ribostamycin (author's transl)]. Immunitat und Infektion, Volume: 9, Issue: 2	1981
Analysis of the phamacokinetics of ribostamycin in serum and perilymph of guinea pigs after single and multiple doses. British journal of audiology, Volume: 16, Issue: 2	1982
Comparative antimicrobial activities of ribostamycin, gentamicin, ampicillin and lincomycin in vitro and in vivo. Drugs under experimental and clinical research, Volume: 15, Issue: 10	1989
Comparative nephrotoxicity of ribostamycin and gentamicin in rats evaluated by urinalysis. Drugs under experimental and clinical research, Volume: 15, Issue: 6-7	1989
Pharmacokinetics of ribostamycin in paediatric patients. Clinical pharmacokinetics, Volume: 22, Issue: 2	1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

ribostamycin

Description

Cross-References

Synonyms (56)

Research Excerpts

Overview

Roles (3)

Drug Classes (2)

Protein Targets (1)

Other Measurements

Bioassays (53)

Research

Studies (110)

Study Types

Research Highlights

Safety/Toxicity (3)

Pharmacokinetics (4)

Bioavailability (1)

Dosage (5)